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Abstract 
The intestinal immune system plays an essential role in maintaining the delicate balance 
between mounting protective responses against invading pathogens and sustaining 
tolerance towards self-antigens and the endogenous microbiota. Disturbing this balance 
leads to intestinal inflammation, such as is seen in inflammatory bowel disease (IBD). IBD 
is characterised by alterations in the mucosa-associated microbiota, such as the increase in 
adherent and invasive Escherichia coli (AIEC) species in Crohn’s disease (CD) patients. 
Concomitantly, the inflamed mucosa exhibits an elevated rate of apoptosis in IBD, a 
phenomenon that also accompanies infection with a range of enteric bacterial pathogens. 
While phagocytosis of apoptotic cells by dendritic cells (DC) is required for self-tolerance 
in the healthy intestine, there is evidence to suggest that apoptotic cell uptake during 
infection activates protective T cell responses. 
In order to investigate the link between the recognition of apoptotic cells and intestinal 
inflammation, we used a range of different in vivo enteric bacterial infection models. 
Previously published work had implicated the AIEC strain NRG857c in the induction of 
chronic intestinal inflammation in vivo. We did not, however, find that NRG857c caused 
any signs of chronic colitis in mice, either by histological examination, or in-depth analysis 
of both innate and adaptive immune responses in the lamina propria and mesenteric 
lymph nodes (MLN). 
Due to the important role of DC in acquiring apoptotic cell antigen and priming protective 
T cell responses, we next characterised the expression of apoptotic cell receptors, 
specifically TIM4, on DC populations in steady state mucosal tissues. We demonstrated 
that TIM4 expression was enriched on CD11b- CD103+ DC, which have previously been 
shown to cross-present apoptotic cell-derived antigen. However, upon migration in 
mesenteric lymph, all intestinal DC populations upregulated TIM4, and migratory CD11b+ 
CD103+ had the highest frequency of TIM4+ cells in the MLN. However, blocking TIM4 
did not affect DC migration in vivo. We also found that infection with C. rodentium 
elevated the percentage of TIM4+ DC in a population-specific manner, but that TIM4 was 
not essential for the induction of protective T cell responses during infection with either 
C. rodentium or S. Typhimurium. We therefore provide a detailed analysis of the intestinal 
immune response to bacterial infection, focussing specifically on the role of the apoptotic 
cell receptor TIM4 on intestinal DC populations.
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Chapter 1: General Introduction 
1.1 The cells and anatomy of the intestinal immune system 
Nourishment and defence are two of the body’s fundamental functions sustained by the 
gastrointestinal (GI) tract, which facilitates nutrient and water absorption, and contains the 
largest proportion of the body’s immune cells. Both the anatomical and cellular structure of 
the intestine ensures these functions are maintained and can adapt to outside changes and 
challenges. 
1.1.2 Anatomy and physiology of the gastrointestinal tract 
The GI tract reaches from the stomach, involved in the mechanical and chemical 
breakdown of food, to the large intestine and rectum, where indigestible foodstuffs are 
passed out of the system. Along the tract, the structure and function of the intestine 
changes. The small intestine begins at the pyloric sphincter and is divided into three 
segments; the duodenum, which is the most proximal, followed by the jejunum, and finally 
the ileum, which connects the small intestine with the colon at the ileocaecal valve. The 
presence of villi, finger-like protrusions into the lumen of the small intestine, significantly 
increases its surface area and provides an essential requirement for its central function – 
the absorption of nutrients. Connecting the small intestine with the colon is the caecum, 
which varies in size depending on the organism. Herbivores such as rabbits and mice have 
a relatively large caecum with a high microbial burden that allows breakdown of cellulose. 
The human caecum, on the other hand, is much smaller, reflecting a more varied diet. 
Lastly, the colon allows reabsorption of water and the digestion of dietary fibre by 
commensal bacteria. 
The intestinal epithelium and lamina propria 
The regional specialisation of the distinct compartments within the GI tract is reflected by 
differences in their tissue structure and cellular composition (Mowat and Agace 2014). On 
the luminal side, the GI tract is lined by a single cell layer of columnar epithelium. This is 
made up of a variety of different cell types with specialised functions, all of which arise 
from stem cell precursors situated in the intestinal crypts. Cells are constantly renewed and 
undergo differentiation as they move as on an “escalator” upwards away from the crypt, 
before finally being shed at the tip of the villus or intestinal fold into the lumen (Creamer et 
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al. 1961a, Creamer et al. 1961b, Clarke 1970, Cliffe et al. 2005). In the small intestine, 
enterocytes facilitate the digestion and uptake of food components through the expression 
of enzymes and nutrient transporters. Furthermore, the presence of microvilli, forming an 
apical “brush border”, further increases the surface area to ensure maximum absorptive 
capacity. Microvilli are not present on colonic enterocytes, which allow active reabsorption 
of water across the membrane. 
In the small intestine, specifically the ileum, Paneth cells are located at the base of the crypt. 
These have important functions in maintaining crypt stem cell survival (Sato et al. 2011), as 
well as in the production of anti-microbial peptides (Eisenhauer et al. 1992, Salzman et al. 
2010). Paneth cells are not present, however, in the healthy colon. Conversely, the 
concentration of goblet cells in the epithelium is greater in the colon than the small 
intestine. These are mucus-secreting cells that allow formation of a protective mucus layer, 
or “glycocalyx”, separating the epithelium from the luminal contents. In the small intestine 
a single thin mucus layer is formed, whilst the glycocalyx is comprised of two layers in the 
colon, where it serves to prevent commensals from accessing the epithelium (Johansson et 
al. 2008). A third population of intestinal epithelial cells (IEC) are tuft cells, the function of 
which has only recently begun to be uncovered. They are a minor secretory cell population 
in the epithelium of both the small intestine and colon (Sato 2007) and have an important 
role in initiating Th2 responses to intestinal helminth infections (Gerbe et al. 2016). They 
expand rapidly upon infection with the helminth Nippostrongylus brasiliensis, and secrete 
IL-25, which stimulates the production of IL-4 and IL-13 by Type 2 innate lymphoid cells 
(ILC2) (Moro et al. 2010, Neill et al. 2010, Gerbe et al. 2016, Moltke et al. 2016).  
Underneath the epithelium is the lamina propria (LP), separated from the former only by a 
basement membrane. This tissue provides structural support to villi and crypts and 
contains the extensive blood supply to and from the tissue, which underpins both nutrient 
transport and leukocyte recruitment. In addition to blood vessels, lymphatic vessels 
mediate efficient transport of nutrients to the blood, and antigens to secondary lymphoid 
organs. The LP is filled with leukocytes that maintain a delicate balance between tolerance 
and defence. The composition of leukocytes found in the LP differs between intestinal 
compartments (Mowat and Agace 2014), allowing further functional specialisation and 
adequate responses to be mounted against tissue-specific challenges. 
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Lymphoid tissues associated with the intestines 
As well as in the LP itself, immune interactions also take place within tertiary lymphoid 
structures that make up the gut-associated lymphoid tissue (GALT). Among these, 
macroscopically visible structures are present in the small intestine and the caecum, in the 
form of Peyer’s patches (PP) and the caecal patch, respectively, and smaller colonic patches 
in the colon and rectum. These organised lymphoid structures are characterised by B cell 
follicles containing germinal centres, flanked by T cell areas. On the luminal side, they are 
covered by a follicle-associated epithelium, containing microfold cells (M cells), which 
allow antigen uptake and transfer to underlying antigen-presenting cells (Mabbott et al. 
2013). As well as being a site of T cell priming (Smith et al. 2002), an important function of 
organised lymphoid structures in the intestine is the production of secretory IgA in 
response to the commensal microbiota (Masahata et al. 2014). Small isolated lymphoid 
tissues (SILT) are only visible under microscopic examination and are present in both the 
small intestine and colon. These vary in size with age (Pabst et al. 2005) and include 
cryptopatches and the larger isolated lymphoid follicles (ILF), which may represent a 
continuum of maturation states (Mowat and Agace 2014). ILF contain B cell zones and 
germinal centres and have been implicated in the production of IgA. However, contrary to 
PP, this is T cell independent (Tsuji et al. 2008). Formation of ILF and their maturation is 
dependent on the microbiota and Toll-like receptor (TLR) signalling (Bouskra et al. 2008). 
Furthermore, development of both SILT and the larger GALT such as PP requires 
lymphotoxin B signalling (Futterer et al. 1998, Pabst et al. 2005) and RORγt+ Type 3 ILC 
(ILC3) (Eberl and Littman 2004).  
In the intestine, the main site of antigen presentation and T cell priming are the lymph 
nodes (LN) that drain the GI tract. Studies in both rats and mice have shown that the tissue 
compartments of the intestine are drained by distinct LN (Tilney 1971, Carter and Collins 
1974, Houston et al. 2016). The principal LN that drain the intestines are found in the 
mesentery, hence their designation as mesenteric lymph nodes (MLN). These are arranged 
in a chain, with the proximal and middle nodes draining the jejunum and ileum (hereafter 
termed small intestine-draining MLN, or sMLN) (Carter and Collins 1974, Houston et al. 
2016), whilst the colon is drained by the most distal LN in the chain and a smaller LN 
associated with the connective tissue below the MLN chain (hereafter colon-draining 
MLN, or cMLN) (Houston et al. 2016). Furthermore, lymph flow from the distal colon and 
rectum is directed to the caudal LN, located below the bifurcating aorta (Tilney 1971, 
1. General Introduction 
 
24 
Carter and Collins 1974, Veenbergen et al. 2015). This compartmentalisation of lymphatic 
drainage has important implications for the tissue-specific nature of immune responses 
initiated (Houston et al. 2016), thus further maintaining and regulating the differential 
functions of intestinal tissues. 
1.1.2 Innate immunity in the intestine 
In the intestine, innate immune cells both maintain tissue homeostasis and serve as a front-
line defence to invading pathogens. Mononuclear phagocytes (MNP) constitute an 
important arm of innate immunity in the intestine. Macrophages and dendritic cells (DC) 
are the main MNP found in the intestinal LP. They are phagocytic cells capable of sensing 
pathogen-associated molecular patterns (PAMPs) and presenting antigen to T cells via 
MHC class II (MHCII) molecules. Due to these similarities, studies in the past have often 
failed to correctly distinguish macrophages and DC from one another. More in depth study 
of their phenotype, function and development, however, has highlighted that these distinct 
cell types indeed possess unique roles in regulating immunity (Cerovic, Bain, et al. 2014).  
Macrophages 
Intestinal macrophages constitutively produce large amounts of interleukin 10 (IL-10) 
(Denning et al. 2007, Takada et al. 2010), which is required for the maintenance of 
tolerance in the LP, partly through IL-10 signalling in macrophages themselves (Murai et 
al. 2009, Shouval et al. 2014). Furthermore, expression of inhibitory receptors such as 
CD200R (Snelgrove et al. 2008) further underpins their tolerogenic role in the intestine. 
Macrophages in most tissues of the body have been shown to be of embryonic origin 
(Gomez Perdiguero et al. 2015), and to undergo self-renewing proliferation in situ 
(Hashimoto et al. 2013, Yona et al. 2013). However, this is not the case in the intestine. 
Instead, colonic LP macrophages are constantly replenished from incoming blood 
monocytes, which lose expression of Ly6C during differentiation and concomitantly 
upregulate MHC II (Bain et al. 2014). This process is primarily driven by the microbiota 
(Bain et al. 2014). Mature intestinal macrophages are characterised by expression of CD64 
(FcγR1) (Tamoutounour et al. 2012), F4/80 and CD11b, as well as high levels of the 
fractalkine receptor CX3CR1 (Bain et al. 2013, 2014). Macrophages are tissue resident cells 
that do not migrate in lymph (Yrlid et al. 2006b, Cerovic et al. 2013), and are therefore not 
primary inducers of an adaptive immune response (Figure 1. 1). They can, however, 
mediate the secondary activation of antigen-specific T cells in the LP (Rossini et al. 2014) 
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(Figure 1. 1) and have been shown to be important for the expansion of intestinal 
regulatory T cells (Treg) (Denning et al. 2007, Hadis et al. 2011).
         
Figure 1. 1: Comparing intestinal macrophages and DC  
Both macrophages and DC in the LP express MHCII and CD11c. However, they can be differentiated based 
on the expression of CD64, which is macrophage-specific. Several other factors that differentially characterise 
macrophages and DC are listed, including migratory capacity, their impact on adaptive immunity, and their 
development in the intestine from pre-cursors.
Dendritic cells 
Together with MHCII and CD11c, specific conventional DC populations share expression 
of CD11b and CX3CR1 with intestinal macrophages. This phenotype similarity has led to 
much of the confusion surrounding the accurate differentiation between these two cell 
types. Intestinal conventional DC, on the other hand, do not express CD64 or F4/80 
(Tamoutounour et al. 2012, Cerovic et al. 2013) (Figure 1. 1). They are developmentally 
distinct from macrophages, as they are not monocyte-derived, but differentiate from pre-
DC that leave the bone marrow and enter the tissue via the blood (Liu et al. 2009). DC 
sample antigen in the LP and subsequently migrate to the draining LN, where they are 
responsible for the initial priming of T cell responses (Figure 1. 1). Conventional DC 
(hereafter referred to simply as “DC”) must be further differentiated from plasmacytoid 
DC (pDC), which in mice are characterised by the expression of B220, and have important 
functions in anti-viral responses via the production of Type I interferons (Kato et al. 2005). 
Mainly present in the small intestinal LP (Wendland et al. 2007, Mowat and Agace 2014), 
pDC do not migrate in mesenteric lymph (Yrlid et al. 2006b). However, they may have an 
important role in activating intestinal DC by the production of interferon-α (IFNα) after 
TLR stimulation (Yrlid et al. 2006c). 
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Polymorphonuclear leukocytes 
A second group of innate immune cells in the intestinal LP are polymorphonuclear 
leukocytes. These include neutrophils and eosinophils, both characterised by the ability to 
release cytotoxic mediators by degranulation, and have important functions during 
inflammation. Neutrophils are highly phagocytic cells that possess potent anti-microbial 
machinery for the killing of internalised bacteria. They are not frequently found in the 
healthy intestinal LP, and their presence is therefore used as a diagnostic indicator of 
infection and inflammation. Eosinophils, on the other hand, are abundant in the LP at 
steady state. Their number is especially high in the small intestine, and decreases along the 
GI tract (Chu, Jimenez-Saiz, et al. 2014). Lack of eosinophils in vivo results in defective IgA 
secretion, possibly due to defective class-switching in PP (Chu, Beller, et al. 2014). 
Interestingly, their numbers are not reduced in germ-free (GF) mice (Mishra et al. 1999), 
indicating that their recruitment and function in the steady state LP is independent of the 
microbiota.  
Innate lymphoid cells 
The importance of ILC in controlling tissue homeostasis at mucosal sites is becoming 
increasingly clear. ILC do not express the T cell receptor (TCR), but develop from common 
lymphoid progenitors in the bone marrow (Serafini et al. 2015). Their differentiation is 
dependent on IL-7 and the transcription factors ID2 and NFIL3 (Serafini et al. 2015, Lim et 
al. 2017). ILC can be classified into three main subsets, based on their differential 
expression of the transcription factors Tbet (ILC1), GATA3 (ILC2) and RORγt (ILC3). 
These subsets have different effector functions, which are linked to the expression of 
cytokines mirroring CD4+ T helper cell responses (see below), such as IFNγ (ILC1), IL-4 
and IL-33 (ILC2), as well as IL-17 and IL-22 (ILC3) (Serafini et al. 2015). The production 
of cytokines by ILC is an important factor in the coordination of early responses against 
bacterial and helminth pathogens in the intestine (Hoyler et al. 2012, Qiu et al. 2012, Gerbe 
et al. 2016).  
1.1.3 Adaptive immunity: lymphocyte subsets in the intestine 
The induction of intestinal adaptive immune responses is mediated in both the MLN and 
the GALT. Both humoral immunity, based on the production of antibody by B cells, as well 
as cell-mediated immune responses carried out by effector T cells, have important roles in 
maintaining intestinal homeostasis in the steady state and during inflammation. 
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B cells 
B cells located in the MLN and the GALT engage in cognate antigen-binding via the B cell 
receptor, which triggers B cell proliferation and antigen presentation on MHCII molecules, 
for recognition by CD4+ T cells. This interaction between B cells and T helper cells is 
required for the formation of a germinal centre (Qi et al. 2008), where antibody class-
switching occurs and B cells differentiate into mature plasmablasts. These then migrate 
into the LP and produce antibody. As previously mentioned, the production of IgA in the 
intestine constitutes an important defence mechanism that is dependent on the presence of 
the microbiota (Talham et al. 1999, Kunisawa et al. 2013). Its protective roles include 
limiting the translocation of bacteria into the LP (Macpherson and Uhr 2004), as well as 
shaping microbiota composition (Fagarasan et al. 2002). 
CD4+ T helper cell subsets 
CD4+ T cell responses in the LP are required to coordinate immune interactions and 
maintain intestinal homeostasis, by the release of pro-inflammatory or regulatory 
cytokines. CD4+ T cells are primed by DC in the MLN and subsequently home back to the 
intestine to carry out effector functions. In general, it is thought that this initial priming 
step is required for skewing CD4+ T cell differentiation into one of four main subsets 
(Figure 1. 2), depending on the signals received from the DC in the form of cytokines or 
other mediators. Expression of subset-specific master transcription factors drives the 
differentiation of CD4+ T cells and their commitment to a certain phenotype and function.
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Figure 1. 2: Differentiation and function of LP CD4+ subsets 
Different signals in the form of specific cytokines and metabolites are required to drive development of CD4+ 
T cell subsets. These display unique effector functions, which are governed by the expression of master 
transcription factors. The frequency of distinct CD4+ T cell subsets in the LP differs between the healthy state 
and infection, with certain pathogens preferentially eliciting the differentiation of one or more effector T cell 
subsets.
The Th1 lineage of CD4+ T cells is induced by IL-12 signalling (Figure 1. 2) (Macatonia et 
al. 1995). Expression of the transcription factor Tbet is central to their ability to produce 
IFNγ, the hallmark feature of these cells (Szabo et al. 2000). Th1 cells are present in the 
steady state LP throughout the GI tract (Mowat and Agace 2014), but are also readily 
induced during viral and bacterial infection. In the healthy intestine, IFNγ coordinates cell 
proliferation and turnover of IEC (Nava et al. 2010). However, it is also a vital mediator in 
the response against pathogens. IFNγ is required for the expansion of CD4+ and CD8+ 
T cells during infection with S. Typhimurium and successful clearance of the pathogen 
(Bao et al. 2000). This is likely due to the induction of IL-12 by IFNγ signalling in MNP 
(Snijders et al. 1998, Monteleone et al. 1999). IFNγ is also important for the killing of 
intracellular pathogens phagocytosed by macrophages, as it increases the capacity of these 
cells to undergo oxidative burst (MacMicking 2012) and initiates transcription of GTPases 
that are involved in the assembly of intracellular defence machinery such as 
inflammasomes (Kim et al. 2012).  
The transcription factor GATA3 marks Th2 cells, which are rare in the healthy LP, but 
form an essential part of the defence against intestinal helminths through the production of 
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Th2-associated cytokines IL-4, IL-5 and IL-13 (Figure 1. 2). Signalling through the IL-4 
receptor is vital to the coordination of humoral immunity to helminths, as it induces class 
switching to IgE in B cells (Yoshida et al. 1990). It also stimulates the production of anti-
helminthic mediators such as Arginase-1 and RELMα by macrophages (Nair et al. 2005). 
Apart from Th1 cells, a further CD4+ effector T cell type important in the response against 
invading bacteria is the Th17 cell. Enteric pathogens such as Citrobacter rodentium 
(C. rodentium) induce a robust Th17 response (Symonds et al. 2009), which is 
characterised by the production of IL-17 by CD4+ T cells that express the transcription 
factor RORγt (Figure 1. 2). Th17 cells are also important mediators of anti-fungal defences 
(Saijo et al. 2010). IL-17 promotes the haematopoiesis and recruitment of neutrophils into 
the infected tissue via the upregulation of granulocyte colony stimulating factor (G-CSF) 
(Ye et al. 2001) and of chemokines on endothelial cells (Griffin et al. 2012). Th17 cells also 
produce IL-22, which acts on the intestinal epithelium to maintain barrier integrity and 
production of antimicrobial peptides (Sonnenberg et al. 2011). IL-22 is vital for efficient 
clearance of bacteria, as C. rodentium-infected mice deficient in IL-22 signalling succumb 
to infection (Zheng et al. 2008). However, these functions are also important in 
maintaining epithelial homeostasis in the healthy intestine, and it is therefore not 
surprising that Th17 cells are present in the LP at steady state (Denning et al. 2011). Several 
cytokines have been implicated in the induction and maintenance of Th17 cells. The 
combined effects of TGFβ and IL-6 signalling on naïve T cells instructs their differentiation 
towards a Th17 phenotype (Bettelli et al. 2006, Veldhoen et al. 2006). Furthermore, in the 
absence of TGFβ, IL-6 and IL-1β can synergistically induce Th17 cell differentiation 
(Ghoreschi et al. 2010). IL-23, on the other hand, whilst not vital for induction, is required 
for Th17 maintenance in the tissue (Veldhoen et al. 2006, Stritesky et al. 2008, McGeachy 
et al. 2009). Th17 induction in the intestine is dependent on the microbiota, specifically the 
presence of segmented filamentous bacteria (SFB) in mice (Ivanov et al. 2009, Lécuyer et al. 
2014), and microbial adherence to the epithelium has been shown to be a vital underlying 
factor for this (Atarashi et al. 2015). The frequency of Th17 cells is highest in the small 
intestine and decreases along the GI tract in mice (Denning et al. 2011), which is likely to 
be linked to the small intestinal colonisation of SFB. 
In contrast to these effector CD4+ T helper cell subsets that have been implicated in the 
clearance of different types of pathogens, FoxP3+ Treg cells support the maintenance of 
tolerance in the face of dietary antigens and the commensal microbiota. Their regulatory 
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function is mediated to a large extent by the production of IL-10 and TGFβ (Figure 1. 2) 
(Bollrath and Powrie 2013). Two main types of Treg cells with different origins have been 
identified; natural Treg (nTreg) cells are induced in the thymus after recognition of self 
peptides (Fontenot et al. 2003), while induced Treg (iTreg) cells differentiate in the 
periphery (Liang et al. 2005) via TGFβ signalling (Chen et al. 2003). In the MLN, Treg cell 
induction has also been linked to the production of retinoic acid (RA) by DC (Coombes et 
al. 2007). The frequency of LP Treg cells is higher in the colon than the small intestine at 
steady state (Denning et al. 2011), in contrast to the pattern identified for Th17 cells. 
However, evidence suggests this is also linked to the microbiota, specifically to the presence 
of Clostridia species in the colon (Atarashi et al. 2011).  
CD8+ T cells 
Also present in the intestinal LP are CD8+ T cells, which have a tissue resident phenotype, 
thus ensuring the mounting of fast and efficient responses upon activation (Sheridan et al. 
2014). They produce granzyme B (Masopust et al. 2006), a potent cytotoxic mediator, and 
constitute an important defence mechanism during viral and bacterial infections (Rose et 
al. 1998, Bergsbaken and Bevan 2015). These LP resident CD8+ T cells are distinct from 
CD8+ intraepithelial lymphocytes (IEL). The latter express CD103, which is upregulated in 
a TGFβ-dependent manner (Sheridan et al. 2014), and act as sentinels guarding the 
epithelial barrier. IEL frequency is highest in the small intestine, and these decrease to low 
numbers in the colonic epithelium (Camerini et al. 1993). Furthermore, CD8+ IEL can 
express either the αβTCR, or the γδTCR, with the latter being mainly present in the small 
intestine (Camerini et al. 1993). Infection with Listeria monocytogenes (L. monocytogenes) 
induces a rapid increase in CD8+ IEL numbers (Sheridan et al. 2014), highlighting their 
protective role in anti-microbial immune responses. 
1.1.4 Control of T cell homing to the intestine 
Intestinal T cell responses are initiated in the MLN, after which activated T cells recirculate 
in the bloodstream and enter the LP via high endothelial venule (HEV)-like structures. In 
the small intestine, this homing process is mediated by the induction of CCR9 and the 
α4β7 integrin on T cells during priming in the MLN. Induction of both is dependent on 
the production of RA by DC (Iwata et al. 2004, Jaensson et al. 2008), which is metabolised 
from dietary Vitamin A by the retinaldehyde dehydrogenase family of enzymes, specifically 
RALDH2 (Iwata et al. 2004). The integrin α4β7 interacts with mucosal addressin cell 
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adhesion molecule-1 (MAdCAM-1) found on the vascular endothelium of venules in the 
small intestinal LP (Hamann et al. 1994). Furthermore, α4β7 also directs lymphocyte 
homing to PP (Berlin et al. 1993, Farstad et al. 1997). Integrin α4β7 expression on CD8+ 
memory T cells is required for their ability to effectively combat rotavirus infection in vivo 
(Rose et al. 1998), indicating that as well as controlling homeostatic homing to the small 
intestine, it is also required under inflammatory conditions. In fact, this has successfully 
been targeted therapeutically in Crohn’s disease, where treatment with vedolizumab, a 
monoclonal antibody against α4β7, increased the rate of clinical remission (Sandborn et al. 
2013). 
Expression of CCL25, the cognate ligand for CCR9, is limited to the small intestinal 
epithelium under homeostatic conditions (Svensson et al. 2002), and decreases in 
expression from the duodenum to the ileum (Stenstad et al. 2007). Deficiency in CCR9 in 
vivo decreases the accumulation of effector CD4+ T cells in the small intestinal LP (Stenstad 
et al. 2006), and is also required for the recruitment of CD8+ IEL to the epithelium 
(Stenstad et al. 2007). Interestingly, there is some evidence to suggest that, while not 
involved in T cell migration to the healthy colon, CCR9/CCL25 interactions may play a 
regulatory role during colitis (Wurbel et al. 2011). CCL25 expression increases in the 
colonic epithelium after recovery from dextran sodium sulphate (DSS)-induced colitis in 
mice, and Ccr9-/- mice exhibit decreased survival in this model (Wurbel et al. 2011). 
However, it is as yet unclear if these interactions play an essential role in the recruitment of 
colonic effector T cells during inflammation. 
The mechanisms that govern T cell homing to the colon under homeostatic conditions are 
as yet unclear. The expression of CCL28, the cognate ligand for the chemokine receptor 
CCR10, on colonic epithelium (Pan et al. 2000) has sparked investigation into the 
possibility that CCR10/CCL28 interactions instruct T cell migration to the colon. IgA+ 
plasmablasts in the colon are CCR10+ (Kunkel et al. 2003), and experiments tracking 
plasma cells in the GI tract have shown that CCR10+ IgA+ plasmablasts are generated in the 
caecal patch and subsequently migrate to the colon (Masahata et al. 2014). However, it is 
still unknown if CCR10 expression is required for T cell homing to the colon. A second 
candidate for the induction of colon-specific migration is the G-protein-coupled receptor 
GPR15. This has been shown to be expressed on colonic Treg cells and is required on these 
cells to rescue CD40-mediated colitis in T cell-deficient mice (Kim et al. 2013). Treg cell 
and CD44+ CD4+ T cell accumulation in the colon is decreased in mixed bone marrow 
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chimeras of Gpr15het with Gpr15-/- origin (Nguyen et al. 2014). However, GPR15 expression 
was not detected in the colon-daining MLN (Houston et al. 2016), which calls into 
question whether GPR15 is indeed induced during priming. Further investigation will be 
required to help address how GPR15 mediates accumulation of T cells in the colon, and 
what other potential molecules are involved in this process. 
1.2 Microbiota-immune interactions in the intestine 
1.2.1 Structure of the microbiota throughout the gastrointestinal tract 
The advent of sophisticated and powerful genomic, transcriptomic and metabolomic 
techniques in the past decade has been instrumental for the in-depth characterisation of 
the intestinal microbiota (Turnbaugh et al. 2007). The intestinal microbiota is made up of 
bacteria, fungi and viruses, and while the latter two components are receiving increasing 
attention, bacteria have been the focus of the vast majority of studies. Bacterial 
composition of the microbiota changes throughout the GI tract (Figure 1. 3) (Mowat and 
Agace 2014, Pereira and Berry 2017). While not a sterile organ, the stomach exhibits a very 
low microbial burden, owing to its acidic pH (Nardone and Compare 2015). Similarly, 
bacterial colonisation of the duodenum and jejunum is limited, with mainly facultative 
anaerobes such as Lactobacillus and Streptococcus being present (Figure 1. 3) (Zoetendal et 
al. 2012, Gu et al. 2013). In the descending parts of the GI tract, however, microbial burden 
and diversity increase. Other facultative anaerobes begin to thrive; Enterobacteria such as 
Escherichia coli (E. coli) and Enterococcus, members of the Firmicutes phylum, are both 
commensals of the terminal ileum and colon that have also been described as 
“pathobionts” as they have the potential to cause inflammation after perturbation of the 
microbiota (Arias and Murray 2012, Ayres et al. 2012). In contrast to facultative anaerobes, 
obligate anaerobes fail to survive in oxygenated environments. Examples of these are 
Clostridium and Bacteroides, which are enriched in the colon (Figure 1. 3) (Mowat and 
Agace 2014). The shift from predominantly facultative anaerobes in the small intestine to a 
mixture of facultative and obligate anaerobes in the colon is underpinned by the decreasing 
oxygen tension as the GI tract descends (He et al. 1999) and reduced flux of intestinal 
content. 
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Figure 1. 3: Structure of the gastrointestinal tract and its microbiota 
Simplified schematic of the different tissue compartments within the gastrointestinal tract and the 
accompanying changes in various factors influencing the colonisation of facultative and obligate anaerobes. 
Microbial burden is highest in the colon, and correlates with a greater availability of complex 
polysaccharides. On the other hand, higher oxygen tension and the increased levels of simple sugars favour 
colonisation of the small intestine with a limited number of facultative anaerobes.
Diet itself has an important role in regulating species abundance in the intestine (Faith et 
al. 2011), and the distribution of nutrients within the tissue is thought to establish 
ecological niches allowing different bacterial species to thrive (Pereira and Berry 2017). 
This instigates competition between bacterial species, and is thought to be an important 
factor driving colonisation resistance of pathogenic species, such as Salmonella enterica 
serovar Typhimurium (S. Typhimurium) (Barthel et al. 2003, Deriu et al. 2013). The 
abundance of simple sugars found in the small intestine is a ready food source for 
facultative anaerobes (Zoetendal et al. 2012). In the colon, on the other hand, complex 
polysaccharides and mucins that make up the secreted glycocalyx are the dominant 
nutrients available for the commensal microbiota. Indeed, the abundance of dietary fibre is 
an important determinant of species abundance in the colon (Walker et al. 2011), with 
specific bacteria such as members of Bacteroides and Clostridium genera being the main 
metabolisers of fibre in vivo (Tannock et al. 2014).  
Microbiota composition not only varies between intestinal tissues, but studies have 
highlighted the importance of differentiating between luminal and mucosa-associated 
bacterial communities (Eckburg et al. 2005, Lepage et al. 2005, Ringel et al. 2015). Again, 
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factors such as nutrient availability and oxygen concentration, as well as adhesion and 
sensitivity to host defence factors play a role in determining bacterial composition of these 
compartments (Van den Abbeele et al. 2011). As mentioned previously, the mucus layer 
not only serves to protect the underlying epithelium and LP from translocating 
commensals, but also acts as a food source. While the inner mucus layer in the colon is 
normally sterile (Johansson et al. 2008), the outer mucus layer harbours a bacterial 
community distinct from that found in the lumen (Li et al. 2015). Members of both 
Bacteroidetes and Firmicutes phyla can be found associated with the mucus layer (Hong et 
al. 2011, Nava et al. 2011). The ability to degrade mucins is likely to be one factor 
influencing this (Macfarlane and Gibson 1991), as well as the propensity to adhere to the 
mucus layer itself (Huang et al. 2011). Very few commensal bacteria penetrate the mucus 
layer and survive in close proximity to the epithelium. A well-studied example is afforded 
by SFB (Jepson et al. 1993, Schnupf et al. 2015). Taken together, this spatial regulation of 
the microbiota is important to maintaining intestinal health, as intestinal inflammation is 
induced by the ability of enteric pathogens such as Shigella and enteroaggregative E. coli to 
penetrate the mucus layer and interact with the underlying epithelium (Harrington et al. 
2009). 
1.2.2 Microbial antigen acquisition 
The commensal microbiota provides a wealth of bacterial-derived antigen, especially in the 
colon. Both the acquisition of, and the immune responses to, these antigens are tightly 
controlled in the intestine to prevent inflammation. In order to achieve this, microbiota-
derived antigen must be safely sampled without allowing translocation of bacteria across 
the epithelium. Tight junction integrity is central to ensuring the epithelial barrier is 
maintained, but also prevents the passive transit of soluble antigen between IEC.  
The best documented route of antigen sampling in the mucosa is through M cells in the 
GALT. These can engage in phagocytosis and transcytosis of both soluble antigen and 
whole bacteria (Mabbott et al. 2013), functions which are supported by the expression of a 
range of receptors that allow recognition of bacterial antigen. For example, the M cell-
specific protein GP2 binds FimH on bacterial pili, and mediates bacterial uptake (Hase et 
al. 2009). Interestingly, the expression of GP2 on M cells is higher in the PP compared with 
the caecal patch, which was accompanied by suppressed M cell maturation in the latter 
(Kimura et al. 2014). This may allow the exercising of tighter control over antigen sampling 
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in the face of an elevated microbial burden. Transcytosed antigen is released into 
basolateral pockets, invaginations of the M cell membrane (Neutra et al. 1987), where it 
can be taken up by antigen-presenting cells. Indeed, M cells closely interact with MNP 
situated under the follicle-associated epithelium (Wang et al. 2011), and there is some 
evidence that MNP can extend dendrites through M cells to sample luminal contents 
(Lelouard et al. 2012).  
As well as M cells, goblet cells have been implicated in the transfer of soluble luminal 
antigen to underlying MNP (McDole et al. 2012). So-called “goblet cell-associated 
passages” (GAPs) were first identified in the small intestinal, but not colonic epithelium 
(McDole et al. 2012). However, antibiotic-treated and GF mice do exhibit the formation of 
GAPs in the colon, found to be mediated by a MyD88-dependent mechanism (Knoop et al. 
2015). Together with the regional differences observed in GP2 expression and 
differentiation of M cells (Kimura et al. 2014), this further supports the conclusion that 
antigen uptake, be it active or passive, is tightly controlled in the presence of the 
microbiota. 
In addition to the transcellular carriage of antigen, several reports exist of antigen-
presenting cells extending dendrites between epithelial cells, so-called “trans-epithelial 
dendrites” (TEDs), indicating the possibility of active sampling of the luminal 
environment. Even though often classified as DC, these CD11c+ (Chieppa et al. 2006), 
CX3CR1+ (Niess et al. 2005) cells are most likely to instead be LP macrophages, given that 
these express higher levels of CX3CR1 than DC (Cerovic et al. 2013). On the other hand, 
some evidence indicates the ability of CD103+ cells to form TEDs in the small intestine, 
especially after infection with S. Typhimurium (Farache et al. 2013), which may indeed 
point to the ability of DC to undertake similar functions.  
1.2.3 Metabolites produced by the microbiota and their impact on intestinal 
immunity 
It is becoming increasingly clear that the ways the microbiota shape intestinal immunity 
are not limited to the delivery of antigens, but also that the production of 
immunoregulatory metabolites is important for immune cell survival and function in the 
intestine. Many of these metabolites are generated as by-products of bacterial fermentation 
of dietary fibre. 
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Tryptophan metabolites and the aryl hydrocarbon receptor 
An example of these are indoles, tryptophan derivatives that arise from plant product 
metabolism (Zelante et al. 2013, Jin et al. 2014). Tryptophan metabolism is mainly carried 
out by the host enzyme Indoleamine 2,3-Dioxygenase-1 (IDO1), which is expressed at high 
levels in the intestine (Dai and Zhu 2010). However, indoles are found at high 
concentration in the caecal content of wildtype (WT) mice (Jin et al. 2014), and can be 
produced by commensal E. coli (Domka et al. 2006). This suggests that the microbiota itself 
can also metabolise tryptophan. Indeed, IDO1 deficiency leads to the increased abundance 
of tryptophan producing Lactobacillus species detected in the stomach (Zelante et al. 2013). 
Furthermore, deficiency in CARD9, a signalling component of the NOD2 receptor 
complex recognising intracellular bacterial components, induces a shift in the colonic 
microbiota and a simultaneous reduction in tryptophan metabolites, which correlates with 
increased susceptibility to colitis (Lamas et al. 2016). Taken together, these findings admit 
the possibility that tryptophan metabolism by both the host and the microbiota is 
interdependent and has profound effects on both.  
Indoles constitute ligands for the aryl hydrocarbon receptor (AhR), which has been shown 
to have an important role in regulating intestinal homeostasis and inflammation in 
leukocyte populations (Martin et al. 2009, Kiss et al. 2011, Li et al. 2011). Ahr-/- mice 
develop more severe colitis when treated with 3% DSS than WT controls, characterised by 
enhanced bacterial translocation to the LP (Li et al. 2011). This was due to a decrease in 
IEL numbers, as AhR signalling was required to maintain their survival in the epithelium 
(Li et al. 2011). A second way that AhR ligands maintain intestinal barrier integrity is by 
inducing the production of IL-22. AhR is preferentially expressed in CD4+ T cells that have 
undergone in vitro differentiation to a Th17 phenotype, and its ligation induces the 
production of IL-22 by these cells (Veldhoen et al. 2008). As well as LP Th17 cells, ILC3 
produce large amounts of IL-22 that is required for protection against enteric infection 
(Qiu et al. 2012). As seen in Th17 cells, AhR signalling induces the upregulation of IL-22 in 
intestinal ILC3 (Qiu et al. 2012). In fact, ILC3 numbers are significantly reduced in both 
the small intestinal and colonic LP of Ahr-/- mice (Kiss et al. 2011), indicating that, as in 
IEL, AhR signalling sustains ILC3 survival. Consequentially, AhR signalling deficiency 
leads to lack of isolated lymphoid follicle formation after birth (Kiss et al. 2011), a process 
that is dependent on ILC3 (Eberl and Littman 2004). Together, these findings highlight the 
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vital protective role of AhR ligands in maintaining the gut barrier and enabling the 
acquisition of microbiota-derived antigen in the GALT. 
Dietary fibre and short chain fatty acids 
The breakdown of dietary fibre by the commensal microbiota generates short chain fatty 
acids (SCFA), which act both directly on the epithelium to promote integrity of the 
intestinal barrier, and have important immunoregulatory functions. Acetate is the most 
abundant SCFA present in luminal content (Cummings et al. 1979), and is produced by 
most enteric commensals via carbohydrate fermentation (Louis et al. 2014). Distinct 
pathways operated by different species of bacteria have been described for the production 
of the other two SCFA, propionate and butyrate (Reichardt et al. 2014). While propionate 
is predominantly produced by Bacteroidetes (Louis et al. 2014, Reichardt et al. 2014), 
butyrate is mainly generated by Firmicutes (Louis et al. 2014). Acetate itself can also be 
converted to butyrate by certain commensal species (Duncan et al. 2002). The composition 
of the microbiota is therefore a key determinant of the levels of available SCFA at any given 
time.  
The abundance of colonic SCFA contributes to the colonisation resistance of enteric 
pathogens. For example, propionate has bactericidal properties against E. coli and 
Salmonella (Cherrington et al. 1991, Shin et al. 2002), and butyrate negatively regulates 
expression of virulence factors in S. enterica (Gantois et al. 2006). Furthermore, acetate 
production by Bifidobacteria has been shown to impart resistance to enteropathogenic 
E. coli-induced mortality in vivo (Fukuda et al. 2011). Thus, in the first instance, SCFA 
production by the commensal microbiota reduces the ability of pathogenic bacteria to 
cause inflammation.  
However, SCFA also have a substantial impact on the host. One example is the 
maintenance of epithelial barrier function. Butyrate constitutes one of the primary energy 
sources for colonocytes (Roediger 1980, Ardawi and Newsholme 1985, Zambell et al. 2003) 
and thus inhibits the induction of autophagy by IEC (Donohoe et al. 2011). Furthermore, it 
has been implicated in reducing IEC layer permeability (Kinoshita et al. 2002). SCFA can 
also act via engagement of G-protein coupled receptors (Brown et al. 2003). Deficiency in 
GPR43, one of the main SCFA receptors, leads to increased severity of DSS colitis in mice 
(Maslowski et al. 2009). Furthermore, feeding mice a high fibre diet is protective during the 
induction of DSS colitis, which is dependent on GPR43 signalling (Macia et al. 2015). 
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Furthermore, GPR43 was required for the induction of the NLRP3 inflammasome in 
colonic epithelial cells, a protective response in the face of epithelial cell damage and 
inflammation (Macia et al. 2015). There is also evidence to suggest that SCFA stimulate the 
production of antimicrobial peptides from IEC (Schauber et al. 2003, Sunkara et al. 2012). 
As well as IEC, it is becoming increasingly clear that SCFA exercise potent regulatory 
functions on immune cells, both influencing innate responses via myeloid cells, and 
shaping adaptive immune responses. For example, SCFA treatment of neutrophils reduces 
the production of pro-inflammatory mediators upon stimulation (Vinolo, Rodrigues, et al. 
2011), and SCFA signalling via GPR43 stimulates neutrophil chemotaxis (Vinolo, 
Ferguson, et al. 2011). Recent work has shown that butyrate treatment decreases the 
production of pro-inflammatory mediators by intestinal macrophages both in vitro and in 
vivo (Chang et al. 2014). Furthermore, this was shown to be independent of G-protein-
coupled receptor signalling, but mediated instead via the inhibition of histone deacetylases 
(Chang et al. 2014). In addition to regulating immune function in the intestinal 
environment, SCFA can impact immunity on a systemic level by stimulating 
haematopoiesis of DC precursors (Trompette et al. 2014). 
GF mice have reduced Treg cell frequencies in the colonic LP compared with specific 
pathogen-free (SPF) mice (Smith et al. 2013) and two seminal studies have shown that 
SCFA are required for the maintenance of colonic Treg cells in vivo (Furusawa et al. 2013, 
Smith et al. 2013). Thus, SCFA produced by members of the microbiota are likely to be 
important for sustaining Treg cell-mediated tolerance in the colon. Findings by Atarashi et 
al. (2013) indicate that Clostridia species may be one important source of SCFA. They 
showed that colonisation of GF mice with a mixture of 17 human Clostridia strains led to 
the increased intestinal concentration of SCFA and mediated colonic Treg cell expansion 
by stimulating the release of TGFβ (Atarashi et al. 2013). Together, these findings indicate 
that SCFA production by members of the commensal microbiota such as Clostridia is 
required for maintaining the large pool of colonic Treg cells, and as a consequence, 
immunological tolerance towards the microbiota. 
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1.3 When things go wrong: mechanisms of intestinal inflammation  
1.3.1 Host-microbiota interactions in inflammatory bowel disease 
In the healthy gut, the mucosal immune system must maintain a delicate balance between 
tolerance to food antigens and commensal bacteria, and defence against invading 
pathogens. Disturbing this balance can lead to the onset of inflammatory bowel disease 
(IBD), which affects approximately one in 150 people in Europe and is becoming 
increasingly common around the world (Molodecky et al. 2012). The aetiology of IBD 
remains unclear, but the current understanding based on a large body of research suggests 
a role for both an unbalanced intestinal microbiota and a deregulated mucosal immune 
response in perpetuating a state of relapsing-remitting inflammation of the intestine. IBD 
is a broad term describing two main diseases; Crohn’s disease (CD), which can affect any 
part of the GI tract and is often characterised by transmural, granulomatous inflammation, 
and ulcerative colitis (UC), which only involves colonic inflammation and presents as 
mucosal ulceration. However, the considerable variation in symptoms and clinical 
characteristics within both CD and UC indicates that these in themselves in fact may 
represent a spectrum of diseases with potentially different mechanisms of pathogenesis 
(Cleynen et al. 2015).  
Changes in the intestinal microbiota 
An increasing body of evidence points towards the microbiota as an underlying, and 
potentially causative, factor in driving intestinal inflammation in IBD. This is based on 
studies that have used sequencing approaches to define both the luminal and mucosa-
associated microbiota in patients with IBD compared with healthy individuals. In CD, 
disease phenotype and genotype have been correlated with changes in Faecalibacterium 
and Escherichia taxa (Frank et al. 2011), and an overall decrease in Firmicutes, specifically 
Clostridia, has been observed (Gophna et al. 2006, Scanlan et al. 2006, Morgan et al. 2012). 
Given the importance of Clostridia in the production of SCFA and maintenance of Treg 
cells in the colon (Atarashi et al. 2013), the availability of SCFA may be a contributing 
factor in IBD pathogenesis. However, it does not seem to be the case that a universal CD 
signature exists (Frank et al. 2007). Instead, the common factor to be exposed by most 
studies is a decrease in microbial diversity (Manichanh et al. 2006, Sepehri et al. 2007, 
Dicksved et al. 2008). It is yet unclear if this state of microbial imbalance, also termed 
dysbiosis, results in, or is a result of inflammation.  
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Recently, the fraction of the faecal microbiota that is coated by host IgA has been 
compared between IBD patients and healthy individuals (Palm et al. 2014). In defence 
against enteric pathogens, IgA-coating allows recognition by myeloid cells and pathogen 
neutralisation. However, commensal bacteria are also coated with IgA, albeit with antibody 
of lower affinity and specificity (Pabst 2012). For example, flagellin-specific IgA-coating 
helps prevent crossing of the intestinal barrier by commensal bacteria (Cullender et al. 
2013). In their seminal work, Palm et al. (2014) showed that the frequency of IgA-coated 
bacteria was increased in IBD, and were able to identify disease-specific signatures based 
on the coating of bacterial strains. Moreover, while colonisation of GF mice with these 
strains was not sufficient to induce colitis, they did exacerbate pathology in DSS colitis 
(Palm et al. 2014). This indicates that the IBD-associated microbiota is not pathogenic in 
itself, but is likely to contribute, together with other host susceptibility factors, to on-going 
inflammation. Interestingly, faecal microbiota transplantation has shown varying levels of 
success in the treatment of UC (Moayyedi et al. 2015, Rossen et al. 2015), thus further 
highlighting the need to understand what components of the microbiota or its downstream 
effects are involved in the disease process. 
How disease susceptibility impacts host-microbe interactions 
Taken together, these findings indicate that unravelling the interactions between the 
intestinal microbiota and host susceptibility factors is likely to be important in 
understanding IBD pathogenesis. Genome-wide association studies (GWAS) have been 
instrumental in explaining some degree of inherited disease susceptibility in IBD, as well as 
identifying important pathways in different arms of the immune response as potential 
drivers of pathogenesis. Indeed, many genetic associations are linked with the host 
response to microbial infection (Jostins et al. 2012). One extensively studied example is the 
NOD2 locus on chromosome 16 (Ogura et al. 2001). NOD2 belongs to the NOD-like 
family pathogen recognition receptors (PRR) and is involved in the activation of NF-κB 
and downstream pro-inflammatory pathways (Inohara et al. 2001) upon sensing of 
intracellular bacteria. The three most common CD-associated variants of the NOD2 gene 
are loss-of-function mutations and result in inability to efficiently clear intracellular 
bacteria (Cooney et al. 2010). Bacterial persistence could also be brought about by defective 
autophagy. The CD-associated T300A allele variant of autophagy-related gene ATG16L1, is 
impaired in its ability to induce autophagy, and drives enhanced levels of IL-1β production 
by CD11c+ cells from MLN and CD11b+ cells of the LP (Lassen et al. 2014), indicating that 
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aberrant caspase activation by this variant in MNP may be one of the factors driving 
inflammation in CD.  
GWAS have also pointed towards the role of many immunological signalling pathways in 
IBD pathogenesis. For example, IBD-associated loci include regulatory cytokines such as 
IL10 (Jostins et al. 2012, Bank et al. 2014). In fact, defective IL-10 signalling leads to early-
onset IBD in children (Glocker et al. 2009), indicating that maintenance of a tolerogenic 
environment in the intestine is essential for the prevention of inflammation during the 
increasing microbial colonisation in the first few months of life. Another gene with IBD-
associated polymorphisms encodes the chemokine receptor CCR6 (Barrett et al. 2008). 
CCR6 is expressed by Th17 cells (Liu and Rohowsky-Kochan 2008) and its cognate 
chemokine ligand, CCL20, is elevated in the epithelium of CD patients (Kwon 2002). This 
suggests that aberrant lymphocyte migration control could contribute to the development 
of CD. It also points to a role for Th17 cells in the pathogenesis of IBD. Association of CD 
with STAT3 polymorphisms (Barrett et al. 2008) further supports this, as STAT3 
phosphorylation is induced by IL-6 signalling, one of the factors that induces Th17 cell 
differentiation (Bettelli et al. 2006). Production of IL-22, required for the maintenance of 
epithelial barrier integrity (Sonnenberg et al. 2011), is regulated by STAT3 signalling in 
Th17 cells (Backert et al. 2014), again highlighting the importance of regulating host 
defence to the commensal microbiota. 
Animal models used in the investigation of IBD pathogenesis 
Important insights into intestinal immune regulation during inflammation have been 
uncovered using in vivo models. The pivotal role of Treg cells in maintaining intestinal 
homeostasis was first shown using a model of T cell-dependent colitis (Read et al. 2000), 
which involves the adoptive transfer of naïve CD4+ T cells to T cell-deficient mice (Leach et 
al. 1996). Transfer of CD4+ CD25+ T cells, which contain a large proportion of Treg cells, 
together with naïve CD4+ T cells, inhibited the onset of colitis (Read et al. 2000). On the 
other hand, the vital protective role of the epithelium is evident from studies using DSS 
colitis, which involves chemical-induced destruction of the colonic epithelium (Dieleman 
et al. 1994). In this model, the chemical damage to the intestinal tissue, coupled with 
translocation of bacteria to the underlying LP, drives inflammation. During DSS colitis, 
bacterial recognition is vital for the induction of an adequate immune response, and for 
limiting dissemination of bacteria to the MLN (Fukata 2005). This model has been used 
extensively to study intestinal immune cell function in the context of inflammation.  
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In line with the findings from GWAS studies in IBD patients, mice that lack components of 
disease-associated pathways can also develop spontaneous colitis. Interestingly, in many of 
these models, the microbiota has an important impact on the initiation or severity of 
inflammation. For example, Il10-/- mice develop colitis only in the presence of the 
pathobiont Helicobacter hepaticus (Kullberg et al. 1998, Sellon et al. 1998). Similarly, 
treatment of H. hepaticus-infected mice with IL-10 receptor blocking antibody induces the 
onset of caecal and colonic pathology (Kullberg et al. 2006). Another example is provided 
by TnfΔARE mice that lack AU-rich elements (ARE) at the Tnf gene locus (Kontoyiannis et 
al. 1999). SPF, but not GF TnfΔARE, mice develop spontaneous ileitis that is transferrable to 
GF mice upon transplantation of the microbiota (Schaubeck et al. 2015). More recently 
described, IEC-specific deletion of ATG16L1 induces transmural ileitis in mice, although 
in this case it was not transmissible via faecal microbiota transplantation 
(Tschurtschenthaler et al. 2017). Nevertheless, conventionally housed TnfΔARE and 
Atg16l1ΔIEC animals exhibit dysbiosis (Schaubeck et al. 2015, Tschurtschenthaler et al. 
2017). This highlights the important possibility that, as well as being impacted by the 
microbiota, intestinal inflammation may also cause alterations in the host microbiota that 
further perpetuate disease.  
1.3.2 Commensal turned rogue: adherent and invasive E. coli 
The search for a single bona fide microbial driver of inflammation for IBD has remained 
largely unfruitful. However, over the past decade there has been an accumulation of 
evidence in support of a role for the human gut commensal E. coli in CD. Commensal 
strains of E. coli can colonise the intestinal mucus layer due to the availability of mono- and 
disaccharides, which serve as nutrients (Møller et al. 2003, Miranda et al. 2004). However, 
E. coli is associated with 100% of early and 65% of chronic CD inflammatory lesions 
(Darfeuille-Michaud et al. 1998) and many of the E. coli strains isolated from these CD 
patients have adhesive and invasive properties (Martin et al. 2004), coining the term 
“adherent invasive E. coli” (AIEC). These can be found in 20-40% CD patient intestinal 
biopsies compared with 2-4% healthy controls (Darfeuille-Michaud et al. 2004, la Fuente et 
al. 2014). Their ability to adhere to and invade IEC is thought to be mediated by binding to 
CEACAM6 (carcinoembyonic antigen related cell adhesion molecule 6), an adhesion 
molecule that is upregulated in the CD epithelium (Barnich and Darfeuille-Michaud 2007, 
Carvalho et al. 2009). CD patients with systemic manifestations of inflammation in the 
form of peripheral spondyloarthritis have elevated levels of faecal IgA-coated E. coli 
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compared with patients with gut-limited disease (Viladomiu et al. 2017). These strains 
were identified as AIEC based on both genomic and functional analyses (Viladomiu et al. 
2017), indicating that an active on-going immune response against AIEC in the gut 
correlates with systemic disease presentation in CD. 
Granulomas are a common histological feature used in the diagnosis of CD and E. coli may 
be one of the driving factors in their development, as a sizeable proportion of granulomas 
in intestinal sections from CD patients have been shown to contain E. coli DNA (Ryan et 
al. 2004). Accordingly, certain AIEC strains are able to persist and replicate in 
macrophages in vitro and activate the inflammasome (Glasser et al. 2001, la Fuente et al. 
2014), as well as induce granuloma-like cell aggregates when cultured with human 
peripheral blood mononuclear cells (PBMC) (Meconi et al. 2007). Furthermore, antibodies 
against E. coli proteins are found at increased concentrations in the serum of CD patients 
(van Schaik et al. 2013). It is conceivable that the dysbiosis observed in many CD patients 
may allow outgrowth of E. coli strains in proximity to the mucosal wall. Indeed, antibiotic 
treatment of mice has been shown to induce the expansion of E. coli in mice, indicating 
that a functional microbiota may be required to control the abundance of this commensal 
in the intestine (Ayres et al. 2012). This is further supported by the fact that dysbiosis 
during DSS colitis allows enhanced growth of commensal E. coli strains in vivo due to their 
ability to utilise nitrate released during inflammation (Winter et al. 2013). The ability of 
AIEC to invade IEC and translocate to the underlying LP may enable these strains to act as 
opportunistic pathogens and contribute to the development of intestinal inflammation and 
the chronic inflammatory phenotype of CD. 
Elucidating dynamics and immunological effects of AIEC colonisation in vivo 
Studying the colonisation dynamics and pathogenicity of E. coli strains in vivo has been 
carried out mainly in mice with streptomycin pre-treatment, which allows exogenous 
E. coli strains to occupy distinct niches created in the otherwise colonisation-resistant 
mouse intestine (Meador et al. 2014). A recent study in five different WT mouse strains 
showed that streptomycin can be used to establish a chronic and persistent colonisation 
with an AIEC strain isolated from a CD patient, NRG857c O83:H1, that mimics the 
intestinal inflammation seen in CD (Small et al. 2013). The main site of pathology was the 
caecum, with transmural fibrosis developing as early as seven days post-infection (p. i.). 
Furthermore, the pathology was accompanied by an increase in F4/80+ cells within the 
mucosa, likely to be inflammatory macrophages, as well as higher numbers of mucosal 
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T cells (Small et al. 2013). Concomitantly, NRG857c infection resulted in elevated levels of 
TNFα, IFNγ and IL-17 in both the caecum and colon (Small et al. 2013). Interestingly, in 
C57BL/6 mice this T cell-mediated pathology persisted after clearance of AIEC at later 
stages of the infection (Small et al. 2013), suggesting that the bacteria trigger a permanent 
shift in the mucosal immune response from tolerance to misdirected defence. 
Other studies have employed variations of the DSS colitis model to disrupt the intestinal 
barrier and allow colonisation of the CD-associated AIEC strain LF82. Flagellated LF82 
caused exacerbated inflammation during DSS colitis, whilst this effect was lost with non-
flagellated mutants (Carvalho et al. 2008). This implicates flagellin as an important AIEC-
derived PAMP recognised by the immune system after epithelial cell injury. Using a 
humanised mouse model, where the human CEACAM6 adhesin is present on the apical 
surface intestinal epithelium (Chan and Stanners 2004), Carvalho et al. (2009) showed that 
colonisation was dependent on expression of type I pili such as FimH on LF82, as the 
ΔfimH mutant was significantly decreased in its ability to colonise and cause intestinal 
inflammation. Given previous work showing that FimH binds the GP2 receptor on M cells 
(Hase et al. 2009), this could be one mechanism by which LF82 mediates transcytosis of 
across the epithelium. Similarly, genomic analysis of the NRG857c strain of AIEC has 
revealed two amino acid variations in its FimH (N91S, S99N) (Nash et al. 2010) that have 
been associated with E. coli strains isolated from IBD patient tissue (Sepehri et al. 2011). As 
of yet however, it is unclear what effect these variations may have on bacterial virulence. 
Using the streptomycin pre-treatment model of AIEC infection, Small et al. (2013) found 
that Rag1-/- mice developed more severe intestinal inflammation than WT mice (Small et al. 
2013). Furthermore, when they selectively depleted CD4+ or CD8+ T cells in WT animals, 
they found that absence of CD8+ T cells similarly induced a pronounced aggravation of 
inflammation, while CD4+ depletion showed no change in pathology (Small et al. 2013). 
Given the important role of CD8+ IEL in surveillance of the epithelial barrier, this indicates 
that a defect in the mucosal CD8+ T cell compartment may contribute to the persistence of 
E. coli species within the epithelium and LP, thus leading to chronic inflammation.  
1.3.3 Bacterial enteric infections 
Intestinal inflammation not only occurs with the onset of IBD, but can also be caused by 
infection with enteric bacterial pathogens. Infectious diarrhoeal-associated mortality is one 
of the leading causes of death in children globally, with most cases occurring in developing 
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countries (Black et al. 2010). The most common infectious agents responsible for enteric 
infections include Salmonella, E. coli, Campylobacter and Shigella (Fletcher et al. 2013). The 
expression of virulence factors such as adhesins and bacterial toxins allow pathogen 
colonisation, invasion of host cells and the subversion of immune responses. The 
mechanisms that govern the intestinal immune response to enteric pathogens have been 
extensively studied using in vivo models. Two commonly used examples are infection with 
S. Typhimurium (Barthel et al. 2003) and C. rodentium (Higgins et al. 1999, Atarashi et al. 
2015).  
Salmonella: subverting immunity to establish infection 
In humans, S. Typhimurium causes a self-limiting gastroenteritis, whilst during infection 
with a related strain, S. Typhi, the pathogen spreads to systemic sites after establishing a 
seat of infection in the GI tract, and causes typhoid fever. Mice are generally resistant to 
S. Typhimurium-induced intestinal infection, although in genetically susceptible mouse 
strains S. Typhimurium causes systemic disease and mortality, without eliciting colitis 
(Griffin and McSorley 2011). The resistance to intestinal infection can be overcome by pre-
treatment of mice with streptomycin (Barthel et al. 2003), and this model of infection has 
been widely used to study the intestinal immune response to S. Typhimurium. 
S. Typhimurium is a Gram-negative, flagellated facultative anaerobe that preferentially 
colonises the terminal ileum and colon. Its first point of entry is through binding to M cells 
in PP (Jones et al. 1994, Clark et al. 1994) and the SILT in the small intestine (Halle et al. 
2007). The pathogen’s ability to successfully colonise and cause inflammation is largely due 
to the expression of motility genes (Schmitt et al. 2001) and of virulence factors encoded on 
the Salmonella pathogenicity islands (SPI) (Tsolis et al. 1999). Among these virulence 
factors, one of two Type III secretion systems (T3SS-1, encoded by SPI-1) allows insertion 
of effector proteins into host cells, and subsequent invasion (Raffatellu et al. 2005), which is 
important for the induction of inflammation (Zhang et al. 2002). Replication of 
S. Typhimurium within the epithelial cell cytosol leads to the activation of caspase-1 in 
these cells and subsequent inflammatory cell death. This is followed by extrusion of IEC 
from the epithelial layer, thus enabling shedding of S. Typhimurium in the faeces (Knodler 
et al. 2010). 
In order to maintain infection and allow systemic spread, S. Typhimurium effectively 
subverts innate immune responses. Once it is engulfed by an MNP, the second T3SS, 
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encoded by SPI-2, is activated and sustains bacterial survival by the inhibition of 
phagosome maturation (Ochman et al. 1996). Furthermore, as in IEC, S. Typhimurium can 
induce MNP inflammatory cell death, also termed pyroptosis, which relies on the 
activation of caspase-1. This is mediated by the T3SS protein SipB, which binds to and 
cleaves caspase-1 (Hersh et al. 1999, van der Velden et al. 2003), but can also be initiated 
via the activation of the NLRC4 inflammasome (Miao, Leaf, et al. 2010). During infection 
with S. Typhimurium, the host upregulates the production of anti-microbial proteins such 
as lipocalin-2 and calprotectin, which act to limit the availability of metals such as iron 
required for bacterial growth (Goetz et al. 2002, Corbin et al. 2008). However, 
S. Typhimurium is able to compete with these host pathways of metal sequestration by 
expression of its own metal chelating proteins, thus giving it a selective advantage over 
other bacteria in the intestine and sustaining its rapid growth (Raffatellu et al. 2009, Liu et 
al. 2012, Behnsen et al. 2014). The uptake of S. Typhimurium by DC in the LP, together 
with cell-free migration in lymph, allows its spread to the MLN (Voedisch et al. 2009). 
Containment in the MLN is vital for inhibiting further dissemination to the liver and 
spleen, and the onset of systemic disease (Voedisch et al. 2009). 
Citrobacter rodentium: an attaching effacing pathogen 
The murine pathogen C. rodentium has been used as a model of human disease caused by 
enteropathogenic and enterohaemorrhagic E. coli (EPEC, EHEC). These strains establish 
infection in the intestine by forming attaching and effacing (A/E) lesions (Frankel and 
Phillips 2008). The initial site of colonisation by C. rodentium in vivo is the caecal patch, 
after which it establishes infection in the distal colon and rectum by ten days p. i. (Wiles et 
al. 2004) and causes colitis (Mundy et al. 2005). The infection is self-limiting and is cleared 
after three to four weeks (Wiles et al. 2004). 
Expression of genes encoded by the locus of enterocyte effacement (LEE) (McDaniel et al. 
1995), which is shared by C. rodentium and both EPEC and EHEC, is required for A/E 
lesion formation (Jarvis et al. 1995, Frankel and Phillips 2008). The LEE encodes a T3SS 
that mediates translocation of the bacterial effector Tir, which incorporates into the 
mammalian membrane and acts as a binding site for the bacterial adhesin intimin 
(Hartland et al. 1999). Intimin binding results in epithelial cell actin polymerisation and 
the formation of a pedestal, on top of which the bacteria resides (Frankel and Phillips 
2008). Expression of these LEE-encoded virulence factors is essential for the establishment 
of infection by Citrobacter (Schauer and Falkow 1993, Deng et al. 2003). GF mice infected 
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with C. rodentium do not clear the infection naturally as SPF mice do (Kamada et al. 2012), 
indicating that the microbiota plays an important role in the resolution of infection. 
Indeed, Kamada et al. (2012) showed that LEE-encoded virulence genes were expressed 
early during infection, but not during the clearance phase, leading to increased detection of 
C. rodentium in the lumen at later time points. The propensity of members of the 
commensal microbiota for utilising similar nutrient sources to C. rodentium may therefore 
lead to the outcompeting and clearance of this pathogen in vivo (Kamada et al. 2012). 
C. rodentium is well-equipped for the subversion of host defences. For example, 
colonisation of the intestinal epithelium by C. rodentium causes the weakening of tight 
junctions, leading to increased barrier permeability (Guttman, Li, et al. 2006, Guttman, 
Samji, et al. 2006). Opsonisation of bacteria by components of the complement pathway 
allows targeted phagocytosis by MNP, and C. rodentium effector EspJ has been shown to 
inhibit complement-mediated uptake (Marches et al. 2008). This pathogen can also inhibit 
the induction of apoptosis in host cells via its effector proteins NleH and NleB1 
(Hemrajani et al. 2010, Pearson et al. 2013), thereby preventing the detachment and 
shedding of enterocytes, that are required for C. rodentium colonisation of the intestine. In 
particular, NleB1 mediates this via inhibiting Fas ligand-induced activation of caspase-8 
(Pearson et al. 2013). This is especially important given the ability of IEL to activate Fas 
ligand-induced apoptosis (Corazza et al. 2000). C. rodentium therefore has a range of 
virulence factors at its disposal for supporting its growth in the intestine and escaping 
elimination by the host immune system.  
1.3.4 Phases of inflammation based on cellular involvement 
The immune response to bacteria is coordinated in phases, with different immune cells 
playing their part during the acute and chronic stages of the infection (Figure 1. 4). Early 
acute responses against bacteria are carried out by tissue neutrophils that are recruited by 
epithelial cell-derived IL-8 (Singer and Sansonetti 2004). Their ability to efficiently 
phagocytose bacteria and secrete cytotoxic mediators makes them an important 
component of the innate response. Infection with S. Typhimurium causes a robust IL-8 
response, presumably orchestrated by sustained interactions with the epithelium (Hobbie 
et al. 1997, Gewirtz et al. 1999). Neutrophils thus attracted to the epithelial barrier not only 
combat infection whilst resident in the LP, but can also transmigrate across the epithelium 
into the lumen, induced by the IEC release of chemoattractant protein hepoxilin A3 
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(McCormick et al. 1998, Mrsny et al. 2004). Once on the apical side, neutrophils can 
further combat the infection via the secretion of cytotoxic mediators and the formation of 
neutrophil extracellular traps. During infection with C. rodentium, neutrophils are 
recruited via a CXCR2-dependent mechanism, due to the production of CXCL1, 2 and 5 by 
MNP in the LP (Spehlmann et al. 2009). 
 
Figure 1. 4: Role of innate and adaptive immune cells during progression of bacterial infection from 
acute to chronic  
Simplified schematic summarising the time-dependent roles of innate and adaptive immune cells in 
combatting bacterial infection. Epithelial cell-derived IL-8 attracts Ly6G+ neutrophils, which in turn 
phagocytose bacteria and secrete cytotoxic mediators. As the infection progresses, classical blood Ly6C+ 
MHCII- monocytes enter the tissue and differentiate by acquiring MHCII into Ly6C- MHCII+ pro-
inflammatory macrophages. These then engage in phagocytosis and secrete pro-inflammatory cytokines such 
as TNFα. Finally, an enhanced infiltrate of CD4+ T cells is a marker of the final and chronic stage of infection. 
These home to the intestine after having been activated by dendritic cells in the MLN and once at the site of 
infection, secrete pro-inflammatory cytokines such as IFNγ and IL-17A in response to bacterial antigen 
recognition.
Eosinophils are a second type of granulocyte that has mainly been implicated in Th2-
driven diseases such as allergies or parasitic infections. However, recent work by Griseri et 
al. (2015) suggests that they may be important mediators of chronic intestinal 
inflammation. This group reported on a granulocyte macrophage colony-stimulating factor 
(GM-CSF)-dependent mechanism of eosinophil expansion in the LP, which was induced 
by colitis-driven IL-23. H. hepaticus and IL-10R blockade-induced colonic inflammation 
was significantly associated with eosinophil production of cytotoxic mediators such as 
eosinophil peroxidase and tumour necrosis factor α (TNFα) (Griseri et al. 2015).  
Once a robust acute response to the invading pathogen has been established, monocyte 
recruitment to the LP and their differentiation to inflammatory macrophages constitute 
the second important innate response to bacteria in the intestine (Figure 1. 4). DSS colitis 
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leads to an influx of Ly6C+ monocytes into the LP (Bain et al. 2013), caused by the 
translocation of commensal bacteria across the damaged barrier. During C. rodentium 
infection, intestinal monocytes are recruited in a CCR2-dependent manner and give rise to 
macrophages, which produce pro-inflammatory cytokines such as IL-1β via the activation 
of the inflammasome by C. rodentium (Seo et al. 2015). This is required for the activation 
of ILC3 (Seo et al. 2015), important mediators of pathogen clearance (Qiu et al. 2012). As 
well as ILC, macrophages help to polarise and maintain intestinal T cell responses during 
infection via the production of IL-12 (Schreiber et al. 2013) and IL-23 (Aychek et al. 2015). 
Following the initial innate response to a pathogen, DC migration to the draining lymph 
node will initiate the adaptive response in the form of T cell activation and differentiation. 
Activated T cells home to the site of infection through the upregulation of chemokine 
receptors, where they orchestrate the final phase of the defence by production of pro-
inflammatory cytokines (Figure 1. 4). C. rodentium infection elicits an increase in LP Th17 
cells (Mangan et al. 2006), while infection with S. Typhimurium causes a mixed Th1/Th17 
response (Lee et al. 2012). A similar inflammatory T cell response is observed in the 
chronic intestinal inflammation of patients with IBD, characterised by both Th1 and Th17 
infiltration of the inflamed mucosa (Rovedatti et al. 2009, Olsen et al. 2011).  
A deeper understanding of the phases of immune activation and the factors that trigger 
and control each step will be important to both further illuminating the mechanisms of 
pathogenesis in IBD, and identifying therapeutic targets in the resolution of acute and 
chronic inflammation. 
1.4 Intestinal dendritic cells and their role in anti-bacterial immunity 
1.4.1 Development of dendritic cell subsets 
In the context of the different phases of the immune response to bacterial infection, DC are 
at the cross-section of innate and adaptive immunity, as they provide the initial stimulus 
for T cells to become activated and differentiate into a particular effector phenotype. 
Originally described by Steinman and Cohen (1973), these professional antigen-presenting 
cells develop from bone marrow precursors via several rounds of differentiation (Figure 1. 
5), and are dependent upon the cytokine Fms-like tyrosine kinase 3 ligand (Flt3L) 
(Maraskovsky 1996, McKenna et al. 2000, Naik et al. 2007, Waskow et al. 2008). The 
dynamics of this process have mainly been studied in mice, with some recent insights from 
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human studies. During haematopoiesis, the common DC precursor (CDP) (Naik et al. 
2007, Onai et al. 2007) differentiates from common myeloid progenitors, possibly via an 
intermediary step of the macrophage and DC precursor (MDP), although conflicting 
evidence exists for the involvement of this step (Fogg et al. 2006, Sathe et al. 2014, Lee, 
Breton, et al. 2015). Both pDC and cDC lineages originate from the CDP (Naik et al. 2007, 
Onai et al. 2013). In cDC development, the CDP further gives rise to pre-cDC (Naik et al. 
2007, Breton et al. 2015), which leave the bone marrow and circulate in the blood to 
lymphoid organs and peripheral tissues (Figure 1. 5) (Diao et al. 2006, Naik et al. 2006, 
Bogunovic et al. 2009, Ginhoux et al. 2009). Once arrived in the tissue environment, pre-
cDC terminally differentiate into tissue cDC subsets.
 
Figure 1. 5: Murine cDC development and lineages 
In the bone marrow, the CDP (common DC precursor) gives rise to pre-DC, which are already committed to 
either the cDC1 or cDC2 lineage. These pre-cDC circulate in the blood to tissues, where they undergo 
terminal differentiation into tissue cDC. Transcription factors implicated in the development and survival of 
cDC lineages are detailed, as well as the phenotype of cDC1 and cDC2 in the intestine, lung and spleen, based 
on their surface marker expression.
Within tissues, a varying number of DC populations can be defined, based on the 
expression of a range of cell surface markers (Figure 1. 5). In the spleen, CD4 and CD8 
define two subsets of DC, while CD11b, SIRPα and CD103 help distinguish two to four 
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mucosal DC populations at different sites (Guilliams et al. 2014). The observation of some 
level of functional overlap between DC populations found at distinct tissue sites, together 
with the increasing evidence for shared transcriptional regulation of their developmental 
pathways has led to the proposal that DC can be classified into two main subsets, cDC1 and 
cDC2 (Guilliams et al. 2014). Development of DC precursors into either of these subsets is 
likely determined during the transition from CDP to pre-cDC, as recent work has 
discovered the presence of cDC1 and cDC2 committed pre-cDC in the bone marrow of 
mice (Schlitzer et al. 2015) and in human blood (See et al. 2017). 
The cDC1 lineage of DC comprises the CD8α+ DC in the spleen, and CD11b- CD103+ DC 
at mucosal sites such as the intestine and lung (Figure 1. 5) (Guilliams et al. 2014). These 
are characterised by their dependence on the transcription factors Batf3 (Hildner et al. 
2008) and IRF8 (Schiavoni et al. 2002, Tamura et al. 2005), and their ability to activate 
CD8+ T cells by cross-presentation of antigen (Hildner et al. 2008, Cerovic, et al. 2014b). 
The cDC2 lineage of DC, on the other hand, is made up of CD4+ splenic DC and CD11b+ 
SIRPα+ DC in peripheral tissues (Guilliams et al. 2014). These are dependent on Notch2 
(Satpathy et al. 2013) and IRF4 (Persson et al. 2013b, Schlitzer et al. 2013) signalling, and 
are functionally heterogeneous, although evidence indicates they may be important for 
orchestrating CD4+ T cell responses during infection (Satpathy et al. 2013, Schlitzer et al. 
2013). 
1.4.2 Dendritic cell populations in the intestine 
Four murine intestinal populations of migratory DC can be identified based on their 
differential expression of CD11b and CD103. Among these, CD11b- CD103+ DC are 
classed as cDC1, whilst CD11b+ CD103- and CD11b+ CD103+ DC form part of the cDC2 
lineage (Figure 1. 6). The origin of the fourth DC population, which is CD11b- CD103-, 
remains unclear. In the human intestine, a similar classification can be achieved based on 
expression of SIRPα and CD103, with SIRPα+ CD103- and SIRPα+ CD103+ DC exhibiting 
a transcriptional profile aligned with murine cDC2, while SIRPα- CD103+ DC belong to the 
cDC1 lineage (Watchmaker et al. 2014). 
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Figure 1. 6: Intestinal DC populations and their functions 
Four intestinal DC populations can be identified in the intestine based on the differential expression of 
CD11b and CD103. The differential expression of additional cell surface markers, as well as their tissue 
localisation are detailed. Furthermore, intestinal DC populations have been implicated in the induction of 
different effector T cell responses both in vitro and in vivo.
The distribution of DC populations changes along the GI tract. For example, 
CD11b+ CD103+ DC are the most prominent population in the small intestine and sMLN, 
whilst their frequency in the colon and cMLN is reduced (Houston et al. 2016). On the 
other hand, CD11b- CD103+ DC constitute the highest percentage of total DC in the 
colonic LP and cMLN (Houston et al. 2016). These tissue-specific differences point to both 
the functional specialisation of intestinal DC populations, and the important role of the 
tissue environment in conditioning DC differentiation and survival. Indeed, a range of 
studies has identified population-specific phenotypes and functions both in vitro and in 
vivo. 
Intestinal CD11b+ CD103- DC 
The role of intestinal CD11b+ CD103- DC in orchestrating mucosal immune responses has 
long been overlooked, due to the inaccurate discrimination between DC and macrophage 
populations in the LP. This is perhaps not surprising, as among all the four intestinal DC 
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populations, they are the phenotypically most similar to macrophages. For example, 
together with the shared expression of CD11b, they also express intermediate levels of 
CX3CR1, which is found at high levels on mature intestinal macrophages (Cerovic et al. 
2013). However, they are in fact a bona fide DC population, as they migrate in lymph 
(Cerovic et al. 2013), and constitute one of the four migratory DC populations found in the 
MLN. Furthermore, they arise from pre-DC and are Flt3L-responsive (Cerovic et al. 2013, 
Scott et al. 2014a). They also express SIRPα, one of the shared characteristics of the cDC2 
lineage (Cerovic, Houston, et al. 2014, Watchmaker et al. 2014). Lymph CD11b+ CD103- 
DC are highly potent in their ability to prime antigen-specific CD4+ T cell responses in 
vitro, and can induce the differentiation of IFNγ+ Th1 and IL-17A+ Th17 cells without prior 
stimulation (Denning et al. 2007, Cerovic et al. 2013). Whether this also translates to the in 
vivo setting still remains to be determined. CD11b+ CD103- DC have, however, been 
implicated in the production of IL-23 during infection with C. rodentium (Aychek et al. 
2015), suggesting that they may have a role in sustaining Th17 responses in the LP, as well 
as inhibiting excessive Th1-mediated pathology (Aychek et al. 2015). Furthermore, CD11b+ 
CD103- DC have also been shown to drive Th2 responses to Schistosoma mansoni (S. 
mansoni) eggs in the colon (Mayer et al. 2017). This population of intestinal DC therefore 
seems to be able to respond to a range of different stimuli, leading to distinct T cell 
differentiation fates both in vitro and in vivo. 
Intestinal CD11b+ CD103+ DC 
The CD11b+ CD103+ population of DC is unique to the intestine, as for example the lung 
mucosa only contains two main DC populations, CD11b- CD103+ DC (cDC1) and 
CD11b+ CD103- (cDC2) (Desch et al. 2013, Persson et al. 2013a). Intestinal CD11b+ 
CD103+ DC are SIRPα+ (Cerovic et al. 2014b) and express intermediate levels of SiglecF 
(Houston et al. 2016). They are developmentally dependent on IRF4 (Persson et al. 2013b, 
Schlitzer et al. 2013) and Notch2 (Lewis et al. 2011, Satpathy et al. 2013), as well as RA 
signalling (Klebanoff et al. 2013). Contrary to CD11b+ CD103- DC, whilst able to drive 
antigen-specific CD4+ T cell activation in vitro, they are less capable of eliciting a T cell-
mediated cytokine response (Cerovic et al. 2013). Only after stimulation with TLR ligands 
do they induce antigen-specific Th1, but not Th17 differentiation in vitro (Cerovic et al. 
2013). Conversely, IRF4 deficiency decreases the frequency of LP Th17 cells in the steady 
state, as well as after induction of an immune response (Persson et al. 2013b, Schlitzer et al. 
2013). Similarly, DC specific deletion of Notch2 leads to the worsening of colitis and 
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increased mortality during C. rodentium infection (Satpathy et al. 2013). These findings 
point to a role for CD11b+ CD103+ DC in the induction of Th17 responses in vivo. 
Interestingly, depletion of intestinal CD11b+ CD103+ DC in mice that express diphtheria 
toxin under control of the human Langerin promoter (huLangerin-DTA mice) does not 
lead to increased weight loss during C. rodentium infection (Welty et al. 2013). A lack of 
protective responses induced by Notch2 deficiency may therefore also be due to functional 
defects in CD11b+ CD103- DC, the other cDC2 population, rather than simply a reduction 
in CD11b+ CD103+ numbers. Furthermore, while huLangerin-DTA mice also exhibited 
reduced LP IL-17A+ CD4+ T cells, this was independent of MHCII expression on CD11b+ 
CD103+ DC (Welty et al. 2013). Given that mesenteric lymph CD11b+ CD103+ DC do not 
drive Th17 differentiation in vitro (Cerovic et al. 2013), the contribution of this population 
to Th17 responses in the intestine may therefore be independent of T cell activation in the 
MLN, and further work will be required to fully elucidate their functional role in 
maintaining Th17 responses in vivo. Intriguingly, whilst CD11b+ CD103- DC were shown 
to drive Th2 responses in the colon, CD11b+ CD103+ DC were the only population in the 
small intestine to induce Th2 activation to S. mansoni eggs in the small intestine (Mayer et 
al. 2017). This indicates that tissue environment regulates the differential ability of DC 
populations to prime protective CD4+ T cell responses in vivo and further work will be 
required to identify tissue-specific factors that are involved in shaping the function of 
intestinal DC populations. 
Intestinal CD11b- CD103+ DC 
As in the spleen, intestinal CD11b- CD103+ cDC1 express CD8α. Whilst all mesenteric 
lymph DC populations can induce the antigen-specific proliferation of CD8+ T cells in 
vitro, only CD11b- CD103+ DC are able to do so in vivo (Cerovic et al. 2014b). This unique 
ability to acquire and process antigen for cross-presentation has also been shown for cDC1 
in other tissues, including the lung (Desch et al. 2011) and spleen (Iyoda et al. 2002). 
Furthermore, they uniquely express the chemokine receptor XCR1 (Cerovic et al. 2014b). 
Its ligand XCL1 is secreted by CD8+ T cells upon activation by CD8α+ DC (Dorner et al. 
2009), and is required for the maintenance of XCR1+ DC and CD8+ T cell populations in 
the intestine (Ohta et al. 2016). Their ability to undergo cross-presentation in vivo is likely 
due to an enhanced capacity to take up cell-derived antigen. Indeed, CD11b- CD103+ in the 
MLN contain cytokeratin inclusions, indicating an increased rate of IEC uptake (Cerovic et 
al. 2014b). Furthermore, they express high levels of Clec9A (also known as DNGR-1) 
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(Cerovic et al. 2014b), which allows recognition of damaged cells via binding of actin 
filaments (Zhang et al. 2012), thus providing a possible explanation for their ability to 
acquire and present cell-derived antigen.  
Batf3 deficiency selectively depletes cDC1, including intestinal CD11b- CD103+ DC 
(Hildner et al. 2008, Edelson et al. 2010, Cerovic et al. 2014b), and lack of this population is 
associated with increased mortality during Toxoplasma gondii infection (Mashayekhi et al. 
2011). This is mediated by the loss of protective IL-12 production by CD11b- CD103+ DC 
(Mashayekhi et al. 2011). On the other hand, they are not required for mounting a 
protective response against C. rodentium (Satpathy et al. 2013). Instead, the production of 
IL-12 by CD11b- CD103+ DC is decreased during C. rodentium infection due to its negative 
regulation by IL-23 signalling, which thus prevents the induction of a detrimental Th1 
response (Aychek et al. 2015). In vitro findings indicate that CD11b- CD103+ DC can 
induce the differentiation of Th1 cells, but only after stimulation (Cerovic et al. 2013). 
Together, these observations provide evidence for a functional role of CD11b- CD103+ DC 
in the induction of Th1 responses in the context of infection. 
Intestinal CD11b- CD103- DC 
While the smallest population of DC in the intestine does not express either CD11b or 
CD103, it does express SIRPα (Cerovic et al. 2013). Much still remains to be clarified as to 
their origin and function, which are likely to represent a heterogeneous population of cells. 
CD11b- CD103- DC migrate in lymph and can activate antigen-specific CD8+ T cells in 
vitro (Cerovic et al. 2014b). They also induce the differentiation of Th17 cells without the 
need for prior stimulation (Cerovic et al. 2013). Furthermore, lymph CD11b- CD103- DC 
express co-stimulatory molecules such as CD80 and CD86 (Cerovic et al. 2013). In the light 
of these findings, they must, therefore, be classed as bona fide DC. With respect to their 
origin, Cerovic et al. (2013) found that CD11b- CD103- DC were decreased in Rorc-/- mice, 
which lack intestinal organised lymphoid tissues. It is therefore conceivable that these are 
primarily present in the GALT, and there contribute to the priming of T cells. A further 
possibility is that a proportion of these cells represent precursors for cDC2 in the LP, given 
their expression on SIRPα, but this hypothesis is yet to be tested. 
The regulation of T cell homing by intestinal DC populations 
As detailed above, the induction of CCR9 and α4β7 on activated T cells in the MLN is 
dependent on RA production by DC (Iwata et al. 2004). Furthermore, this ability to induce 
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homing markers seems to be specific to CD103+ DC (Jaensson et al. 2008), which would 
include both CD11b+ CD103+ and CD11b- CD103+ DC. Mice that lack either CD11b- 
CD103+ DC due to Batf3 deficiency, or CD11b+ CD103+ DC after deletion of IRF4 in 
CD11c+ cells have normal levels of CCR9 and α4β7 induction in the MLN (Edelson et al. 
2010, Persson et al. 2013b). It is therefore likely that a high degree of redundancy exists in 
the ability to induce homing receptor expression between the two CD103+ populations. 
More recently, however, it has become clear that all mesenteric lymph DC populations are 
able to metabolise Vitamin A to produce RA to the same extent and induce CCR9 
expression on CD8+ T cells in vitro (Cerovic et al. 2013). Further investigation will 
therefore be required to elucidate the functional role for RA production by CD103- DC 
during this process in vivo. Moreover, it will also be important to investigate the 
contribution of stromal cells in the MLN, which have previously been shown to be able to 
sustain the induction of CCR9 on T cells in vitro (Hammerschmidt et al. 2008).  
1.4.3 DC migration and antigen presentation 
Once a DC has taken up antigen in the intestine, it leaves the LP via lymphatic endothelial 
vessels and migrates in lymph to the MLN. This process of migration is constitutive and 
has been studied in several different ways. The first involves the feeding or injection of 
fluorescent antigen and detection of fluorescent DC in the MLN. While this can be 
informative, the ability of many antigens to travel cell-free in lymph means that labelled 
DC in the MLN may not exclusively be made up of migratory populations. Instead, antigen 
can be taken up by LN resident DC and processed for presentation (Sixt et al. 2005). 
Recently, the generation of transgenic Kaede mice has provided an elegant way of 
circumventing this problem (Tomura et al. 2008). These mice ubiquitously express the 
fluorescent Kaede-green protein, which derives from the stony coral Trachyphyllia 
geoffroyi, and can be photoconverted from a green to red emission state under exposure to 
violet light (Ando et al. 2002). The Kaede-red state is stable in vitro (Ando et al. 2002) and 
for up to seven days in vivo, where it allows tracking of immune cells across tissues 
(Tomura et al. 2008). Indeed, Houston et al. (2016) successfully used this technique to 
study the differentiation migration pattern of small intestinal and colonic LP DC to the 
MLN. A third method involves surgical removal of MLN, and subsequent cannulation of 
the thoracic duct once lymphatic vessels have reanastomosed (Cerovic et al. 2013). Instead 
of only tracking cell migration, this technique allows isolation and the carrying out of 
functional assays on DC that are still in the process of migration, rather than having 
1. General Introduction 
 
57 
arrived in the MLN where their phenotype is likely to change due to the altered tissue 
environment. It also permits analysis of DC without prior activation during the digestion 
protocols otherwise necessary for their isolation from tissues. 
DC migration is primarily controlled by the upregulation of CCR7 (Förster et al. 1999, Jang 
et al. 2006). This allows DC to migrate along a chemokine gradient of the CCR7 ligands 
CCL19 and CCL21, which are expressed in the T cell areas of LN, as well as by the 
lymphatic endothelium (Gunn et al. 1998, Luther et al. 2000). Furthermore, DC migration 
to draining LN was shown to be independent on the expression of integrins that can 
mediate cell-cell contact between leukocytes and the lymphatic endothelium 
(Lämmermann et al. 2008). CCR7 upregulation is induced upon TLR ligands binding by 
DC, as well as by the action of pro-inflammatory cytokines such as TNFα (Sallusto et al. 
1998, Sozzani et al. 1998). Indeed, Myd88-/- mice have significantly lower expression of 
CCR7 (Hägerbrand et al. 2015), confirming a role for PAMPs in inducing DC migration.  
DC enter the MLN via the afferent lymphatics and first accumulate in the subcapsular 
sinus region before migrating to T cell zones (Girard et al. 2012). There, DC encounter 
naïve T cells and present antigen in the form of peptide-MHCII or peptide-MHCI 
complexes recognized by CD4+ and CD8+ T cells, respectively. Antigen-specific activation 
is controlled by the need for recognition of the peptide-MHC by the TCR. This interaction 
forms “Signal 1” required for antigen-specific T cell activation and is the central interaction 
that constitutes the formation of the stable immunological synapse (Huppa and Davis 
2003). The second essential signal is provided by costimulatory molecules expressed by DC 
upon maturation, such as CD80 and CD86. These are upregulated in response to TLR 
ligands, but also by the binding of CCL19 by DC once they have entered the LN (Marsland 
et al. 2005). CD80 and CD86 bind CD28 and CTLA-4 on the T cell, further stabilizing the 
immunological synapse (Brzostek et al. 2016). The resulting signaling cascade initiated in 
the T cell induces the production of IL-2, which is required for T cell proliferation 
(Brzostek et al. 2016). Production of cytokines such as IL-6, IL-10 and IL-12 by DC further 
helps to instruct T cell differentiation. After antigen presentation, DC are thought to 
remain in the MLN and undergo apoptosis (Chen et al. 2006), as thoracic duct lymph does 
not normally contain DC (Pugh et al. 1983, Cerovic et al. 2013). 
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1.4.4 Pathogen sensing by DC 
Antigen presenting cells such as macrophages and DC can respond microbial stimuli 
provided by the microbiota or bacterial infection via the recognition of PAMPs. These 
encompass a wealth of different molecular components (Fukata and Arditi 2013, 
Muralidharan and Mandrekar 2013). MNP sense PAMPs via expression of a range of 
membrane-bound and intracellular PRR (Figure 1. 7), which can be largely grouped into 
two main families, TLR and NOD-like receptors (NLR) (Fukata and Arditi 2013, 
Muralidharan and Mandrekar 2013).
      
Figure 1. 7: PRR signalling in response to PAMPs 
Simplified schematic giving an overview of PRR signalling pathways in antigen-presenting cells. Activation of 
different extracellular TLR by a range of ligands induces the recruitment of MyD88 and subsequent 
activation of a signalling cascade leading to the activation of NF-κB and MAP Kinase (MAPK). NF-κB and 
the MAPK-induce transcription factor AP-1 in turn initiate the transcription of genes encoding pro-
inflammatory cytokines and chemokines. TLR located in the membrane of endosome or phagosomes also 
induce MyD88 signalling, but this leads to the mobilisation of interferon response factor 7 (IRF7) to the 
nucleus and the subsequent expression of Type I interferons. Cytoplasmic PAMPs, including components of 
bacterial T3SS, are recognised by a range of NLR, which include NOD2 and NLRC4. These assemble to form 
the inflammasome, which mediates caspase-1 cleavage. This in turn facilitates the activation of IL-1β.
Extracellular PAMPs include peptidoglycan from Gram-positive bacteria, recognised by 
TLR2, lipopolysaccharide (LPS) that is bound by TLR4, and flagellin that activates TLR5. 
Binding of these TLR recruits the master regulator MyD88, together with a range of 
adapter proteins, and initiates a downstream signalling cascade that leads to the activation 
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of NF-κB and the MAP-kinase pathway (Figure 1. 7). NF-κB and the MAP-kinase activated 
transcription factor AP-1 then trigger the transcription of cytokines, chemokines and 
antimicrobial peptides. Intracellular PAMPs are confined in endosomes generated either 
through viral infection or in phagosomes after the phagocytosis of bacteria (Figure 1. 7). 
For example, single stranded viral RNA is recognised by TLR7/8, and bacterial single 
stranded DNA harbouring CpG motifs is bound by TLR9 (Figure 1. 7). Again, MyD88 is 
recruited and in this case induces a signalling cascade that leads to the activation of IRF7, 
which is then able to trigger transcription of Type I interferons.  
Intestinal macrophages are hyporesponsive to TLR stimulation (Denning et al. 2007, 
Smythies et al. 2010). This inert state is not due to a lack of TLR expression, but rather due 
to negative regulation of downstream signalling (Smythies et al. 2010). This constitutes a 
vital safety mechanism in the face of the wealth of PAMPs provided by the commensal 
intestinal microbiota. On the other hand, there has been some debate about the 
responsiveness of intestinal DC to PAMPs via TLR activation. Intestinal CD11c+ MHCII+ 
cells have been shown to be hyporesponsive to signalling via a range of TLR (Monteleone 
et al. 2008), including TLR4 (Uematsu et al. 2006). However, due to the lack of 
differentiation based on macrophage-specific markers in these studies, it is impossible to 
determine if these observations hold true for LP DC as well as macrophages. More 
definitive studies on mesenteric lymph DC have shown that hyporesponsiveness is limited 
to TLR4 signalling (Cerovic et al. 2009), and further indicate that mesenteric lymph DC 
populations differ in their ability to respond to TLR stimulation (Yrlid et al. 2006a).  
The other main class of PRR comprises the NLR family. These PRR are present in the 
cytoplasm and their activation results in the formation of the inflammasome (Fukata and 
Arditi 2013). NOD2 for example recognises muramyldipeptide, a component of the 
bacterial cell wall, while flagellin and components of bacterial T3SS can activate NLRC4 
(Miao et al. 2010b, Fukata and Arditi 2013) (Figure 1. 7). Upon assembly, the 
inflammasome cleaves pro-caspase-1 to generate active caspase-1, which then goes on to 
cleave and activate IL-1β (Figure 1. 7) (Gagliani et al. 2014).  
NOD signalling in DC and macrophages has been shown to induce autophagy (Cooney et 
al. 2010, Travassos et al. 2010). This involves the sequestration of cytoplasmic components 
such as organelles, or bacteria in infected cells, into autophagosomes, which can 
subsequently be degraded (Levine and Kroemer 2008). Furthermore, this leads to the 
upregulation of MHCII and antigen presentation on DC (Cooney et al. 2010), providing a 
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further example of the ability of PAMPs to induce DC maturation. During infection with 
S. Typhimurium, the expression of NOD1 in DC, another NLR, was required to control 
systemic spread of the pathogen (Le Bourhis et al. 2009). Furthermore, activation of the 
NLRC4 inflammasome by S. Typhimurium induces pyroptosis in macrophages and the 
subsequent release of intracellular bacteria, which are then effectively phagocytosed and 
killed by neutrophils (Miao et al. 2010a). Thus, NLR signalling in DC and macrophages is a 
vital mechanism by which these cells are able to respond to intracellular pathogens, both by 
the production of IL-1β and the elimination of cytoplasmic bacteria by autophagy or 
pyroptosis. 
1.5 Importance of apoptotic cell uptake in regulating intestinal immunity 
1.5.1 Apoptosis at steady state and during intestinal inflammation 
Early experiments investigating the rate of epithelial turnover in the GI tract showed that 
IEC rapidly migrate upwards from the intestinal crypt and are shed within a matter of days 
(Creamer, Shorter, and Bamforth 1961a, 1961b, Clarke 1970). Later work demonstrated 
that apoptosis occurs in the epithelial layer throughout the GI tract, but that this is mainly 
confined to IEC at the tips of villi or equivalent superficial positions in the colonic crypt 
structure (Hall et al. 1994, Strater et al. 1995). This was accompanied by extrusion of 
apoptotic cells from the epithelial cell layer (Strater et al. 1995). More recent work has 
confirmed the presence of cleaved caspase-3 in shedding IEC (Bullen et al. 2006). However, 
these appear to be in the early stages of apoptosis, due to the lack of evidence for late stage 
apoptotic cell bodies higher up in the crypts (Bullen et al. 2006). There is still some debate 
about whether apoptosis precedes shedding, or if shedding and the resulting loss of cell 
adhesion instead initiate cell death via anoikis in IEC. In vitro data indicate that apoptotic 
epithelial cells in a monolayer signal to neighbouring cells via S1P to induce actin 
rearrangements to facilitate cell extrusion (Rosenblatt et al. 2001, Gu et al. 2011). However, 
this process was caspase independent (Rosenblatt et al. 2001), and recent work has 
highlighted that overcrowding in the epithelial layer can also lead to the extrusion of live 
cells that is dependent on similar signalling pathways as previously described for apoptotic 
cells (Eisenhoffer et al. 2012). Taken together, therefore, it is possible that a range of 
mechanisms exists to ensure the efficient turnover of the intestinal epithelium.  
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Regulation of cell death during enteric bacterial infections 
IEC cell death is also a phenomenon observed in infections with a range of bacterial 
pathogens such as EHEC, Helicobacter pylori and Shigella (Moss et al. 1996, Zychlinsky et 
al. 1996, Barnett Foster et al. 2000). Host defences rely on the elimination of infected cells 
to prevent bacterial spread and loss of barrier integrity. For example, epithelial cells 
infected with Salmonella enterica serovar Dublin or enteroinvasive E. coli undergo delayed 
apoptosis dependent on the action of TNFα and nitric oxygen synthase (Kim et al. 1998). 
Paesold et al. (2002) further showed that this delayed cell death response to S. Dublin was 
dependent on virulence factors encoded by SPI-2. Similarly, EHEC and C. rodentium can 
induce apoptosis via the effector protein EspF (Torchinsky et al. 2009, Zhao et al. 2013), 
which causes mitochondrial dysfunction (Nougayrède and Donnenberg 2004, Nagai et al. 
2005). Shigella flexneri also induces necrosis-like cell death in non-myeloid cells via 
disruption of mitochondrial function (Carneiro et al. 2009). Interestingly, the increased 
exposure of phosphatidylethanolamine during EHEC-induced apoptosis may support 
bacterial adhesion (Barnett Foster et al. 2000), which indicates that pathogens can exploit 
the host cell death mechanisms intended for defence. 
On the other hand, the control of IEC cell death during infection is also crucial for the 
pathogen (Kim et al. 2010). Bacteria must inhibit the induction of apoptosis during the 
early stages of infection to allow colonisation and immune evasion. S. Typhimurium, for 
example, can activate caspase-3 during the early stages of IEC infection without inducing 
apoptosis (Srikanth et al. 2010). Instead, it exploits this as a means of activating the T3SS 
effector protein SipA (Srikanth et al. 2010). A second S. Typhimurium effector, SopB, 
inhibits IEC apoptosis by sustaining cell survival signalling within the cell (Knodler et al. 
2005, Kum et al. 2011). EPEC is also equipped with several strategies to subvert host cell 
apoptosis; for instance, it can antagonises death receptor signalling by expression of the 
effector NleB1 (Pearson et al. 2013). A second effector protein, NleH, directly interferes 
with the host cell pro-apoptotic protein Bax inhibitor-1, thus preventing caspase-3 cleavage 
and stalling apoptosis (Hemrajani et al. 2010). During bacterial infection, therefore, a 
constant state of antagonism exists between pathogenic survival strategies and host 
defences in regulating apoptosis in the intestine. 
Apoptosis in IBD 
As well as acute infectious gastroenteritis, chronic inflammation of the intestinal mucosa 
has been associated with increased levels of apoptosis. The epithelium of affected mucosa 
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has a higher frequency of apoptotic enterocytes in both CD (Di Sabatino et al. 2003) and 
UC (Iwamoto et al. 1996, Hagiwara et al. 2002) patients compared with healthy controls. 
Furthermore, proteomic analysis of IEC from IBD patients revealed an increase in 
potential pro-apoptotic mediators (Shkoda et al. 2007). However, the interplay between 
factors governing this increased frequency of apoptosis in IBD is yet unclear, although they 
are likely to be made up of genetic susceptibility, dysregulated recognition and clearance of 
bacteria by phagocytes, and perturbations of the microbiota. 
One indication of a possible role for host genetics comes from the finding that 
polymorphisms in the XBP1 gene are associated with IBD (Kaser et al. 2008). This 
transcription factor plays an important role in regulating the response to ER stress (Calfon 
et al. 2002), and XBP1 deletion caused Paneth cell apoptosis in vivo (Kaser et al. 2008). 
Furthermore, IEC cell death in this model is linked to NF-κB signalling and can be 
ameliorated by the induction of autophagy (Adolph et al. 2013). However, the loss of both 
ER stress pathways and autophagy in the intestinal epithelium has a compounded 
detrimental effect, causing severe CD-like ileitis in vivo, which is dependent on the 
microbiota (Adolph et al. 2013). Given that genetic variation in the autophagy-related 
ATG16L1 gene are also associated with IBD, these findings indicate that increased 
apoptosis in IBD may stem from a dysregulation in IEC autophagy and ER stress response 
mechanisms. 
A second important factor involved in the induction of apoptosis during inflammation is 
TNFα. This pro-inflammatory cytokine is increased in the mucosa of IBD patients (Murch 
et al. 1993, Breese et al. 1994). TNFα signalling induces NF-κB nuclear localisation and this 
is required for the induction of a pro-survival response (Beg and Baltimore 1996, Van 
Antwerp et al. 1996). Whilst this protective mechanism occurs in most tissues, treatment 
with TNFα induces rapid and wide-spread apoptosis in the intestinal epithelium (Piguet et 
al. 1999). Conversely, anti-TNFα therapy in CD patients effectively decreases IEC 
apoptosis (Zeissig 2004), thus providing a potential mechanism for its effectiveness. A 
similar effect was also observed in a murine model of chronic ileitis (Marini et al. 2003). 
Furthermore, polymorphisms in genes linked with apoptosis, including caspase-9 and Fas 
ligand, are predictive of a treatment response to the TNFα-targeting monoclonal antibody 
infliximab in IBD (Hlavaty et al. 2005). Thus, TNFα-mediated apoptosis is likely to 
constitute a fundamental driving factor in IBD-associated pathology. 
1. General Introduction 
 
63 
1.5.2 Innate recognition of apoptotic cells 
Macrophages and DC in the LP can recognise and take up apoptotic cells or cell-derived 
antigen. This is mediated by the expression of various apoptotic cell receptors (ACR), and 
enabled by the phagocytic nature of these cells. Given the rapid turnover of IEC and 
extrusion of cells from the epithelial layer before showing signs of the late stages of 
apoptosis, there has been some debate over the ability of macrophages in particular to 
acquire IEC-derived antigen. Early studies identified sub-epithelial macrophages intimately 
associated with the epithelium and apoptotic cells (Han et al. 1993, Iwanaga et al. 1993, 
Shibahara et al. 1995). However, later work using more sophisticated staining techniques 
was not able to show the same; instead, CD68 staining was concentrated in the LP and did 
not associate with shedding IEC (Bullen et al. 2006). Nonetheless, cytokeratin inclusions 
have been found both in LP macrophages (Nagashima et al. 1996) and DC (Huang et al. 
2000, Cerovic et al. 2014b), indicating that these cells nonetheless do succeed in 
phagocytosing epithelial cell-derived antigen. 
One of the principal and most well studied signals that is recognised by MNP on apoptotic 
cells is phosphatidylserine (PS). This lipid component of the cell membrane is associated 
with the inner membrane leaflet in live cells, but becomes externalised upon induction of 
apoptosis (Fadok et al. 1992, Leventis and Grinstein 2010). Recognition of PS by MNP can 
be facilitated by a range of PS receptors (PSR). Among these, some receptors directly 
mediate binding to PS, whereas others require the presence of an adapter molecule. An 
example for the latter is given by the TAM receptor family. This is made up of three 
distinct receptors, Tyro3, Axl and MerTK, which all mediate uptake of apoptotic cells via 
the recognition of PS by adapter molecules Gas6 or Protein S (Lemke 2013). Upon adapter 
binding, TAM receptors dimerise, allowing phosphorylation of their intracellular tyrosine 
kinase domains, and the activation of signalling cascades that result in the rearrangement 
of the actin cytoskeleton and phagocytosis (Lemke 2013). TAM receptor signalling also 
serves to activate immunosuppressive pathways in the phagocyte upon activation. For 
example, Gas6 binding in bone marrow-derived DC (BMDC) inhibited the inflammatory 
response downstream of TLR9 induction, and this was shown to be due to the mobilisation 
of SOCS1 and SOCS3, important negative regulators of TLR signalling (Rothlin et al. 
2007). Expression of TAM receptors on intestinal MNP is variable. For example, MerTK is 
expressed on colonic LP macrophages (Bain et al. 2014), but not mesenteric lymph DC 
(Cerovic et al. 2014b). Furthermore, Axl expression in BMDC is low at steady state, but is 
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increased upon TLR stimulation (Rothlin et al. 2007). Together, these findings indicate that 
differential regulation of TAM receptor expression on MNP populations may be important 
for coordinating the downstream response to apoptotic cells. 
A further example of a PSR is given by members of the T cell immunoglobulin and mucin 
(TIM) domain family of proteins. TIM1, TIM3 and TIM4 are conserved between humans 
and mice, with genes clustering together on human chromosome 5q33.2, within a region 
that has been linked with allergy and asthma (Marsh et al. 1994, McIntire et al. 2001). 
These three proteins have been shown to have PS binding ability (Kobayashi et al. 2007, 
Freeman et al. 2010), with TIM1 and TIM4 mediating uptake of apoptotic cells by 
macrophages (Kobayashi et al. 2007). High expression of TIM4 has been documented on 
peritoneal macrophages (Kobayashi et al. 2007), and facilitates their homeostatic function 
of apoptotic cell clearance in vivo (Wong et al. 2010).  
In addition to PSR, scavenger receptors mediate the sampling of apoptotic cell antigen via 
recognition of other cellular components that are accessible in dying or damaged cells. 
These components are also referred to as danger-associated molecular patterns (DAMPs), 
and resemble PAMPs in their ability to induce pro-inflammatory signalling in MNP. 
CD205 (also known as DEC205) is a member of the mannose receptor family that allows 
recognition of apoptotic cells by binding keratins (Cao et al. 2016). These are intermediate 
filaments that have been implicated as having an important role in regulating colonic 
epithelial cell differentiation (Lahdeniemi et al. 2017). Furthermore, activated caspases 
induce keratin cleavage during apoptosis (Caulin et al. 1997), which may in turn lead to 
keratin exposure during later stages of apoptosis. CD205 can localise to the endosome 
(Chatterjee et al. 2012), and recognises apoptotic cell components after a conformational 
change due to low pH (Cao et al. 2015). In cells undergoing apoptosis the cytoplasm 
becomes acidified (Matsuyama et al. 2000), which may in turn lower the environmental pH 
due to leakage from the dying cell, and allow CD205 binding. Initially, CD205 was 
described as a DC-specific marker (Kraal et al. 1986, Pack et al. 2008), but has subsequently 
also been described on intestinal macrophages (Kamada et al. 2009). 
1.5.3 Role of apoptotic cell-derived antigen in driving intestinal T cell responses 
Apoptotic cell uptake can have opposing effects on downstream T cell-mediated immunity 
(Green et al. 2009). Firstly, it allows the processing of self peptides and thus constitutes an 
important mechanism for the induction of tolerance (Steinman et al. 2000). Over the past 
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two decades, the cellular and molecular determinants for this process have become 
increasingly clear. As mentioned in an earlier section, cDC1 are characterised by their 
ability to cross-present antigen to CD8+ T cells (Guilliams et al. 2014). As well as being an 
important defence mechanism during viral infection (Hildner et al. 2008), cross-
presentation allows the expansion of CD8+ T cells in response to self-antigen associated 
with apoptotic cells (Liu et al. 2002). However, subsequent deletion of antigen-specific 
CD8+ T cells leads to the induction of tolerance (Liu et al. 2002). In a different study, the 
cross-presentation of apoptotic cell-derived antigen by CD8α+ DC induced activation of 
CD8+ T cells which in themselves were found to mediate regulatory functions, although 
this was not linked to the production of immunosuppressive cytokines such as IL-10 or 
TGFβ (Ferguson et al. 2002). In the intestine, tolerance induction to cross-presented self-
antigen mainly occurs in the MLN, as depletion of PP via administration of lymphotoxin-β 
receptor antibody does not abolish tolerance to luminal OVA, contrary to simultaneous 
depletion of MLN and PP (Chung et al. 2005). Similarly, Worbs et al. (2006) showed that 
the induction of oral tolerance was CCR7-dependent and that it was abrogated in 
mesenteric lymphadenectomised mice. Accordingly, CD11b- CD103+ lymph DC that have 
been able to acquire epithelial cell-derived antigen drive antigen-specific expansion of 
MLN CD8+ T cells in vivo (Cerovic et al. 2014b). 
The phagocytosis of apoptotic cells in vitro induces production of immunosuppressive 
cytokines by antigen-presenting cells, including IL-10 and TGFβ (Fadok et al. 1998, Lucas 
et al. 2003, Chung et al. 2007, Perruche et al. 2008, Torchinsky et al. 2009). Furthermore, 
ingestion of apoptotic cells by antigen-presenting cells decreases expression of CD86, 
resulting in a decreased capacity to induce antigen-specific CD4+ T cell activation, despite 
prior stimulation with LPS (Stuart et al. 2002). Macrophages increase the production of RA 
after apoptotic cell uptake (Sarang et al. 2014). In line with the importance of TGFβ and 
possibly RA in Treg cell differentiation (Chen et al. 2003, Coombes et al. 2007), antigen-
presenting cells that have taken up apoptotic cells can induce Treg cell responses in vitro 
(Torchinsky et al. 2009). In vivo, the systemic infusion of apoptotic cells expanded the Treg 
cell population in the spleen (Maeda et al. 2005, Kleinclauss et al. 2006). Furthermore, 
presentation of tissue-derived antigen by Langerin+ dermal DC mediates Treg cell 
differentiation in vivo via the production of active TGFβ (Azukizawa et al. 2011). 
Therefore, the induction of Treg cell responses is a second important mechanism by which 
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the phagocytosis of apoptotic cells could facilitate tolerance to self-antigen. However, the 
exact mechanisms that govern this process in the intestine still remain to be established. 
In addition to the induction of tolerance, apoptotic cell uptake can also mediate the 
activation of pro-inflammatory processes (Green et al. 2009), including the differentiation 
of effector T cell responses. This occurs primarily due to the stimulation of antigen-
presenting cells by TLR ligands that are present in the phagocytosed material (Torchinsky 
et al. 2009). Indeed, stimulation of TLR signalling in macrophages that have ingested 
apoptotic cell material changes their cytokine expression profile from TGFβ alone to 
include pro-inflammatory TNFα and IL-12 (Lucas et al. 2003). Similarly, in vitro 
phagocytosis of apoptotic cells infected with E. coli stimulates both IL-6 and TGFβ 
production by antigen-presenting cells, which in turn leads to the differentiation of Th17 
cells (Torchinsky et al. 2009). In addition, antigen-presenting cells that have been loaded 
with virus-infected apoptotic fibroblasts can induce IFNγ responses by CD8+ T cells in vitro 
(Arrode et al. 2000). The downstream effect of apoptotic cell uptake by DC and 
macrophages is therefore highly dependent on the immunogenic state of the dying cell, 
thus tailoring the adaptive response to distinguish between self-antigens and infection. 
1.6 The phosphatidylserine receptor TIM4 
1.6.1 TIM4 structure 
Sharing a similar structure with the other TIM molecules, TIM4 is made up of an 
immunoglobulin (Ig) V-like domain, a mucin-like domain containing N-linked and O-
linked glycosylation sites, and a transmembrane domain with a cytoplasmic tail (Freeman 
et al. 2010) (Figure 1. 8). PS binding is mediated by the PS-binding pocket located in the 
IgV domain (Santiago et al. 2007). Within this binding pocket, TIM4 has a metal ion 
coordination site, which facilitates Ca2+-dependent ligand binding (Santiago et al. 2007). 
Furthermore, the presence of four further PS-binding residues, which engage in weaker 
interactions with the ligand, could allow TIM4 to differentiate between differential levels of 
PS exposure based on ligand density in the binding pocket (Tietjen et al. 2014). The IgV 
domain also contains an RGD motif (Kuchroo et al. 2003) that is removed from the PS 
binding pocket but predicted to be accessible to potential binding by integrins (Flannagan 
et al. 2014). The large number of O-linked glycosylation sites found on the extracellular 
mucin-like domain mediates the potential for extensive glycosylation of TIM4. Moreover, 
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the presence of an additional N-glycosylation site facilitates even further possible 
diversification of the glycosylation pattern exhibited by TIM4. This could mediate specific 
cell-cell interactions which rely on the recognition of glycolipids, a process that is vital 
during leukocyte trafficking (Wright and Cooper 2014). Contrary to other members of the 
TIM family, TIM4 does not contain a tyrosine kinase phosphorylation site in its 
cytoplasmic tail (Freeman et al. 2010), and was found not to mediate intracellular 
signalling (Park et al. 2009). However, subsequent work has shown that this domain is 
important for initiating phagocytosis of apoptotic cells, as removal abrogates this function 
(Wong et al. 2010). 
          
Figure 1. 8: TIM4 domain structure 
Simplified schematic showing the domain structure of the murine TIM4 molecule. Its immunoglobulin V 
(IgV) domain contains a PS (phosphatidylserine)-binding pocket with a Ca2+-dependent coordination site 
and four residues that mediate additional, but weaker, PS binding. The IgV domain also contains an RGD 
motif located at a position removed from the PS-binding pocket. A mucin-like domain containing numerous 
O-linked glycosylation sites and one N-linked glycosylation site connects the IgV domain with the cell 
membrane, where it is anchored by a transmembrane (TM) domain. Within the cell, TIM4 extends a 
cytoplasmic tail that lacks a tyrosine kinase phosphorylation site.
1.6.2 TIM4 expression pattern in tissues and on cells 
The first study to characterise murine TIM4, originally given the name SMUCKLER 
(spleen, mucin-containing, knockout of lymphotoxin) showed that TIM4 was highly 
expressed in lymphoid tissue such as the spleen, LN and PP in mice (Shakhov et al. 2004). 
The enrichment of TIM4 in peripheral lymphoid tissue has since then been confirmed by 
additional studies in mice (Meyers et al. 2005, Miyanishi et al. 2007) and humans 
(Kobayashi et al. 2007, Uhlen et al. 2015). TIM4+ cells were mainly found in the 
subcapsular sinus area in the LN and the subepithelial dome in the PP, with some 
penetrating into T cell areas (Shakhov et al. 2004). Subsequently, this has also been shown 
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in the mediastinal LN (Albacker et al. 2013). Mice deficient in lymphotoxin signalling 
exhibit defective lymphoid organ development, and have a dramatic decreased expression 
of TIM4 in both spleen and MLN (Shakhov et al. 2004). These findings first highlighted a 
possible role for TIM4 in the induction of immune responses in lymphoid tissue. 
Whilst TIM1 and TIM3 were first described as mainly expressed by T cells (McIntire et al. 
2001, Khademi et al. 2004, Meyers et al. 2005), TIM4 was shown to be restricted to antigen-
presenting cells (Meyers et al. 2005). Since then it has become clear that TIM4 is found on 
macrophages and DC in a range of different tissues. For example, resident peritoneal 
macrophages express high levels of TIM4 (Kobayashi et al. 2007, Miyanishi et al. 2007, 
Nishi et al. 2014, Thornley et al. 2014), as do CD169+ subcapsular macrophages in skin-
draining LN (Thornley et al. 2014) and medullary macrophages in mediastinal LN 
(Albacker et al. 2013). Furthermore, TIM4 is expressed by resident DC in the mediastinal 
LN, as well as both CD11b+ CD103- and CD11b- CD103+ subsets of migratory DC 
(Albacker et al. 2013). Recently, TIM4 was shown to be present on a small population of 
CD103+ CD207+ dermal DC (Zhang et al. 2016) and Yang et al. (2007) demonstrated that 
TIM4+ CD11c+ cells could be detected in the small intestinal LP. 
It is still unclear what factors mediate transcriptional control of TIM4 expression. 
However, several studies indicate that TLR signalling could be involved in its regulation. 
For example, bone marrow-derived mast cells can upregulate expression upon stimulation 
with flagellin (Li et al. 2014). Furthermore, human PBMC-derived macrophages and 
murine BMDC increase TIM4 upon culture with LPS (Rodriguez-Manzanet et al. 2008, Xu 
et al. 2013), and CD11c+ PBMC upregulate TIM4 when stimulated with Staphylococcal 
enterotoxin B (Liu et al. 2007). TIM4 is also increased on splenic CD11c+ cells upon LPS 
and CD40L stimulation (Mizui et al. 2008). In liver tissue TIM4 expression is elevated 
during ischemia-reperfusion injury, possibly due to a concomitant elevation in PS levels, 
and there TIM4 was shown to be expressed by infiltrating CD11b+ F4/80lo cells (Ji et al. 
2014). This indicates that both TLR ligands in the form of PAMPs or DAMPs, as well as 
possibly the increased density of exposed PS itself, can modulate TIM4 expression. 
Intriguingly, there is also some evidence for the ability of RA to elevate TIM4 expression 
on bone marrow-derived macrophages (Sarang et al. 2014). 
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1.6.3 TIM4 function in vitro and in vivo 
Phosphatidylserine binding and uptake of apoptotic cells 
The first definitive description of a functional role for TIM4 was made by Miyanishi et al. 
(2007), who showed that TIM4 acted as a bona fide PSR and mediated the uptake of 
apoptotic cells. This was confirmed around the same time by another group that further 
demonstrated the same for TIM1 (Kobayashi et al. 2007). At resting state, TIM4 
distribution in the cell membrane of peritoneal macrophages is diffuse, but upon culturing 
with apoptotic thymocytes, punctate clusters becomes visible at the intersection between 
macrophages and apoptotic cells (Wong et al. 2010). While the molecular mechanisms that 
govern TIM4-mediated phagocytosis upon PS binding have yet to be fully elucidated, there 
is evidence to suggest that it acts in concert with other PSR and integrins. It was thought 
initially that TIM4 simply acts as a tethering receptor and requires the additional action of 
integrins or other PSR to facilitate phagocytosis. These conclusions were based on the 
observation that TIM4 on its own bound PS-bearing apoptotic cells without engulfing 
them (Toda et al. 2012, Nishi et al. 2014). Instead, phagocytosis was induced upon 
additional expression of MerTK (Nishi et al. 2014) or αvβ3 integrin (Toda et al. 2012). 
Subsequent work showed, however, that TIM4 actively participates in phagocytosis, and 
confirmed that it does indeed associate with integrins, specifically the β1 subunit, during 
this process (Flannagan et al. 2014). Furthermore, integrin binding was required for the 
uptake of apoptotic cells by TIM4, and this was accompanied by the activation of integrin 
signalling components (Flannagan et al. 2014). Interestingly, blocking TIM4 abrogated 
tyrosine kinase phosphorylation of MerTK during phagocytosis of apoptotic cells, further 
indicating that TIM4 can act synergistically with other PSR (Toda et al. 2012).  
Phagocytosis of apoptotic cells is followed by formation of a double-membraned vesicle 
termed the phagosome (Kinchen and Ravichandran 2008). A series of acidification steps 
then lead to the degradation of phagosomal cargo, components of which can subsequently 
be loaded onto MHC molecules for antigen presentation (Kinchen and Ravichandran 
2008). Autophagy and phagocytosis share some signalling components, and indeed, 
phagocytosis of TLR ligand-bearing particles induces engagement of autophagy pathways, 
including the recruitment of autophagosome marker LC3 (Sanjuan et al. 2007). This has 
also been shown to be an important pathway governing the clearance of apoptotic cells 
(Martinez et al. 2011). This could be initiated by the presence of DAMPs on dying cells, as 
well as possible TLR stimulation by PAMPs if apoptosis was induced due to infection. 
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Intriguingly, LC3-associated phagocytosis by macrophages was dependent on TIM4 
(Martinez et al. 2009), highlighting this as an intracellular pathway initiated by TIM4-
mediated apoptotic cell uptake. 
TIM4 has been implicated in the clearance of dying cells by resident peritoneal 
macrophages in vivo (Rodriguez-Manzanet et al. 2010, Wong et al. 2010), and Timd4-/- 
mice exhibit higher cellularity in the peritoneal cavity, although the frequency of leukocytes 
among these was not assessed (Wong et al. 2010). However, Timd4-/- peritoneal 
macrophages produced higher levels of TNFα than their WT counterparts at resting state, 
but were unable to respond by increasing this after stimulation with LPS, indicating that 
deletion of TIM4 fundamentally changes their ability to adequately respond to 
environmental stimuli (Wong et al. 2010). Moreover, overexpression of TIM4 on 
macrophages in vivo increased the rate of survival during LPS-induced endotoxic shock by 
negatively regulating NF-κB signalling and the resulting production of pro-inflammatory 
cytokines by peritoneal macrophages (Xu et al. 2016). Liver macrophages from Timd4-/- 
mice do not upregulate the expression of chemokines to the same level as WT 
macrophages during hepatic ischemia-reperfusion injury, providing evidence for the 
TIM4-mediated clearance of apoptotic cells during sterile inflammation having the 
potential to stimulate leukocyte recruitment to the site of injury (Ji et al. 2014). As well as 
being externalised on dying cells, PS can be found on the surface of vesicles released by 
cells infected with L. monocytogenes (Czuczman et al. 2014). Uptake of these by 
macrophages mediated by TIM4 has been shown to facilitate L. monocytogenes spread 
(Czuczman et al. 2014). Thus, TIM4 may play an important role in determining the course 
of bacterial infections in vivo with bacteria using either apoptotic cells or cellular debris as 
Trojan horses to mediate spread to phagocytes, and possibly subsequent systemic 
dissemination via migratory DC. 
Several studies have highlighted that TIM4 may mediate immune tolerance by controlling 
the pool of antigen-specific T cells (Albacker et al. 2010, 2013). The number of activated 
T cells increases dramatically at the induction of an adaptive immune response, but then 
undergoes a phase of contraction, mediated by apoptosis (Kaech and Wherry 2007). 
Blocking TIM4 in vivo during viral infection increased the percentage of antigen-specific 
CD8+ T cells in the spleen. Conversely, mice that overexpressed TIM4 in MHCII+ cells 
exhibited a decreased level of secondary antigen-specific T cell activation after 
subcutaneous immunisation (Albacker et al. 2010). This was not, however, due to the 
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enhanced activation of Treg cells in these mice (Albacker et al. 2010).  The recognition and 
engulfment of Jurkat cells by macrophages is controlled by the level of PS exposed, with 
macrophages being able to mediate phagocytosis even at lower levels of PS than normally 
present on apoptotic cells (Borisenko et al. 2003). Low-level PS is transiently exposed on 
activated T cells (Fischer et al. 2006) and it is therefore possible that TIM4-overexpressing 
cells are able to recognise and engulf T cells that have just undergone activation, decreasing 
the resulting memory pool (Albacker et al. 2010). In a similar set of experiments, mice 
immunised intranasally with antigen exhibited reduced tolerance and an elevated number 
of antigen-specific T cells in mediastinal LN when TIM4 was blocked in vivo (Albacker et 
al. 2013). In these mice antigen-specific T cells could be detected in close proximity to, or 
within TIM4+ cells in the LN medulla, and depletion of F4/80+ macrophages reduced the 
induction of tolerance (Albacker et al. 2013). Based on these findings, the intriguing 
possibility presents itself that TIM4-mediated clearance of antigen-specific T cells is an 
important mechanism driving tolerance. 
TIM4 as a co-stimulatory or inhibitory molecule during T cell priming 
There have been several conflicting reports of TIM4 directly binding T cells and mediating 
either co-stimulatory or inhibitory effects on proliferation. As well as binding PS, TIM4 
can interact with TIM1 in vitro (Meyers et al. 2005, Wilker et al. 2007). This binding 
required both the IgV domain and the glycosylated mucin-like domain (Wilker et al. 2007). 
TIM4-Ig fusion protein was able to increase T cell proliferation and differentiation in vitro 
(Rodriguez-Manzanet et al. 2008), and induced T cell hyperproliferation during 
immunisation in vivo, which was attributed to its ability to engage TIM1 on the surface of 
activated T cells (Meyers et al. 2005). Furthermore, treatment of T cells with TIM4-Ig 
induced TIM1 phosphorylation in vitro (Rodriguez-Manzanet et al. 2008), which had 
previously been noted after TIM1 crosslinking on T cells (Binne et al. 2007). Interestingly, 
contrary to the indication that TIM4 may be important in decreasing the activated T cell 
pool by clearance of activated or apoptotic T cells (Albacker et al. 2010, 2013), TIM4-Ig 
treatment upregulates anti-apoptotic machinery in T cells and decreases cell death 
(Rodriguez-Manzanet et al. 2008). On the other hand, TIM4-Ig has also been shown to 
inhibit naïve CD4+ T cell activation, but this was not mediated by TIM1 (Mizui et al. 2008, 
Cao et al. 2011). However, when T cells were first stimulated and treated with TIM4-Ig 
12 h later, the inhibitory response was abrogated (Mizui et al. 2008). It is likely, therefore, 
that TIM4-mediated interactions with T cells will be context and ligand-dependent, thus 
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allowing the differential control at various phases of the T cell response. Timd4-/- animals 
exhibit normal lymphocyte subset frequencies in the thymus, spleen and peripheral LN 
(Rodriguez-Manzanet et al. 2010), indicating that loss of TIM4 signalling does not induce 
T cell hyperproliferation at the steady state. However, in Timd4-/- animals immunised with 
peptide plus adjuvant, splenic and LN T and B cells exhibited increased production of 
effector cytokines or antibodies, respectively (Rodriguez-Manzanet et al. 2010), indicating 
that TIM4 interaction with T cells may be more important during the initiation of antigen-
specific responses. 
Blocking TIM4 in several different systems has been shown to have an effect on the 
downstream differentiation fate of CD4+ T cells. Co-culture of BMDC with naïve T cells in 
the presence of both αCD3 and αTIM4 antibodies without the addition of conditioning 
factors increases TGFβ concentration in culture supernatants (Yeung et al. 2013). 
Furthermore, blocking TIM4 increased the percentage of FoxP3+ Treg cells generated in 
the presence of TGFβ (Yeung et al. 2013). A similar increase in Treg cell frequencies upon 
systemic αTIM4 administration was seen in vivo during a model of skin allograft 
transplantation (Yeung et al. 2013). These findings suggest that TIM4 may negatively 
regulate the differentiation of Treg cells in the periphery. 
It has also been reported that TIM4 may act to skew T cell responses towards a Th2 
phenotype. Conditioning of small intestinal LP CD11c+ cells with Staphylococcal 
enterotoxin B stimulates Th2 differentiation in an antigen-specific manner (Yang et al. 
2007). However, this was abrogated by treatment with either αTIM4 or αTIM1 antibody 
(Yang et al. 2007). This study showed a similar effect in a food allergy model, where mice 
were sensitised intraperitoneally with OVA and Staphylococcal enterotoxin B before oral 
re-challenge seven and 14 days later. Mice that had received αTIM4 at the point of 
sensitisation exhibited reduced serum and tissue levels of IL-4 (Yang et al. 2007). This was 
also the case for TIM1 blockade, indicating that these effects could be mediated by TIM4-
TIM1 interactions (Yang et al. 2007).  
Whilst the above discussed findings suggest that TIM4 on antigen-presenting cells inhibits 
regulatory T cell responses (Yeung et al. 2013) and can instead induce Th2 differentiation 
upon prior conditioning with Staphylococcal enterotoxin B (Yang et al. 2007), further 
evidence points to its ability to inhibit Th17 differentiation (Cao et al. 2011). This was 
shown in vitro after culture of naïve T cells under Th17 polarising conditions (Cao et al. 
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2011). However, this was not accompanied by a decrease in STAT3 phosphorylation, a 
central transcription factor governing Th17 fate (Cao et al. 2011). Given the range of 
systems employed across these studies, as well as the difficulty in accounting for differences 
in cell culture conditions, drawing an overall conclusion about the role of TIM4 in T cell 
differentiation is challenging. Interestingly, opposing effects on the activation and skewing 
of effector T cell responses have been documented during the use of two different αTIM1 
blocking antibodies (Xiao et al. 2007). Whilst one antibody caused strong activation and 
induction of Th1 and Th17 responses, the other did not and instead induced a robust Th2 
response (Xiao et al. 2007). Upon further investigation, this was shown to be due to a 
higher avidity for TIM1 exhibited by the activating antibody (Xiao et al. 2007). Thus, the 
use of different antibody clones and concentrations may have a marked effect on the 
outcome of studies employing TIM4 blockade. Further work in vivo employing clearly 
defined models will be required to shed more light on the molecular and cellular 
mechanisms involved in TIM4-mediated effects on T cells. 
1.7 Main aims and hypotheses 
The induction of immune responses to the microbiota and bacterial pathogens is tightly 
regulated in the intestine. DC are important players in facilitating this control due to their 
ability to integrate signals from the tissue environment and sampled antigen in order to 
instruct the mounting of adequate T cell responses. A great amount of progress has been 
made over the past two decades in furthering our understanding of the molecular and 
cellular mechanisms that govern these processes. However, unanswered questions remain, 
especially with regard to the functional specialisation of DC populations in the intestine 
and its determining factors. We therefore sought to begin addressing these questions with a 
particular focus on the mechanisms that drive intestinal inflammation. 
Given the important contribution of the microbiota to the pathogenesis of IBD, we first 
sought to establish the role of AIEC in driving intestinal inflammation in vivo. Previous 
work had indicated that the ileal clinical AIEC isolate NRG857c was able to cause chronic 
colitis in mice (Small et al. 2013). We therefore hypothesised that infection with NRG857c 
would lead to intestinal pathology characterised by the elevated infiltration of myeloid and 
T cells into the LP and an increased frequency of activated T cells in the MLN.  
Both the chronic intestinal inflammation that characterises IBD and infection with enteric 
bacterial pathogens such as C. rodentium are associated with increased levels of apoptosis. 
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Furthermore, the uptake of apoptotic cells is important for priming of protective T cell 
responses both in the healthy intestines and during inflammation. Our second main aim 
was to characterise the expression of ACR on DC populations across different tissues, with 
a special focus on TIM4. Among DC populations, the cDC1 lineage has been implicated in 
the acquisition and cross-presentation of apoptotic cell-derived antigen. We therefore 
hypothesised that expression of ACR such as TIM4 would be enriched on cDC1. 
Furthermore, we set out to test the hypothesis that TIM4 expression on DC populations 
was tissue-specific, and could therefore be differentially regulated by environmental 
factors. In order to begin to shed light on how the uptake of apoptotic cells might affect DC 
function, we also aimed to determine if TIM4+ and TIM4- DC exhibited altered functional 
profiles. 
Whilst there have been a number of in vitro studies investigating what factors induce 
expression of TIM4 on various cell populations, not much is known about how these 
findings translate into the in vivo setting. As part of our third aim, we hypothesised that 
TIM4 expression is regulated either by cytokine signalling, or by microbial stimulation 
mediated by the microbiota or bacterial infection. TIM4 has been linked to the induction 
of Th2 responses (Yang et al. 2007), and we therefore first characterised TIM4 expression 
in IL-4-deficient mice. Given the importance of TGFβR signalling on DC in maintaining 
intestinal homeostasis (Ramalingam et al. 2012), we next hypothesised that TIM4 
expression is TGFβR-dependent and tested this in transgenic mice lacking TGFβR 
specifically on CD11c+ cells. TIM4 is upregulated on cells after TLR stimulation (Xu et al. 
2013, Li et al. 2014). We thus hypothesised that an intact microbiota was required to 
stimulate TIM4 expression in the healthy intestine, and that infection would lead to its 
upregulation in vivo. 
Our final aim was to determine the functional role of TIM4 on DC in the healthy and 
inflamed intestine. We hypothesised that blocking TIM4 would interfere with different 
DC-specific functions, including migration and antigen presentation, in ways that would 
be important for the development of protective immune responses against intestinal 
pathogens. To this end, we tracked DC migration to the MLN in Kaede mice, and analysed 
the induction of T cell responses both in vitro, and in vivo during bacterial infection, after 
blocking TIM4. These investigations will form the basis for future work determining the 
role of TIM4 on intestinal DC populations both in the LP and the MLN, and what 
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functional implications this has for the regulation of intestinal T cell responses to apoptotic 
cell antigen.
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Chapter 2: Materials and Methods 
2.1 Mice and in vivo procedures 
2.1.1 Mice 
C57BL/6 and CD1 mice were purchased from Harlan or Charles River Laboratories and 
maintained in individually ventilated cages (IVC) prior to infection. OT-II mice were 
either bred under specific pathogen-free conditions at the Veterinary Research Facility or 
Central Research Facility, Glasgow. CD11c-cre Tfbr1fl/fl Rag1-/-, Kaede, Cx3cr1+/gfp, Ly5.1, 
OT-I, KN2 and KN2het mice were bred under specific pathogen-free conditions at the 
Central Research Facility, Glasgow. Ccr7gfp/gfp mice were bred and maintained under 
specific pathogen-free conditions at the Universtätsklinikum, Aachen. Animals fed on AhR 
ligand deficient chow or infected with C. rodentium were a mixture of C57BL/6 and 
Rorc+/gfp mice bred under specific pathogen-free conditions at the Veterinary Research 
Facility, Glasgow. All protocols were approved by the local ethical committee and 
conducted under licenses issued by the UK Home Office.  
2.1.2 Mouse surgical procedures 
Kaede photoconversion 
Kaede mice were anaesthetised by continuous inhalation of isoflurane (Abbott Animal 
Health). After laparotomy, either the caecum or proximal colon was exposed and kept 
moist with saline, whilst shielding all other abdominal organs from light using black card 
or aluminium foil. The tissue was photoconverted using two low power violet light sources 
(395 nm, Amazon) for 6 min (caecum) or 10 min (proximal colon) in total. After replacing 
the tissue, the muscle layer was closed by suture and the skin held together with surgical 
clips. Mice were maintained in IVC for 24-48 h until tissue harvest. 
Thoracic duct cannulation 
Male 6-8 week old mice were anaesthetised by continuous inhalation of isoflurane (Abbot 
Animal Health). After laparotomy, mesenteric lymphadenectomy was performed by blunt 
dissection. The muscle layer was sutured, followed by closing the skin with surgical clips, 
and the animals usually maintained in IVC for at least six weeks before thoracic duct 
cannulation to allow the mesenteric lymph vessels to reanastomose. Mice then underwent a 
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second surgical procedure after receiving 200 µl olive oil by gavage to visualise the 
lymphatics, which involved insertion of a polyurethane cannula (2 Fr, Linton 
Instrumentation) into the thoracic duct. The cannula was held in place by securing it with 
super glue (Loctite), and the muscle layer sutured. To avoid biting and severing of the 
cannula, this was fed through a wire tube attached to a harness worn by the mouse. Lymph 
was collected on ice in 1 ml sterile PBS supplemented with 20 U/ml heparin sodium 
(Wockhardt) for 16-24 h after surgery. 
2.1.3 In vivo antibiotic treatment 
Mice were given a cocktail of five antibiotics in their drinking water, supplemented with 
saccharin tablets (10/500 ml) to encourage drinking. The following antibiotics were used: 
ampicillin (1 mg/ml), neomycin (1 mg/ml), gentamicin (1 mg/ml), metronidazole 
(1 mg/ml) and vancomycin (0.5 mg/ml). Control animals received water supplemented 
only with saccharin. Mice were kept on oral antibiotics for seven days, during which both 
groups were weighed daily and received additional baby food mixed with drinking water to 
ensure adequate hydration.  
2.1.4 In vivo blocking of TIM4 
Mice were given i.p. injections of 200 µg αTIM4 (RMT4-53, BioXCell) or Rat IgG2a 
isotype control (2A3, BioXCell). Treatment time points and frequency varied with 
experiments. For assessing DC migration, Kaede mice were treated 24 h prior to 
photoconversion of the proximal colon. For infection experiments, mice were treated 
either 24 h before infection with S. Typhimurium, or four and six days after infection with 
C. rodentium.  
2.2 Bacterial infections 
2.2.1 Bacterial strains and culture 
Overnight cultures of NRG857c were grown in Luria broth (LB) at 37°C, 180 rpm. After 
1:1000 dilution in LB the next day and growth until an OD600 of 0.8 was reached, cells were 
centrifuged at 5000 ×g, 4°C, for 10 min and resuspended in sterile PBS.  
Bioluminescent wildtype C. rodentium strain ICC16842 (Petty et al. 2010) was kindly 
provided by Dr Andrew Roe and Dr James Connolly at the University of Glasgow. It was 
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generated by inserting the plasmid p16S::lux encoding the lux operon of Photorhabdus 
luminescens and an erythromycin resistance gene. The plasmid is permissive at 30°C and 
stable integration into the bacterial chromosome at the 16S locus by site-specific 
recombination was achieved upon temperature shift to 42°C, according to the method 
described by Riedel et al. (2007) . For in vivo infections, C. rodentium was grown overnight 
in LB at 37°C, 180 rpm. The following day, the culture was diluted 1:100 in fresh LB and 
grown until an OD600 of 0.75 had been reached. Cells were then centrifuged at 5000 × g, 
4°C, for 10 min and resuspended in sterile PBS.  
The wildtype S. Typhimurium strain SL1344 was used for in vivo infections. 
S. Typhimurium was incubated in LB overnight at 37°C, 180 rpm. The following day, 
cultures were diluted 1:10 in LB and grown incubated without agitation at 37°C to simulate 
an anaerobic environment until an OD600 of 0.70 was reached. Cells were centrifuged at 
5000 × g, 4°C, for 10 min and resuspended in sterile PBS. 
2.2.2 Mouse infections 
Bacterial infections were carried out in male and female 6-14 week old mice. Animals 
within each experimental group were co-housed where possible. For NRG857c and 
S. Typhimurium infections, mice were treated orally by gavage with 20 mg streptomycin 
sulphate (Sigma) in sterile H2O 24 h before infection. Mice were infected with between 
6 × 108 and 7 × 109 colony forming units (CFU) NRG857c or 6 × 108 CFU 
S. Typhimurium by gavage. Control animals received streptomycin followed by sterile PBS 
24 h later. Serial dilutions of the inoculum were plated on LB agar to determine the actual 
infective dose for each experiment. Mouse weights were monitored on a regular basis. At 
appropriate time points, mice were killed and tissues harvested. For DSS experiments, mice 
were given 0.5% DSS in their drinking water for two days prior to and two days post-
infection with NRG857c. For experiments with AhR ligand deficient diet, mice were fed on 
AIN-76A chow (Special Diet Services) for a week prior to NRG857c infection and for the 
entirety of the experimental period thereafter. 
For C. rodentium infections, mice received between 1-3 × 109 CFU C. rodentium, or sterile 
PBS by gavage. Serial dilutions of the inoculum were plated on LB agar containing 
500 µg/ml erythromycin (Sigma) to determine infective dose for each experiment. At 
appropriate time points, mice were killed and tissues harvested for analysis. 
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2.2.3 Bacterial quantification from faeces and tissues 
Faeces were collected throughout the period of infection and / or at the time of tissue 
harvest. After weighing, samples were homogenised in an appropriate volume of PBS to 
achieve a 10% w/v dilution and samples centrifuged at 9,000 revolutions per minute (rpm) 
for 10 s to sediment debris. Serial dilutions of the supernatants were plated out on 
chloramphenicol (34 μg/ml, Sigma) and ampicillin (100 μg/ml, Sigma) containing LB agar 
to select for NRG857c, or LB agar supplemented with 500 µg/ml erythromycin to select for 
C. rodentium, and incubated overnight at 37°C before quantification of CFU.  
Tissues were harvested in 2 ml sterile PBS, weighed, and kept on ice until further 
processing. Intestinal tissues were placed in 5 ml 5 mM DTT (Sigma) to remove the mucus 
layer and incubated at room temperature for 15 min, 5 min of which were under rotation 
at 300 rpm. Tissues were then placed in 2 ml of fresh PBS and the mucus fraction 
combined with the initial collection fraction. Serial dilutions were performed of this pooled 
suspension for all infected samples and dilutions plated out on chloramphenicol (34 μg/ml) 
and ampicillin (100 μg/ml) containing LB agar. Tissues were homogenised using a tissue 
homogeniser (Benchmark, D1000) and serial dilutions of homogenates plated out on LB 
agar as above. Tissues homogenates from control animals were plated out without prior 
dilution. After incubation of plates at 37°C overnight, the number of CFU per gram of 
tissue were determined. 
2.2.4 Bioluminescent imaging and analysis 
Colons and caeca from mice infected with bioluminescent C. rodentium were harvested 
and luminescence measured using an IVIS Spectrum In Vivo Imaging System (Caliper Life 
Sciences). Images were analysed using Living Image software (Caliper Life Sciences). 
Firstly, the scale of luminescence measured in average radiance (photons/s/cm2/sr) was 
standardised across images. Subsequently, a region of interest (ROI) was specified for each 
sample to coincide with the rectum. The total flux (photons/s) was calculated for each ROI 
and then normalised to remove background luminescence by subtracting the mean PBS 
total flux from each sample. 
2.3 Histology and immunofluorescence staining 
For immunofluorescence, tissues were taken under terminal anaesthesia, formed into Swiss 
rolls in O.C.T. medium (Tissue-Tek®, VWR) and snap-frozen in isopentane on dry ice 
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before storing at -80°C. Tissues were cut in 8 μm sections and fixed using 1% 
methanol-free paraformaldehyde (PFA) for 10 min. Sections were blocked for 15 min with 
5% bovine serum albumin (BSA, Sigma Aldrich), followed by washing in PBS and a 15 min 
block each with avidin and biotin blocking solutions (Vector). Tissues were stained for 
1.5 h in the dark at room temperature with primary antibodies in 5% BSA. Primary 
antibodies used were anti-O83 (1:50, rabbit polyclonal anti-serum, Oxford Biosystems / 
Statens Serum Institut), anti-EpCAM (1:200, G8.8, AF647-conjugated, Biolegend) or 
isotype control Rat IgG2a, κ (RTK2758, AF647-conjugated, Biolegend). Subsequently 
sections were washed in PBS and incubated with a goat-anti-rabbit AF488-conjugated 
secondary antibody in 5% BSA (1:200, Life Technologies) for 30 min at room temperature 
in the dark. As a control for non-specific secondary antibody binding, additional sections 
were treated with secondary antibody only without previous incubation with anti-O83 
serum (secondary antibody only control, SOC). All sections were washed with PBS and 
nuclei stained with DAPI before mounting. 
Tissue samples for histology were either kept in 10% buffered formalin for at least 24 h 
prior to dehydrating and paraffin embedding, or embedded in O.C.T. medium and snap-
frozen before cryosectioning and fixing in ice-cold acetone/ethanol (75/25%). Paraffin and 
O.C.T. embedded sections were then stained with haematoxylin and eosin (H&E) for 
histological assessment.  
Fluorescence images were captured using an EVOS FL Auto epifluorescence microscope 
and H&E section images were taken using an Olympus BX41 System Microscope. 
2.4 Cell isolation 
2.4.1 Murine intestinal tissues 
Faeces and remaining fat from intestines were removed, tissues opened longitudinally and 
washed in Hanks’ Balanced Salt Solution (HBSS, Life Technologies) supplemented with 2% 
heat-inactivated foetal calf serum (FCS). PP were removed from the small intestine. Tissues 
were then cut into 0.5 cm segments and kept in HBSS / 2% FCS on ice until incubation in 
HBSS / 2 mM EDTA at 37°C under agitation for 2 × 20 min (small intestine) or 2 × 15 min 
(caecum, colon) to remove the mucus and epithelial cell layers. Between incubations 
intestines were washed in pre-warmed HBSS. Small intestines were digested in complete 
media (RPMI 1640 media supplemented with 100 U/ml penicillin and 100 μg/ml 
2. Materials and Methods 
 
81 
streptomycin, 2 mM L-Glutamine, 50 μM 2-mercaptoethanol, and 5-10% FCS) 
supplemented with Collagenase VIII (1 mg/ml, Sigma) for 20 min at 37°C under agitation. 
Colons from Ccr7gfp/gfp mice were digested using the small intestinal protocol. Otherwise, 
colons and caeca were digested in complete media and Collagenase V (0.85 mg/ml, Sigma), 
Collagenase D (1.25 mg/ml, Roche), Dispase (1 mg/ml, Gibco) and DNase (30 μg/ml, 
Roche) for 20-30 min at 37°C under agitation. After tissue digestion, cells were passed 
through a 40 µm cell sieve (colon, caecum), or both 100 µm and 40 µm cell sieves (small 
intestine), washed twice with FACS buffer (PBS supplemented with 2% FCS and 2 mM 
EDTA), and resuspended in FACS buffer for counting and antibody staining for flow 
cytometry analysis. 
2.4.2 Human colonic tissue 
Human colonic resection tissue was collected in sterile PBS. The mucosa was carefully 
dissected from the underlying muscularis externa and cut into 0.5 cm segments. These 
were then placed in pre-warmed HBSS / 2 mM EDTA and incubated at 37°C for 
3 × 15 min under agitation to wash away mucus and the epithelial cell layer. Between 
incubations, tissues were washed in pre-warmed HBSS. After the final wash, tissues were 
digested in complete media (RPMI 1640 media supplemented with 100 U/ml penicillin and 
100 μg/ml streptomycin, 2 mM L-Glutamine, 50 μM 2-mercaptoethanol, and 10% FCS) 
supplemented with Collagenase VIII (1 mg/ml, Sigma), Collagenase D (1.25 mg/ml, 
Sigma), Dispase (1 mg/ml, Gibco) and DNaseI (0.03 mg/ml, Sigma) for 40 min at 37°C 
under agitation. Cells were then passed through a 100 µm and 40 µm sieve prior to being 
washed and resuspended in FACS buffer ready for counting and antibody staining for flow 
cytometry. 
2.4.3 Peyer’s patches 
PP were carefully dissected out from the surrounding tissue and collected in 
HBSS / 2% FCS on ice. They were then transferred into 1 ml complete media supplemented 
with Collagenase VIII (1 mg/ml, Sigma) and digested at 37°C under agitation for 15 min. 
Subsequently, PP were passed through a 40 µm sieve and washed and resuspended in FACS 
buffer for counting and antibody staining for flow cytometry. 
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2.4.4 Lymph nodes 
Lymph nodes were collected on ice in 1 ml serum-free RPMI 1640 media supplemented 
with 100 U/ml penicillin and 100 μg/ml streptomycin, 2 mM L-Glutamine, 50 μM 
2-mercaptoethanol. This was followed by incubation for 40 min at 37°C under agitation in 
serum-free RPMI media as above, supplemented with Liberase (0.4 U/ml, Roche) and 
DNase (50 μg/ml, Roche). After enzymatic digestion, tissues were passed through a 40 μm 
cell sieve, washed with FACS buffer and centrifuged at 400 ×g, 4°C, for 5 min. Cells were 
resuspended in FACS buffer and counted before antibody staining for flow cytometry 
analysis.  
2.4.5 Spleens 
Spleens were passed through a 40 µm cell sieve and washed with FACS buffer. Cells were 
resuspended in 5 ml red blood cell (RBC) lysis buffer (Sigma Aldrich) and incubated for 
5 min on ice. Then cells were washed with FACS buffer, resuspended and counted before 
antibody staining for flow cytometry analysis. 
2.4.6 Lungs 
Lungs were dissected without prior perfusion and cut finely into segments smaller than 
0.5 cm. The tissue was transferred into bijoux containing 3 ml complete media 
supplemented with Collagenase V (0.425 mg/ml, Sigma Aldrich), Collagenase D 
(0.625 mg/ml, Roche) and Dispase (1 mg/ml, Gibco). Tissues were incubated for 40 min at 
37°C under agitation, and shaken vigorously by hand every 5 min. The cell suspension was 
then passed first through a 100 µm sieve, then a 40 µm sieve and washed with FACS buffer. 
The pellets were resuspended in 4 ml RBC lysis buffer (Sigma Aldrich) and incubated on 
ice for 5 min before washing in FACS buffer. After resuspending for counting, cells were 
stained with antibodies for flow cytometry analysis. 
2.4.7 Bone marrow 
Bone marrow isolation was carried out by removing all muscle and fat from the tibia and 
femur separately, followed by carefully cutting an opening on either end of the bones. Four 
bones were placed in a 0.5 ml eppendorf tube, after punching a hole in the bottom of the 
tube using a 21 gauge needle. The 0.5 ml eppendorf tube containing the bones was then 
placed in a 1.5 ml eppendorf tube and spun at 5000 ×g for 30 s, allowing the bone marrow 
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to collect in the 1.5 ml eppendorf tube. Cells were resuspended in 5 ml RBC lysis buffer 
(Sigma Aldrich) and incubated for 5 min before washing in FACS buffer and resuspending 
for counting and staining with antibodies for flow cytometry analysis. 
2.5 Flow cytometry and FACS 
2.5.1 Cell stimulation for intracellular cytokine staining 
Between 2-5 × 106 cells were incubated in 500 µl complete media supplemented with 1:500 
of a cell stimulation cocktail including protein transport inhibitors (eBioscience) at 37°C 
for 4 h. Cells were then washed and resuspended in FACS buffer, ready for surface marker 
staining with antibodies for flow cytometry. 
2.5.2 FACS antibody staining and sample acquisition 
All anti-mouse antibodies were used at a concentration of 1:200 in FACS buffer. The 
following fluorochrome-conjugated antibodies were used: CCR6 (29-2L17), CCR9 
(CW-1.2), CD3 (MEL-14, 17A2), CD4 (GK1.5), CD8α (53-6.7), CD11b (M1/70), CD11c 
(N418), CD19 (6D5), CD25 (PC61), CD44 (IM7), CD45 (30-F11), CD64 (X54-5/7.1), 
CD135 (A2F10), CD205 (NLDC-145), IL-17A (TC11-18H10.1),!Ly6G (1A8), MHCII 
(M5/114.15.2), NK1.1 (PK136), TIM1 (RMT1-4) and TIM4 (RMT4-54) from Biolegend, 
CD8α (53-6.7), FOXP3 (FJK-16s), Ly6C (HK1.4), MHCII (M5/114.15.2) and TIM4 
(RMT4-54) from eBioscience, and SiglecF (E50-2440) and IFNγ (XMG1.2) from BD 
Biosciences. The following fluorochrome-conjugated anti-human antibodies were used at a 
concentration of 1:40 in FACS buffer: CD3 (UCHT1), CD11c (Bu15), CD14 (HCD14), 
CD16 (3G8), CD19 (HIB19), CD56 (5.1H11), CD64 (10.1), CD123 (6H6), HLA-DR 
(L243), SIRPα (SE5A5) and TIM4 (9F4) from Biolegend, CD103 (B-Ly5) from eBioscience, 
and CD45 (HI30) from BD Biosciences. Viability staining was performed using 7AAD 
viability dye (1:10, Biolegend) in FACS buffer, or eFluor780 fixable viability dye (1:10, 
eBioscience) in PBS. Blocking of Fc receptors was carried out for 5 min at 4°C before 
surface staining using anti-mouse CD16/32 (1:200, 93) or Human TruStain FcX (1:40) 
from Biolegend.  
Staining of intracellular proteins such as cytokines or transcription factors was carried out 
using the FOXP3/Transcription Factor staining kit following manufacturer’s instructions 
(eBioscience). Briefly, cells were fixed in 300-500 µl Fix/Perm buffer for 2-3 h or overnight 
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at 4°C before washing and resuspending in 1× Permeabilisation buffer. Cells were then 
incubated with antibodies against intracellular proteins in 1× Permeabilisation buffer for 
1 h at room temperature. Subsequently, they were washed in 1× Permeabilisation buffer 
and then FACS buffer ready for analysis.  
Samples were acquired in FACS buffer on an LSR II, an LSR Fortessa, a FACSAria IIu or 
FACSAria III (BD Biosciences) for analysis. For FACS sorting on a FACSAria IIu or III, 
cells were resuspended in complete medium containing 10% FCS. If cells were to be used 
for in vitro co-culture, they were sorted into complete medium containing 10% FCS. For 
RNA isolation, cells were sorted into 500 µl RLT buffer from the RNeasy Micro kit 
(Qiagen) and stored at -80°C prior to use. !
2.5.3 Aldefluor assay 
RALDH enzyme activity was determined using the Aldefluor assay (Stemcell 
Technologies), according to manufacturer’s specifications. Briefly, 1-2 × 106 cells were 
resuspended in 1 ml Aldefluor assay buffer. For each sample, half the cells were treated 
with Aldefluor reagent only, and half the cells were treated with Aldefluor reagent and an 
inhibitor, DEAB (Diethylaminobenzaldehyde). Samples were incubated as such at 37°C for 
45 min. Cells were then centrifuged to remove the supernatant and resuspended in 
Aldefluor assay buffer ready for staining with antibodies for flow cytometry analysis. 
2.6 Gene expression analysis 
2.6.1 RNA extraction and reverse transcription 
For RNA extraction, samples were thawed and processed using the RNeasy Micro kit 
(Qiagen) according to the supplier’s specifications. RNA was eluted in 14 µl of RNAse-free 
water and kept on ice prior to reverse transcription using the High Capacity 
RNA-to-cDNA kit (Applied Biosciences) according to supplier’s specifications. Samples 
were kept at 4°C prior to quantitative real-time PCR (qRT-PCR). 
2.6.2 Quantitative real-time PCR (qRT-PCR) 
The primer sets used for qRT-PCR are listed in Table 1. PCR reactions were carried out in 
384-well qPCR plates (Starlab) and with a reaction volume of 10 µl, using SYBR Green 
PerfeCTa Fastmix ROX (Quanta Biosciences). Primers were used at a final concentration 
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of 3 µM. Per reaction, 2-3 µl cDNA was added as template. Melt curves and threshold cycle 
(CT) values for each sample and primer set were determined on a Quantstudio Flex 
Real-time PCR machine (ThermoFisher).
Table 1: List of qRT-PCR primers used 
Gene Forward primer sequence (5’3’) Reverse primer sequence (5’3’) 
Ccr7 ATTGCTGCTGAGGGAAGAG ACTTTTGGCTGTCGTTTTGG 
Il1b CGCTCAGGGTCACAAGAAAC GAGGCAAGGAGGAAAACACA 
Aldh1a2 TGTAATCCAGCCACAGGAGAGCAA ACGTCCTCTTTCAGACGCATCCAT 
Itgb8 GGGTGTGGAAACGTGACAAGCAAT TCTGTGGTTCTCACACTGGCAACT 
 
2.7 In vitro OT-II and OT-I MLN cell co-culture with DC  
To establish the ability of various DC populations to drive antigen-specific T cell responses 
in vitro, FACS sorted DC were either kept at 4°C without antigen loading, or pulsed with 
either 2 mg/ml soluble ovalbumin (OVA) protein (Lorne Laboratories) in complete 
medium containing 10% FCS for 2 h at 37°C, or 3 µg/ml 323-339 ovalbumin peptide 
(Invivogen) for 30 min at 37°C. After pulsing, DC were washed twice with 3 ml complete 
medium containing 10% FCS and resuspended in the appropriate volume for co-culture. 
OVA-specific OT-II and OT-I cells were isolated from the MLN of OT-II and OT-I mice 
by mechanical dissociation using a 40 µm cell sieve, and washed with PBS. Prior to co-
culture with DC, 200,000 OT-II and OT-I cells per well were labelled with 5 µM CFSE 
(eBioscience) for 1 min, immediately quenched and washed with 3 ml complete media 
containing 10% FCS. Depending on the experiment, 4,000-12,500 DC were co-cultured 
with 200,000 OT-II or OT-I cells per well for 3-6 days in complete medium containing 10% 
FCS. For in vitro TIM4 blocking experiments, 5µg/ml purified αTIM4 antibody (RMT4-54, 
Biolegend) or Rat IgG2a (RTK2758, Biolegend) were added to co-cultures. Finally, OT-II 
and OT-I cells were stained with antibodies in FACS buffer for analysis by flow cytometry. 
2.8 Statistical analysis 
If data were found to be normally distributed using a D’Agostino & Pearson omnibus 
normality test or a Shapiro-Wilk normality test, a parametric t test was employed for 
statistical analysis. If this was not the case, nonparametric tests were used for comparison 
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testing, such as a Mann-Whitney test or Kruskal-Wallis test. A Dunn’s post-test was 
employed to correct for multiple comparisons. Statistical significance was defined as 
p < 0.05.
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Chapter 3: Colonisation and host response to adherent and 
invasive Escherichia coli 
3.1 Aims and hypotheses 
It is not understood if persistent colonisation with pathobionts such as AIEC in WT mice 
can lead to intestinal inflammation. This is important because bacterial persistence, in 
particular of E. coli species, have been described as causative factors in human IBD. Such 
an in vivo model would therefore be useful in studying the cellular mechanisms that 
contribute to the pathogenesis of IBD. 
To address this, we took advantage of a recently described model system of chronic 
intestinal inflammation that is induced by infection with a strain of AIEC, NRG857c (Small 
et al. 2013). This ileal CD patient isolate induced fibrosis and other signs of chronic caecal 
and colonic pathology, in five different WT mouse strains. This was accompanied by T cell 
infiltrate and elevated cytokine production in these tissues between three and nine weeks 
post infection (p. i.) (Small et al. 2013). To test this in our hands, we set out to analyse the 
cellular host response to long-term infection (3-9 weeks) with NRG857c. We chose this 
time frame based on the previously reported ability of NRG857c to drive chronic 
inflammation (Small et al. 2013). Given the different phases of infection characterised by 
the influx of different immune cells, we assessed the involvement of both innate and 
adaptive immune cells in the intestine and draining LN.  
We aimed to pinpoint which phases of the immune response were active after six and nine 
weeks of infection. This would then allow us to use this model to elucidate the cellular and 
molecular mechanisms driving chronic inflammation and relate them to human disease by 
applying our findings to work with IBD patient samples.  
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3.2 Results 
3.2.1 NRG857c infection causes long-term colonisation of the caecum and colon 
and can be found associated with the intestinal epithelium 
Previous observations suggest that NRG857c causes caecal and colonic pathology in 
wildtype (WT) mouse strains, including C57BL/6 and CD1 mice (Small et al. 2013). We 
began focussing our investigations on the C57BL/6 strain due to the wide availability of 
genetically modified variants on this background that could be of use for future 
mechanistic studies. Mice were treated with streptomycin 24 h before orally infecting with 
NRG857c or treating with PBS (Figure 3. 1a). Shedding of bacteria into the faeces was 
assessed throughout as a measure of colonisation. Colony forming units (CFU) were 
quantified after culturing faecal extracts on LB agar supplemented with chloramphenicol 
and ampicillin to select for NRG857c, as it carries resistance to both antibiotics, unlike 
other intestinal bacteria. Shedding was variable between mice, but could be detected up to 
nine weeks p. i. (Figure 3. 1b). To determine which part of the intestine is preferentially 
colonised by NRG857c, tissues were homogenised seven days p. i. and homogenates 
serially diluted and plated on selective LB agar. The same was performed for the mucus 
fraction of the intestines, isolated by incubating the tissues in 5mM dithiothreitol (DTT) 
prior to homogenisation as described previously (Martin et al. 2004), to break disulphide 
bonds between mucin molecules and allow solubilisation of the mucus. NRG857c was 
found to most heavily colonise the caecum, followed by the colon (Figure 3. 1c). 
Comparable total numbers of bacteria could be recovered from mucus and tissue fractions 
(Figure 3. 1d). These findings led us to focus on the caecal and colonic tissues for further 
characterisation of longer term NRG857c interaction with the host.
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Figure 3. 1: NRG857c infection leads to long-term persistence in the intestines 
(a) Mice were infected with 1-2 × 109 CFU NRG857c by gavage 24 h after treatment with 20 mg streptomycin 
orally. (b) Faecal shedding of NRG857c was monitored over nine weeks and CFU g-1 determined by selective 
growth on LB agar supplemented with chloramphenicol and ampicillin. (c, d) NRG857c burden in tissues 
and mucus seven days p. i. was determined; soluble mucus fractions were collected after incubating tissues in 
5mM DTT; CFU g-1 of tissue were determined by growth on selective LB agar. (c) CFU g-1 per tissue type as 
percentage of total number of CFU recovered per entire intestine. (d) Total additive CFU g-1 recovered from 
tissue and mucus fractions of all intestinal tissue types. Error bars represent S.D. with n = 4-12 (b) and n = 4 
(c, d). Abbr.: Duo = duodenum, Jej = jejunum, Ile = ileum, Cae = caecum, Col = colon
Previous work demonstrated the ability of NRG857c to adhere to and invade human IEC 
in vitro (Eaves-Pyles et al. 2008). Furthermore, AIEC have been shown to induce 
granuloma-like aggregates of macrophages in vitro (Meconi et al. 2007). To determine if 
these observations were similarly maintained during long-term infection of mice with 
NRG857c in vivo, we stained colon sections from mice six and nine weeks p. i. for 
immunofluorescence analysis. NRG587c localisation in caecal crypts four weeks p. i. has 
been previously successfully described using identification of O83, the LPS O antigen 
produced by NRG857c (Small et al. 2013). When colonic sections were co-stained for O83 
and EpCAM to identify epithelial cells, O83+ rod-shaped bacteria could be found in 
aggregates in the lumen, and associated with the epithelial cell layer at six but not nine 
weeks p. i. (Figure 3. 2). No O83+ bacteria were found within the LP, suggesting that 
NRG857c colonises at the mucosal surface without breaching the epithelial barrier.
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Figure 3. 2: NRG857c is found in the lumen and associated with the epithelium of the colon at 6 weeks 
p. i. 
C57BL/6 mice were given 20 mg streptomycin by gavage followed 24 h later by oral infection with 1-3 × 109 
NRG857c or PBS. Immunofluorescence staining of colonic tissue six weeks (6wk) and nine weeks (9wk) p. i. 
with NRG857c and from uninfected animals (PBS). Frozen colonic tissue sections were stained with AF647-
conjugated anti-EpCAM antibody (epithelial cells, red) or isotype control (ISO) and polyclonal rabbit anti-
O83 serum followed by an AF488-conjugated goat-anti-rabbit secondary antibody (bacteria, green). An 
additional control included a section incubated with no anti-O83 serum and subsequent staining with 
AF488-conjugated secondary antibody (secondary antibody only control, SOC). All sections were stained 
with DAPI (nuclei, blue). White arrows denote green O83+ bacteria. Scale bars represent 200 µm. 
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3.2.2 NRG857c infection causes no overt intestinal pathology 
Having demonstrated that NRG857c can colonise the colon and caecum long-term, we 
next aimed to determine if it drives pathology at the site of colonisation. Diarrhoea and 
weight loss are common symptoms of colonic inflammation in mice. However, we 
observed neither diarrhoea, nor changes in weight, over nine weeks p. i. (Figure 3. 3a). A 
further indication of pathology is colon shortening, but this also did not occur in infected 
mice compared to uninfected controls three or six weeks p. i. (Figure 3. 3b). Salmonella 
Typhimurium causes a severe acute infection in mice and caecal shrinking. However, we 
did not observe any changes in caecal appearance after infection with NRG857c (data not 
shown). 
 
Figure 3. 3: NRG857c infection does not cause weight loss or colon shortening 
C57BL/6 mice were treated with 20 mg streptomycin by gavage 24 h before oral infection with 1-2 × 109 CFU 
NRG857c or PBS. (a) Percentage weight changes over nine weeks relative to pre-infection weight at day 0; 
(b) colon lengths at three (3wk) and six (6wk) weeks p. i. compared with PBS-treated controls; Error bars 
represent S.D.; n = 4-12 (a) and n = 3-5 (b).
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Histological indications of intestinal inflammation include crypt elongation, goblet cell 
hyperplasia, a damaged epithelial cell layer, mucosal thickening, and cellular infiltrate into 
the LP. However, we were unable to detect any of these consistently in ileal, caecal or 
colonic tissue sections from infected mice compared with uninfected controls at various 
time points during the course of infection with NRG857c (Figure 3. 4).
 
Figure 3. 4: NRG857c infection causes no overt intestinal pathology. 
C57BL/6 mice were treated with 20 mg streptomycin by gavage 24 h before oral infection with 1-2 × 109 CFU 
NRG857c or PBS. Terminal ileum, caecum and colon were harvested from PBS-treated (a) and infected mice 
at three (b), six (c) or nine (d) weeks p. i. and paraffin or OCT embedded tissue sections stained with H&E. 
Images were taken at 10x magnification and scale bars represent 200 µm.
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3.2.3 NRG857c infection has no effect on innate cell influx to the intestinal LP 
Even though no clear histological evidence of inflammation could be found, changes might 
be happening on the cellular level that are too subtle to be observed in sections. We 
therefore sought to define the changes in immune cell populations during infection with 
NRG857c by flow cytometry. Bacterial infection in the intestine induces a robust early 
neutrophil influx (Spehlmann et al. 2009). As NRG857c could still be detected associated 
with the epithelium at six weeks, increased neutrophils in the LP would be a good 
indication of an active infective process as opposed to non-symptomatic colonisation. 
Neutrophils were defined as CD45+, CD11b+, Ly6G+ cells. However, we did not observe any 
changes in neutrophil frequencies or absolute numbers at six or nine weeks p. i. (Figure 3. 
5). 
 
Figure 3. 5: Long-term NRG857c infection has no effect on Ly6G+ neutrophil frequencies and numbers in 
the caecum and colon 
C57BL/6 mice were treated with 20 mg streptomycin by gavage 24 h before oral infection with 1-2 × 109 CFU 
NRG857c or PBS. Tissues from infected (NRG857c) and uninfected (PBS) animals were collected at six (6wk) 
or nine (9wk) weeks p. i. and cells from colonic and caecal LP were analysed by flow cytometry. 
(a) Representative plots of colonic tissue gated on single, live, CD45+, CD11b+, Ly6G+ cells. Data are shown as 
(b) the percentage of Ly6G+ CD11b+ neutrophils among live cells and (c) their absolute number. Error bars 
represent S.D.; 9wk: data representative of two pooled experiments. Abbr.: Cae = caecum, Col = colon, 
NS = non-shedder, S = shedder
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Recent findings have implicated eosinophils as important effectors of chronic colitis 
through production of TNFα and eosinophil peroxidase (Griseri et al. 2015). We therefore 
investigated if our model caused an influx of eosinophils into the colonic or caecal LP. 
Eosinophilia would be an indication of cellular changes that could lead to chronic 
inflammation. We quantified the percentages of live cells and absolute numbers of SSChi 
CD11b+ Ly6G- granulocytes in the LP, most of which are likely to be eosinophils. However, 
we did not see any changes occurring during infection with NRG857c six or nine weeks 
p. i. (Figure 3. 6). 
 
Figure 3. 6: Long-term NRG857c infection has no effect on SSChi Ly6G- granulocyte frequencies and 
numbers in the caecum and colon 
C57BL/6 mice were treated with 20 mg streptomycin by gavage 24 h before oral infection with 1-2 × 109 CFU 
NRG857c or PBS. Tissues from infected (NRG857c) and uninfected (PBS) animals were collected at six (6wk) 
or nine (9wk) weeks p. i. and cells from colonic and caecal LP were analysed by flow cytometry. 
(a) Representative plots of colonic tissue gated on single, live, CD45+, (CD11b+), Ly6G-, SSChi cells. Data are 
shown as (b) the percentage of SSChi Ly6G- cells among live cells (c) their absolute cell number. Error bars 
represent S.D.; 9wk: data representative of two pooled experiments. Abbr.: Cae = caecum, Col = colon, 
NS = non-shedder, S = shedder
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Intestinal macrophages and inflammatory monocytes are further innate cell populations 
that play an important role in homeostasis and pathogen recognition in the LP. During 
long-term NRG857c infection however, we saw no significant changes in the frequencies or 
absolute numbers of monocyte populations, nor in mature macrophages (Figure 3. 7).
 
Figure 3. 7: NRG857c infection has no effect on monocyte and macrophage populations in the caecum 
and colon at 6 weeks 
C57BL/6 mice were treated with 20 mg streptomycin by gavage 24 h before oral infection with 1-2 × 109 CFU 
NRG857c or PBS. Tissues from infected (NRG857c) and uninfected (PBS) animals were collected at six weeks 
p. i. and cells from colonic and caecal LP were analysed by flow cytometry. (a) Representative plots of colonic 
tissue gated on single, live, CD45+, CD11b+, CD64+ cells. Data are shown as (b) the percentage of monocyte 
and macrophage populations among live cells and (c) their absolute cell number. Error bars represent S.D.; 
open circles: controls, closed red circles: NRG857c shedders; Abbr.: P1 = Ly6C+ MHCII- monocytes, 
P2 = Ly6C+ MHCII+ monocytes, P3 = Ly6C- MHCII+ macrophages.
3. Colonisation and host response to AIEC 
 
96 
3.2.4 Caecal dendritic cells migrate to the first colon-draining lymph node 
As we saw no change in the innate responses in the LP of infected mice, we next sought to 
characterise the T cell response in the draining MLN. Recent work from our laboratory 
showed that distinct LN in the MLN chain separately drain the small intestine and colon 
(Houston et al. 2016). The first node in the chain, often the most prominent, drains the 
colon, together with a second smaller lymph node off the MLN chain (cMLN1 and cMLN2, 
respectively) (Figure 3. 8). The remainder of the MLN drain the small intestine (sMLN) 
(Figure 3. 8). Drainage of the caecum was not included as part of the original investigation, 
but owing to the high colonisation burden of NRG857c in the caecum, this information is 
essential for accurately characterising the tissue-specific T cell response to the bacteria. The 
caecum’s anatomical proximity to the cMLN1 (Figure 3. 8) would make this the most likely 
node involved. 
 
Figure 3. 8: Distinct mesenteric lymph nodes drain the small intestine and the colon. 
The MLN chain is comprised of separate lymph nodes that drain different murine intestinal tissues. The first 
node (from right to left) drains the colon, together with a small node found off the main MLN chain, while 
the other lymph nodes drain the small intestine. Schematic based on findings by Houston et al. (2016). 
To test this hypothesis, we used Kaede mice which ubiquitously express the 
photoconvertable Kaede protein, allowing us to track migration of cells over time in vivo 
(Tomura et al. 2008). In these mice, violet light stably photoconverts the Kaede protein 
from green to red. When we surgically exposed the caecum of these mice to violet light and 
assessed the percentage of Kaede-red+ DC in the cMLN1, cMLN2 and sMLN, we could find 
these only in the cMLN1, confirming this as the major site of caecal dendritic cell 
migration (Figure 3. 9). 
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Figure 3. 9: The cMLN1 is the major site of caecal dendritic cell migration. 
The caeca of Kaede mice were photoconverted using violet light after laparotomy and the presence of Kaede-
red+ dendritic cells in small intestinal MLN (sMLN) and the two colon-draining lymph nodes cMLN1 and 
cMLN2 was assessed by flow cytometry 24 h later. (a) Representative gating strategy of migratory DC; (b, c) 
representative plots and histogram showing Kaede-red+ migratory dendritic cells in cMLN1 of a 
photoconverted mouse, but not in the sMLN, cMLN2 or cMLN1 of a nonconverted (NC) control; 
(d) percentage Kaede-red+ cells of migratory DC in sampled photoconverted (PC) MLN compared with NC 
controls. Overall PC samples p < 0.05 (Kruskall-Wallis test) with n = 3. Error bars represent S.D. 
We concluded therefore that the cMLN1 drains both the proximal colon and the caecum 
(Figure 3. 10) (Houston et al. 2016). Based on these findings, we decided to focus our 
characterisation on T cells in only the cMLN1 and cMLN2 (from now collectively termed 
“cMLN”) to avoid diluting any colon/caecum-specific effect.
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Figure 3. 10: Mapping dendritic cell migration from the three murine intestinal tissues to distinct MLN. 
The now complete picture of the DC migration pattern from the three intestinal compartments; the sMLN 
drain only the small intestine and the cMLN2 only the colon, whilst the cMLN1 constitutes the shared 
destination of both caecal and colonic DC.
3.2.5 NRG857c infection has no effect on CD4+ T cell activation or expression of 
chemokine receptors in the colon-draining MLN 
 We saw no changes in the overall frequencies of CD4+ or CD8+ T cells in the cMLN 
(Figure 3. 11a) six or nine weeks after NRG857c infection.  CD4+ T cell populations in the 
LN can be defined by their expression of CD62L (naïve), CD44 (recently activated) and 
CD25 (ready to undergo proliferation). During an on-going immune response, the 
percentage of CD62L+ CD44- naïve T cells would be expected to decrease, and a 
corresponding increase in activated CD44+ CD62L- T cells should be observed. This was 
not the case; no changes in the frequency of CD44+ CD62L- or CD25+ CD4+ T cells were 
observed six or nine weeks p. i. with NRG857c (Figure 3. 11b). 
NRG857c infection also did not induce increased expression of CCR9 on CD44+ CD4+ 
T cells (Figure 3. 11c), suggesting that infection had no effect on the gut-homing potential 
of activated T cells. We used CCR6 as a surrogate marker for Th17 cells in the cMLN, and 
could detect no changes in the frequencies of CCR6+ CD44+ CD4+ T cells p. i. with 
NRG857c (Figure 3. 11c)
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Figure 3. 11: NRG857c infection has no effect on CD4+ T cell activation or expression of specific 
chemokine receptors in the cMLN.  
C57BL/6 mice were treated with 20 mg streptomycin by gavage 24 h before oral infection with 1-3 × 109 CFU 
NRG857c or PBS. Tissues from infected (NRG857c) and uninfected (PBS) animals were collected at six (6wk) 
or nine (9wk) weeks p. i. and CD4+ T cells from the cMLN were analysed by flow cytometry; (a) percentage 
among live cells and absolute cell number of live CD4+ CD3+ T cells gated on single, live, CD45+ cells. 
(b) CD44+ CD62L- CD4+ T cells and CD25+ CD4+ T cells as percentage among live cells; gated on single, live, 
CD45+, CD3+, CD4+ cells. (c) Expression of CCR6 and CCR9 on CD44+ T cells; gated on single, live, CD45+, 
CD3+, CD4+, CD44+ cells. Error bars represent S.D.; data pooled from two independent experiments for both 
six and nine week time points with n = 3-4 in control and infected groups. Abbr.: NS = non-shedders, 
S = shedders
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3.2.6 Long-term NRG857c infection has no effect on CD4+ or CD8+ T cell 
frequencies and numbers in the caecum and colon 
Even though in our hands no signs of elevated innate responses to NRG857c were seen in 
the LP during long-term infection, the nature of the immune response might have changed 
to a T cell-mediated adaptive response at the chosen time points. The frequencies and total 
numbers of CD4+ and CD8+ T cells infiltrating the LP were therefore determined at six and 
nine weeks p. i. with NRG857c and compared with PBS-treated controls. However, 
contrary to the earlier published work (Small et al. 2013), we were unable to find evidence 
of an elevated T cell response in the colons or caeca of these animals (Figure 3. 12). Taken 
together, these findings suggest that NRG857c colonisation is asymptomatic in our hands 
and that it is unable on its own to establish a persistent and chronic infection in the 
intestine of C57BL6 mice.
 
Figure 3. 12: Long-term NRG857c infection has no effect on CD4+ or CD8+ T cell frequencies and 
numbers in the caecum and colon.  
C57BL/6 mice were treated with 20 mg streptomycin by gavage 24 h before oral infection with 1-2 × 109 CFU 
NRG857c or PBS. Tissues from infected (NRG857c) and uninfected (PBS) animals were collected at six (6wk) 
and nine weeks (9wk) p. i. and T cells from colonic and caecal LP were analysed by flow cytometry. (a) 
Representative plots of colonic tissue gated on single, live, CD45+ CD3+ cells. Data are shown as (b) the 
percentage of CD4+ and CD8+ cells among live cells and (c) their absolute cell number. Error bars represent 
S.D.; 9wk: data from two pooled experiments; Abbr.: Cae = caecum, Col = colon, NS = non-shedder, 
S = shedder
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3.2.7 NRG857c does not cause changes in tissue innate or adaptive responses in 
out-bred CD1 mouse strain 
The immune response to a pathogen can be genetically determined and has been shown to 
vary in different mouse strains. Indeed, Small et al. (2013) found that NRG857c-associated 
pathology manifested itself in both histological changes and a robust increase in pro-
inflammatory cytokine production in both colonic and caecal tissue in C57BL/6 and CD1 
mice (Small et al. 2013). The latter is an out-bred mouse strain that is most commonly used 
in toxicology and oncology. As we were unable to detect any consistent signs of pathology 
in infected C57BL/6 mice, we sought to define the response to NRG857c in CD1 mice in an 
attempt to explore the aspect of genetic susceptibility to disease. The infection was further 
carried out in male and female mice separately, to identify any gender-specific differences. 
The time point for analysis was chosen to be three weeks, as this was the time frame that 
was shown to induce tissue inflammation in CD1 mice in the original report by Small et al. 
(2013). No evidence of consistent neutrophilia as part of an early, acute response to 
NRG857c was found in either males or females (Figure 3. 13). 
 
Figure 3. 13: NRG857c does not cause changes in tissue neutrophil frequencies in out-bred CD1 mouse 
strain.  
Male and female CD1 mice were treated with 20 mg streptomycin by gavage 24 h before oral infection with 2-
3 × 109 CFU NRG857c or PBS. Tissues from infected (NRG857c) and uninfected (PBS) animals were 
collected at three weeks p. i. and cells from colonic and caecal LP were analysed by flow cytometry. 
(a) Representative plots of Ly6G+ CD11b+ colonic neutrophils gated on single, live, CD45+ cells. (b) Data are 
shown as the percentage of Ly6G+ CD11b+ among live cells, and their absolute cell number. Open circles: 
PBS-treated, closed red circles: NRG857c shedders, open red circles: NRG857c non-shedders. Error bars 
represent S.D.; Abbr.: m = males, f = females, Cae = caecum, Col = colon.
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We next quantified the incoming monocyte populations in these mice. No significant 
changes in monocyte influx were observed in female mice (Figure 3. 14). Males displayed a 
trend towards increased Ly6C+ MHCII- monocyte numbers and decreased Ly6C- MHCII+ 
mature macrophage numbers (Figure 3. 14), although more biological repeats would be 
required to determine statistical significance. 
 
Figure 3. 14: NRG857c may cause changes in tissue monocyte and macrophage frequencies in male CD1 
mice. 
Male and female CD1 mice were treated with 20 mg streptomycin by gavage 24 h before oral infection with 2-
3 × 109 CFU NRG857c or PBS. Tissues from infected (NRG857c) and uninfected (PBS) animals were 
collected at three weeks p. i. and cells from colonic and caecal LP were analysed by flow cytometry. 
(a) Representative plots showing colonic monocytes and macrophages gated on single, live, CD45+, CD11b+, 
Ly6G-, SSClo cells. Data are shown as (b) the percentage of monocyte and macrophage populations among 
live cells and (c) their absolute cell number. Open circles: PBS-treated, closed red circles: NRG857c shedders, 
open red circles: NRG857c non-shedders. Error bars represent S.D.; Abbr.: m = males, f = females, Cae = 
caecum, Col = colon, P1 = Ly6C+ MHCII- monocytes, P2 = Ly6C+ MHCII+ monocytes, P3 = Ly6C- MHCII+ 
macrophages. 
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Finally, no indication of an enhanced adaptive T cell response was seen in these mice, as 
CD4+ and CD8+ T cell frequencies and numbers in the colonic and caecal LP remained 
unchanged three weeks p. i. with NRG857c (Figure 3. 15).
 
Figure 3. 15: NRG857c does not cause changes in tissue T cell frequencies in out-bred CD1 mouse strain.  
Male and female CD1 mice were treated with 20 mg streptomycin by gavage 24 h before oral infection with 
2-3 × 109 CFU NRG857c or PBS. Tissues from infected (NRG857c) and uninfected (PBS) animals were 
collected at three weeks p. i. and cells from colonic and caecal LP were analysed by flow cytometry. 
(a) Representative plots showing CD4+ and CD8+ T cells from colonic LP gated on single, live, CD45+, CD3+ 
cells. Data are shown as (b) the percentage of CD4+ and CD8+ T cells among live cells and (c) their absolute 
cell number. Open circles: PBS-treated, closed red circles: NRG857c shedders, open red circles: NRG857c 
non-shedders; Error bars represent S.D.; Abbr.: m = males, f = females, Cae = caecum, Col = colon. 
3.2.8 Treatment with 0.5% DSS does not enhance NRG857c ability to drive 
cellular influx to the colonic or caecal LP 
Previous models investigating the role of AIEC in driving colonic inflammation used an 
alternative strain, LF82 (Carvalho et al. 2008, 2009). This group found that infection with 
LF82 aggravated inflammation when mice were treated with 2% DSS treatment to induce 
colonic epithelial cell injury (Carvalho et al. 2008). As NRG857c could be detected 
associated with the colonic epithelium in our model, we hypothesised that low-level DSS 
treatment concomitantly to infection might be enough to break down the barrier and allow 
NRG857c to cross and induce chronic inflammation. The experimental regimen we used is 
depicted in Figure 3. 16a. Briefly, male and female C57BL/6 mice were given 0.5% DSS in 
their drinking water for 24 h before streptomycin treatment and subsequent infection with 
2 × 109 CFU NRG857c or gavage with PBS for controls. Mice were kept on DSS for a 
further two days p. i. and then put on standard drinking water. 
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Figure 3. 16: DSS treatment may enhance the ability of NRG857c to induce weight loss in female but not 
male mice.  
(a) Male and female C57BL/6 mice were given 0.5% DSS in their drinking water for five days, beginning a day 
before treatment with 20 mg streptomycin by gavage and subsequent oral infection with 1 × 109 NRG857c or 
PBS 24 h later. Weights were monitored at regular intervals throughout the experimental period and colons 
harvested at three weeks p. i. for analysis. (b) Percentage weight changes over three weeks relative to pre-
infection weight on day 2. (c) Colon lengths three weeks p. i.; error bars represent S.D.; statistical analysis was 
carried out using a Kruskal-Wallis test with a Dunn’s test for multiple comparisons; # p < 0.05 between 
female PBS-treated and male NRG857c infected animals, * p < 0.05 between female and male PBS-treated 
animals. Abbr.: f = female, m = male.
We monitored weight over the course of infection, as DSS treatment is known to induce 
weight loss and we hypothesised that additional infection with NRG857c would aggravate 
this. We found that within the control group, male mice had lost weight during by 4-5 days 
of treatment, whereas females had not (Figure 3. 16b). On the other hand, there was no 
difference in weight loss between infected and control animals, regardless of gender. We 
also did not observe any differences in colon lengths between infected and control mice 
three weeks p. i. (Figure 3. 16c).
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To determine if concurrent DSS treatment with infection induced mucosal inflammation, 
colonic LP cells were analysed three weeks p. i. by flow cytometry. No significant increase 
in CD11b+ Ly6G+ neutrophils was detected in males or females infected with NRG857c 
(Figure 3. 17a). 
    
Figure 3. 17: DSS treatment does not enhance the ability of NRG857c to induce granulocyte influx into 
colonic lamina propria.  
Male and female C57BL/6 mice were given 0.5% DSS in their drinking water for five days, beginning a day 
before treatment with 20 mg streptomycin by gavage and subsequent oral infection with 1 × 109 NRG857c or 
PBS 24 h later. Colons were harvested for analysis three weeks p. i. (p. i.) and LP cells analysed by flow 
cytometry. (a) Representative plots showing colonic Ly6G+ CD11b+ neutrophils gated on single, live, CD45+ 
cells; data shown as the percentage of Ly6G+ CD11b+ among live cells and their absolute cell number. 
(b) Representative plots showing colonic SSChi granulocytes gated on single, live, CD45+, CD11b+, Ly6G-, 
CD11c(lo-int) cells. Data are shown as the percentage of SSChi Ly6G- cells among live cells, and as their absolute 
cell number. Error bars represent S.D.
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Furthermore, when analysing CD11b+ SSChi Ly6G- granulocytes, a population that is 
mainly constituted by eosinophils, no change was found between experimental groups 
(Figure 3. 17b). We further hypothesised that infection with NRG857c would enhance the 
influx of monocytes to the LP that had been observed during DSS colitis previously (Bain 
et al. 2013). However, this was not the case, as no changes in monocyte or macrophage 
frequencies were noted between infected and control animals of either gender (Figure 3. 
18). 
 
Figure 3. 18: DSS treatment together with NRG857c infection does not change monocyte and 
macrophage population frequencies in the colonic lamina propria.  
Male and female C57BL/6 mice were given 0.5% DSS in their drinking water for five days, beginning a day 
before treatment with 20 mg streptomycin by gavage and subsequent oral infection with 1 × 109 NRG857c or 
PBS 24 h later. Colons harvested for analysis three weeks p. i. (p. i.) and colonic LP cells analysed by flow 
cytometry. (a) Representative plots showing colonic monocyte and macrophage populations gated on single, 
live, CD45+, CD11b+, CD64+, CD11c(lo-int), SSClo cells. (b) Data are shown as the percentage of monocyte and 
macrophage populations among live cells, and as their absolute cell number. Error bars represent S.D.; 
Abbr.: P1 = Ly6C+ MHCII- monocytes, P2 = Ly6C+ MHCII+ monocytes, P3 = Ly6C- MHCII+ macrophages.
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Finally, CD4+ and CD8+ T cell frequencies and absolute numbers remained unaltered in the 
colons of animals infected with NRG857c relative to PBS-treated mice three weeks p. i. 
(Figure 3. 19).
    
Figure 3. 19: DSS treatment does not enhance the ability of NRG857c to induce T cell influx to colon.  
Male and female C57BL/6 mice were given 0.5% DSS in their drinking water for five days, beginning a day 
before treatment with 20 mg streptomycin by gavage and subsequent oral infection with 1 × 109 NRG857c or 
PBS 24 h later. Colons harvested for analysis three weeks p. i. (p. i.) and colonic LP cells analysed by flow 
cytometry. (a) Representative plots showing colonic CD4+ and CD8+ T cells gated on single, live, CD45+, 
CD3+ cells. (b) Data are shown as the percentage of T cell populations among live cells, and as their absolute 
cell number. Error bars represent S.D.
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3.2.9 Lack of aryl hydrocarbon ligands does not enhance the ability of NRG857c to 
induce intestinal inflammation 
Dietary metabolites such as tryptophan derivatives are important for maintaining survival 
of IEL in the intestinal epithelium (Li et al. 2011). These play a vital role in immune 
surveillance and defence against bacterial pathogens (Edelblum et al. 2015). We set out to 
test the hypothesis that feeding mice an AhR ligand-deficient diet would affect the IEL 
compartment sufficiently to allow increased translocation of NRG857c to the LP after 
infection and lead to persistent inflammation. Mice were fed an AhR ligand-deficient diet 
(AIN-76A) for a week. Animals were then administered streptomycin 24 h prior to 
treatment with NRG857c or PBS (Figure 3. 20a). All animals were kept on the diet for the 
entirety of the experimental period. Weights remained unchanged between PBS-treated 
and infected groups (Figure 3. 20b) and we did not observe any colon shortening three 
weeks p. i. with NRG857c (Figure 3. 20c). 
     
Figure 3. 20: Lack of AhR ligands does not enhance the ability of NRG857c to induce weight loss or 
colonic shortening.  
(a) Mice were fed ad lib. on an AhR ligand-deficient diet (AIN-76A) for a week before treatment with 20 mg 
streptomycin and subsequent oral gavage with 1 × 109 CFU NRG857c or PBS 24 h later. Mice were kept on 
the AIN-76A diet for the duration of the experiment and their weights monitored at regular intervals before 
colons were harvested three weeks p. i.. (b) Percentage weight changes over three weeks relative to pre-
infection weight. (c) Colon lengths compared between NRG857c infected and PBS-treated mice at three 
weeks p. i.. Error bars represent S.D.; both groups contain data pooled from male and female mice 
representative of one experiment with n = 3-4.
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The frequencies of Ly6G+ neutrophils (Figure 3. 21a) and SSChi Ly6G- granulocytes (Figure 
3. 21b) were unchanged in the colonic LP of infected mice compared with controls at three 
weeks. 
  
Figure 3. 21: Lack of AhR ligands does not enhance the ability of NRG857c to induce granulocyte influx 
into the colonic LP  
Mice were fed ad lib. on an AhR ligand-deficient diet (AIN-76A) for a week before treatment with 20 mg 
streptomycin and subsequent oral gavage with 1 × 109 CFU NRG857c or PBS 24 h later. Mice were kept on 
the AIN-76A diet for the duration of the experiment. Colons were harvested three weeks p. i. and LP cells 
were analysed by flow cytometry for frequencies of immune cell populations. (a) Representative plots 
showing Ly6G+ CD11b+ neutrophils gated on single, live, CD45+ cells; data are shown as the percentage of 
Ly6G+ CD11b+ cell among live cells, and as their absolute cell number. (b) Representative plots showing SSChi 
granulocytes gated on single, live, CD45+, CD11b+, Ly6G- cells; data are shown as the percentage SSChi Ly6G- 
cells among live cells, and as their absolute cell number. Error bars represent S.D.; both groups contain data 
pooled from male and female mice representative of one experiment with n = 3-4.
Lack of dietary AhR ligands also had no effect on the ability of NRG857c to drive monocyte 
influx into the LP, and we found no significant change in the frequency of mature 
macrophages in infected mice (Figure 3. 22a). Finally, CD4+ and CD8+ T cell frequencies 
and absolute numbers were not affected in the colonic LP of NRG857c-treated mice 
(Figure 3. 22b), similar to the observations made in infected mice given a standard diet 
(Figure 3. 12). Unfortunately, we did not assess if lack of AhR ligands reduced the 
frequency of IEL in our hands, which would have been important to confirm that the diet 
was indeed inducing a change in the epithelial compartment. 
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Figure 3. 22: Lack of AhR ligands does not enhance the ability of NRG857c to change colonic monocyte, 
macrophage or T cell frequencies.  
Mice were fed ad lib. on an AhR ligand-deficient diet (AIN-76A) for a week before treatment with 20 mg 
streptomycin and subsequent oral gavage with 1 × 109 CFU NRG857c or PBS 24 h later. Mice were kept on 
the AIN-76A diet for the duration of the experiment. Colons were harvested three weeks p. i. and LP cells 
were analysed by flow cytometry for frequencies of immune cell populations. (a) Representative plots 
showing monocyte and macrophage populations gated on single, live, CD45+, CD11b+, Ly6G-, SSClo, 
CD11c(lo-int), CD64+ cells; data are shown as percentage of live cells and absolute numbers. (b) Representative 
plots showing CD4+ and CD8+ T cells gated on single, live, CD45+, CD3+ cells; data are shown as percentage 
of live cells and absolute numbers.  Error bars represent S.D.; both groups contain data pooled from male and 
female mice representative of one experiment with n = 3-4.
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3.3 Discussion 
To investigate microbiota-specific immunity during chronic intestinal inflammation we 
aimed to use a previously published model, in which mice were infected with the 
CD-associated AIEC strain NRG857c. Our results show that NRG857c colonises the 
murine colon and caecum. It persists and is shed by infected mice for up to nine weeks. 
However, we could find no evidence of intestinal inflammation following long-term 
NRG857c infection in two different WT mouse strains. This was also not the case when 
animals were treated in parallel with 0.5% DSS, or when fed an AhR ligand-deficient diet. 
These results are conflicting with the previously published report that suggested a single 
oral dose of NRG857c post-streptomycin treatment is sufficient induce chronic, fibrosing 
inflammation of the caeca of five different WT mouse strains (Small et al. 2013). In our 
hands, even infection of CD1 mice, which were among those exhibiting the most severe 
pathology in the published study, did not result in intestinal inflammation. At six weeks 
p. i. we detected bacteria likely to be NRG857c associated with the colonic epithelium. 
However, we did not observe any bacteria in the LP and crypts, as had previously been 
described (Small et al. 2013).  
The disparities between the previous work and our observations could stem from 
variability introduced by technical issues. For example, the age of mice used in our 
investigations ranged from between seven and 14 weeks and infective doses between 
experiments were variable. However, to control for the latter, data points were analysed 
separately for shedders and non-shedders where possible. Unfortunately, the number of 
data points available was not sufficient in some cases to allow for statistical analysis, and 
where intra-group variability was high (as for example for Ly6G+ neutrophil frequencies), 
more experimental repeats would have added to the conclusiveness of the observed 
outcome. A further confounding factor may have been the use of the anti-helminthic agent 
fenbendazole in administered chow to counteract infection with pinworm that is common 
in our animal facility. To date little is known about the effects of this drug on gut immunity 
or the microbiota. However, it is unlikely to have an inhibitory effect on NRG857c 
pathogenicity, as we saw no intestinal inflammation in infected mice held on AhR ligand-
deficient diet, which does not contain fenbendazole. 
Some of our experiments were carried out using male and some with female mice, whilst in 
the paper by Small et al. (2013) only female mice were used. Work from other groups 
suggests sex-linked differences in the gut microbiota can impact on the pathogenesis of 
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autoimmune disease (Markle et al. 2013, Yurkovetskiy et al. 2013). However, we did not see 
any significant differences in the ability of NRG857c to drive disease in CD1 mice of either 
sex, suggesting that in that strain of mice at least, gender does not play a detectable role in 
determining NRG857c colonisation and pathogenicity. 
Intestinal bacterial infections take different courses dependent on the infecting organism in 
question. For example, S. Typhimurium causes acute and severe gastroenteritis in 
streptomycin pre-treated mice within 48 hours of infection (Barthel et al. 2003). 
C. rodentium infection on the other hand, reaches its peak 9-10 days p. i. (Wiles et al. 
2004), manifesting as colonic pathology similar to that seen in human EHEC infections, 
after which it is cleared naturally by the host (Wiles et al. 2006). The time points that were 
chosen in this study were three, six and nine weeks p. i., in order to assess the level of 
inflammation after long-term infection. However, as seen for enteric infections mentioned 
above, immune responses and bacterial load can change within a matter of days. This could 
have led to the oversight of cellular infiltrate into the LP, for example, due to sampling at 
the wrong point within the course of infection. This could be circumvented in future 
studies by the use of an in vivo endoscopy system to allow more frequent rectal and colonic 
pathology scoring.  
In their characterisation of the NRG857c infection model, Small et al. (2013) showed 
increased immune cell influx into the caecal LP at three weeks p. i., constituted by more 
F4/80+ macrophages and CD3+ T cells in immunostained sections. However, we could not 
detect any significant changes in LP macrophage or T cell populations between infected 
and PBS-treated animals at this time point by flow cytometry. Even though this is already a 
more sensitive read-out for changes in immune cell populations compard with 
immunohistochemistry, we could have added greater depth to our analyses by assessing 
changes in T helper subsets and the cytokines they produce. Indeed, colonic explants from 
infected C57BL/6 mice produced more IL-17 and IFNγ ex vivo than control tissue in 
previous reports (Small et al. 2013), although this could not be replicated conclusively in 
our hands (data not shown). This implicates NRG857c in induction of Th1/Th17-driven 
pathology. The outlined infection experiments could therefore be repeated in the future to 
determine if the percentage of IL-17+/IFNγ+ or RORγt+/T-bet+ CD4+ T cells changes in the 
colonic LP. Furthermore, recently activated CD4+ T cells upregulate expression of CD69 
and CD44, and an on-going T cell mediated tissue immune response would be expected to 
increase the frequency of CD69+ CD44+ CD4+ T cells. Monocyte and macrophage 
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populations are also likely to be changed not only in total cell number, but also in 
expression of cytokines and other regulatory mediators. Differentiated intestinal 
macrophages are tolerogenic and characterised by production of the regulatory cytokine 
IL-10 (Bain et al. 2013). However, upon induction of colitis, they upregulate expression of 
pro-inflammatory mediators such as IL-6 and IL-1β (Bain et al. 2013). Analysing 
macrophage cytokine expression could have therefore also been a more sensitive readout 
for NRG857c-induced mucosal changes. 
Bacterial infection causes antigen-specific CD4+ T cell expansion in the draining LN 
(McSorley et al. 2002). To accurately quantify tissue-specific T cell responses, we first had 
to identify which MLN drained the caecum, which is one of the main sites of inflammation 
in many models of bacterial infection in vivo, including that reportedly caused by 
NRG857c (Small et al. 2013). We were able to confirm that the first cMLN in the chain 
(cMLN1) is the only MLN to drain the caecum, by tracking DC migration over 24 h in 
Kaede mice. However, we could not detect any evidence of CD4+ T cell expansion in the 
cMLN1 at six or nine weeks p. i., and no increase in activation or intestinal homing 
receptors. The MLN T cell response was not characterised by Small et al. (2013) in their 
original description of the model, and our results provide evidence against on-going 
bacterial-induced antigen presentation and CD4+ T cell activation in the draining LN. 
Treatment of animals with low concentrations of DSS concomitant to infection did not 
have any enhancing effect on the ability of NRG857c to induce mucosal inflammation. 
However, this experiment was only performed once and may require some optimisation. 
For example, the percentage of DSS could be too low to have an effect, and the period of 
administration may have been too short. Administration of low-level DSS throughout the 
course of infection for example may have greater potential to cause sufficient colonic 
epithelial damage to allow NRG857c translocation. AhR ligand deficiency also had no 
effect on cellular recruitment to the LP following infection with NRG857c. However, CD8+ 
IEL frequencies were not analysed in these mice, which would have been an important 
control to help understand if the diet was having the effect that had been previously 
reported (Li et al. 2011). 
Apart from issues with experimental design, there may be fundamental biologically 
relevant reasons for NRG857c not causing intestinal pathology in our hands. One of them 
may be the difference in microbiota between animal facilities and suppliers. To begin to 
explore this possibility, experiments were carried out with mice supplied from both Harlan 
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and Charles River, but no differences were observed between batches. Nonetheless, even 
though streptomycin treatment is likely to cause a comparable reduction in species 
diversity in all animals regardless of original microbiota composition, it is conceivable that 
certain resistant species present in our animals could inhibit NRG857c virulence. 
Comparison of the faecal microbiota in our animal facility and that of the original report 
by Small et al. (2013) would be required to confirm this.  
A further biological reason could be intrinsic to NRG857c itself. Virulence factors 
identified in the genome of NRG857c include a Type VI secretion system and long polar 
fimbriae components (Nash et al. 2010), which may be important factors governing its 
ability to persist and drive inflammation in the human terminal ileum. However, it may 
lack the necessary virulence factors required to establish infection in the murine colon. In 
fact, AIEC strain LF82 was shown to induce colitis in mice that expressed human 
CEACAMs (Carvalho et al. 2009) but not in WT mice, suggesting that this strain is adapted 
to express adhesins that specifically allow colonisation of the human mucosa. A similar 
principle may apply to NRG857c. One of the reasons that enteric pathogens such as 
S. Typhimurium and C. rodentium effectively establish an acute infection is that expression 
of a T3SS allows direct interaction with IEC and efficient translocation of bacterial effector 
proteins into the cell. This is not the case for NRG857c (Nash et al. 2010), which may be 
another reason for its inability to cause a strong inflammatory response.  
Based on our findings we conclude that this model is not suitable for investigating the 
cellular and molecular mechanisms governing the intestinal immune response to chronic 
bacterial infection. While able to colonise long-term, NRG857c does not cause tissue 
pathology or any induction of innate or adaptive immunity in the intestine. Since its 
original description by Small et al. (2013) this model has only been used in two papers, one 
follow-up study from the same laboratory (McPhee et al. 2014), and one independent study 
(Cieza et al. 2015). Both focus on bacterial colonisation rather than the immune response 
to NRG857c. However, while the infection regime is maintained in the follow-up 
publication, mice that only had low-level colonisation or had cleared NRG857c were 
excluded from that study’s analysis (McPhee et al. 2014). This points to a significant degree 
of variability in their hands and corroborates our findings. Despite the fact that this strain 
does not breach the epithelial barrier in our hands, it may, however, provide a useful model 
system to elucidate the molecular determinants leading to bacterial colonisation and 
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adhesion in the intestine. Insights from such experiments would represent important 
contributions to understanding the pathogenesis of IBD in humans.
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Chapter 4: Expression of apoptotic cell receptors in the 
intestine 
4.1 Aims and hypotheses 
Bacterial infection in the intestine causes apoptosis (Moss et al. 1996, Zychlinsky et al. 
1996, Barnett Foster et al. 2000), and recognition of apoptotic cells is an important factor 
regulating the outcome of T cell responses (Torchinsky et al. 2009). DC are likely to be key 
players in this process, as they convey tissue- and antigen-specific information to the T cell 
during its priming phase in the LN, thereby directing its differentiation. All intestinal DC 
subsets migrate in lymph (Cerovic et al. 2013) and can cross-present antigen to CD8+ 
T cells in vitro (Cerovic, Houston, et al. 2014). However, only CD11b- CD103+ DC can 
cross-prime CD8+ T cell responses in vivo, which is thought to be due to their unique 
ability to acquire cell-derived antigen (Cerovic, Houston, et al. 2014). Thus, the repertoire 
of ACR expressed by DC may differ between populations. TIM4 is a PSR with expression 
restricted to antigen-presenting cells (Meyers et al. 2005). However, little is known about 
its tissue and population-specific expression on DC. We therefore set out to answer three 
questions. First, is TIM4 expression restricted to one particular population of DC, 
potentially the CD11b- CD103+ DC. Second, does the tissue environment shape the 
expression of TIM4 on DC, indicating how recognition of apoptosis may affect 
downstream tissue-specific T cell responses. This led us to our third aim, to investigate the 
function of TIM4 on DC in different tissues. We aimed to determine which cells TIM4+ 
DC might be interacting with through receptor-ligand interactions, and to understand how 
TIM4+ DC differed from TIM4- DC in their maturation state and ability to prime antigen-
specific T cell responses. 
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4.2 Results 
4.2.1 TIM4 is expressed on a small population of colonic CD11b- CD103+ DC and 
on intestinal macrophages 
To determine if TIM4 is preferentially expressed by a certain DC population in the LP we 
analysed TIM4 expression on DC isolated from small intestinal and colonic LP, as well as 
from PP by flow cytometry (Figure 4. 1, Figure 4. 2). TIM4 expression on all small 
intestinal LP DC was low (Figure 4. 2), whilst in the colon about 10% of CD103+ CD11b- 
DC expressed TIM4 (Figure 4. 2). Interestingly, of the PP CD11b+ CD103+ DC, which are 
the least abundant subset in the PP, more cells expressed TIM4 compared with the small 
intestinal and colonic LP (Figure 4. 2).
      
Figure 4. 1: Gating strategy for intestinal DC populations 
(a) Small intestinal and colonic DC are gated as single, live, CD45+, MHCII+ CD11c+ cells, with further 
exclusion of macrophages (CD64-) and B cells and plasmacytoid DC (pDC, B220-). (b) Peyer’s patch (PP) DC 
are gated as single, live, CD45+, MHCII+ CD11chi, and CD64- B220- cells to exclude macrophages, and B cells 
and pDC. In all intestinal tissues, four DC populations are defined based on the expression of CD11b and 
CD103.
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Figure 4. 2: TIM4 is mainly expressed by colonic CD11b- CD103+ DC 
Intestinal tissues from C57BL/6 male mice were collected and LP cells analysed by flow cytometry. (a) 
Representative plots for small intestinal (SI), PP and colonic DC gated on single, live, CD45+, MHCII+, 
CD11c+, CD64-, B220- cells. Four DC populations can be defined based on expression of CD11b and CD103: 
CD11b+ CD103- (green), CD11b+ CD103+ (red), CD11b- CD103+ (blue) and CD11b- CD103- (orange). (b) 
Data are shown as the percentage of TIM4+ cells among DC populations. Error bars represent S.D.; statistical 
analysis performed using a Kruskal-Wallis test with a Dunn’s post-test for multiple comparisons. * p < 0.05, 
** p < 0.001.
As macrophages differentiate from incoming monocytes, they upregulate MHCII and 
CX3CR1 (Bain et al. 2013) (Figure 4. 3a). We found that about 15% of colonic CX3CR1hi 
macrophages expressed TIM4 (Figure 4. 3b). Interestingly, CX3CR1hi macrophages in the 
small intestine showed a trend to higher expression levels of TIM4 compared with the 
colon, although this did not reach statistical significance (Figure 4. 3b). 
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Figure 4. 3: TIM4 is expressed on CX3CR1hi macrophages in both the small intestine and colon 
Intestinal tissues from Cx3cr1+/gfp mice were collected and LP cells analysed by flow cytometry. (a) 
Representative plots of colonic tissue are shown illustrating the gating strategy for CD11b+ CD64+ CX3CR1hi 
macrophages. (b) Representative plots of TIM4 staining on small intestinal and colonic macrophage 
populations, and summary data shown as the percentage of TIM4+ cells within CX3CR1hi macrophages of 
the small intestine (SI) and colon. Error bars represent S.D.; statistical analysis performed within populations 
between tissues using an unpaired t test.
4.2.2 TIM4 is mainly expressed on human colonic macrophages 
We used tissue obtained from human surgical colonic resections to determine if the 
expression pattern of TIM4 observed in the murine intestine was equivalent to that found 
in the healthy human colon. Human colonic DC were defined with help of a lineage gate to 
exclude major cell populations such as T and B cells, NK cells, granulocytes and monocytes 
(CD3, CD19, CD56, CD14, CD16). Furthermore, DC were classed as CD64- and CD123- to 
exclude macrophages and pDC (Figure 4. 4). As in the murine gut, human colonic DC can 
be grouped into four distinct subsets based on their expression of SIRPα and CD103 
(Watchmaker et al. 2014) (Figure 4. 4). 
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Figure 4. 4: Human colonic macrophage and DC gating strategies 
Healthy mucosa from the margins of human colonic resection tissue was digested and LP cells analysed by 
flow cytometry. Representative plots show gating strategy for 1) colonic macrophages gated as single, live, 
CD45+, LIN+ (CD3, CD19, CD56, CD14, CD16), CD64+, HLA-DR+, CD11cint cells and 2) DC gated as single, 
live, CD45+, LIN-, HLA-DR+, CD11c+, CD64-, CD123- cells. Four DC populations can be defined on the basis 
of their expression of SIRPα and CD103. 
Macrophages on the other hand were defined as LIN+ (CD14+) CD64+ HLA-DR+ (Figure 4. 
4) and about 25% expressed TIM4 (Figure 4. 5). We could not, however, detect TIM4 
expression on SIRPα- CD103+ DC, the human counterparts of the murine CD11b- CD103+ 
DC, or any of the other human colonic DC subsets (Figure 4. 5). 
           
Figure 4. 5: TIM4 is mainly expressed by human colonic macrophages 
Healthy mucosa from the margins of human colonic resection tissue was digested and LP cells analysed by 
flow cytometry. Representative plots show TIM4 expression on colonic macrophages and DC populations. 
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4.2.3 Expression of apoptotic cell receptor CD205 is higher in the colon compared 
with the small intestine 
Having observed that for specific DC and macrophage populations, TIM4 expression was 
higher in the colon than it was in the small intestine, we examined if this also held true for 
another ACR, CD205. We analysed its expression on total colonic macrophages (CD11b+ 
CD64+ MHCII+ cells) and DC (Figure 4. 6a). Interestingly, we found that CD205 
expression was higher on DC than on macrophages, both in the small intestine and the 
colon (Figure 4. 6b). 
 
Figure 4. 6: CD205 expression is higher on DC than on macrophages in both the murine colon and small 
intestine. 
Small intestinal and colonic tissues from C57BL/6 male mice were harvested and CD205 expression on LP 
cell populations analysed by flow cytometry. (a) Macrophages were gated as single, live, CD45+ CD11b+, 
CD64+, MHCII+ cells; DC were gated as single, live, CD45+, MHCII+, CD11chi, CD64- B220- cells. (b) CD205 
expression is higher on DC (orange) than on macrophages (purple) in both the small intestine and colon as 
assessed by mean fluorescence intensity (MFI). Error bars represent S.D.; statistical analysis was performed 
using a Mann-Whitney test. * p < 0.05. 
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CD205 levels on all DC populations was highest in the colon, although expression followed 
the same pattern in the small intestine and the PP, with CD11b- CD103+ DC exhibiting the 
highest levels, followed by CD11b+ CD103+ DC (Figure 4. 7). This provides further 
evidence for the expression of ACR being highest on CD11b- CD103+ DC in the intestine.
 
Figure 4. 7: CD205 expression is highest on colonic CD11b- CD103+ DC 
Small intestines (SI), PP and colons from C57BL/6 male mice were harvested and CD205 expression on DC 
populations analysed by flow cytometry. (a) Representative plots of CD205 and TIM4 expression on small 
intestinal, PP and colonic DC populations gated on single, live, CD45+, MHCII+, CD11c+, CD64-, B220- cells. 
Four DC populations can be defined based on expression of CD11b and CD103: CD11b+ CD103- (green), 
CD11b+ CD103+ (red), CD11b- CD103+ (blue) and CD11b- CD103- (orange). (b) Data are shown as 
percentage CD205+ cells of DC populations. Error bars represent S.D.; statistical analysis carried out using a 
Kruskal-Wallis test and Dunn’s post-test for multiple comparisons. * p < 0.05.
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4.2.4 Lung CD103+ DC, but not splenic CD8α+ DC, highly express TIM4 
CD103+ CD11b- DC are also found in the lung mucosa, and are thought to be the mucosal 
counterparts of splenic CD8α+ DC (Figure 4. 8), as all these subsets are dependent on the 
transcription factors IRF8 and BATF3 and can cross-present antigen to CD8+ T cells 
(Edelson et al. 2010). 
      
Figure 4. 8: Gating strategies for lung and splenic DC subsets 
Lungs and spleens from C57BL/6 mice were harvested and cells analysed by flow cytometry. 
(a) Representative gating strategy for lung DC, gated as single, live, CD45+, MHCII+, CD11c+, CD64-, B220- 
cells. Two lung DC subsets can be differentiated based on exclusive expression of either CD11b or CD103. 
(b) Representative gating strategy for splenic DC, gated as single, live, CD45+, MHCII+, CD11c+, CD64-, B220- 
cells. Two splenic DC subsets can be differentiated based on exclusive expression of either CD11b or CD8α.
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Strikingly, virtually all lung CD103+ CD11b- DC were TIM4+, whilst TIM4 expression was 
low on lung CD11b+ CD103- DC (Figure 4. 9a). In the spleen only a small percentage of 
CD8α+ DC expressed TIM4, similar to the splenic CD11b+ DC (Figure 4. 9b). These results 
indicate that TIM4 expression on DC may be affected locally by tissue-specific factors and 
signals, as opposed to being determined early in cellular differentiation. 
 
Figure 4. 9: Lung CD103+ DC highly express TIM4 
Lungs and spleens from C57BL/6 male mice were harvested and cells analysed by flow cytometry. (a) Lung 
and (b) splenic DC gated on single, live, CD45+, MHCII+, CD11c+, CD64-, (F4/80-), B220- cells. Data are 
shown as percentage of TIM4+ cells among DC populations. Error bars represent S.D.; statistical analysis 
performed using a paired t test. * p < 0.0001.
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4.2.5 TIM4 expression on bone marrow pre-DC is low 
Tissue DC differentiate from pre-DC which egress the bone marrow and travel in the 
blood stream to lymphoid and peripheral tissue sites, where they fully develop into resident 
DC subsets (Ginhoux et al. 2009, Liu et al. 2009).We hypothesised that if, as our previous 
results would suggest, TIM4 expression is regulated in a tissue- and population-specific 
manner, bone marrow pre-DC would not express TIM4. This was indeed the case; when 
we analysed isolated bone marrow MHCII- CCR9- CD135+ CD11c+ pre-DC (Figure 4. 10a), 
only a very small percentage stained positive for TIM4 (Figure 4. 10b).
     
Figure 4. 10: TIM4 is expressed by very few bone marrow pre-DC 
Bone marrow from C57BL/6 male mice was harvested and cells analysed by flow cytometry. (a) 
Representative gating strategy for pre-DC as single, live, CD3-, CD19-, NK1.1-, CD11b-, MHII-, CCR9-, 
CD135+, CD11c+ cells. (b) TIM4 expression is low on bone marrow pre-DC. Data represented as percentage 
TIM4+ cells of pre-DC. Error bars represent S.D.
4.2.6 TIM4 is upregulated on DC migrating in lymph 
We hypothesised that a DC looses TIM4 expression after taking up apoptotic cell-derived 
antigen in the intestine and migrating in lymph to the MLN. There it dies after antigen 
presentation to T cells, which then leave in the efferent lymph to enter back into circulation 
via the thoracic duct (Figure 4. 11a). In order to collect and study the phenotype of 
migratory lymph DC, we performed thoracic duct cannulation on mice that had previously 
undergone lymphadenectomy of the small intestinal (sMLNx) or colonic (cMLNx) 
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draining MLN specifically (Figure 4. 11b, c). This allowed us to differentiate between small 
intestinal and colonic DC that had taken up antigen and received signals to initiate 
migration (Figure 4. 11). 
 
Figure 4. 11: Thoracic duct cannulation procedure overview 
(a) Schematic detailing the anatomical localisation of small intestine and colon-draining MLN, and the 
direction of lymph flow to and from the nodes. After exiting the MLN, efferent lymph collects in the thoracic 
duct. In preparation for thoracic duct cannulation, mice undergo mesenteric lymphadenectomy six weeks 
beforehand, where either the small intestine (sMLNx, b) or colon-draining (cMLNx, c) lymph nodes are 
removed. During the recovery phase, lymph vessels reanastomose (b, c). After thoracic duct cannulation of 
these mice, collected efferent lymph will contain DC that have migrated from either the small intestine (blue, 
b) or colon (green, c). 
Previous work in the laboratory led to production of an RNA-Sequencing (RNA-Seq) data 
set comparing DC from small intestinal LP and MLNx lymph (Dr Vuk Cerovic, Dr Lotta 
Utriainen, John Cole). When interrogated for the expression levels of Timd4 (TIM4), a 
3-4 fold increase in abundance was found in lymph compared with the LP in CD11b+ 
CD103-, CD11b+ CD103+ and CD11b- CD103+ DC (unpublished, data not shown), 
contrary to our original hypothesis. We therefore sought to establish if this translated to 
the protein level, and if the colon-specific expression pattern we had previously observed 
also held true in lymph. We observed an increased percentage of TIM4+ DC in both 
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sMLNx and cMLNx lymph compared with the LP (Figure 4. 2, Figure 4. 12). Furthermore, 
there was indeed a trend towards a higher percentage of TIM4+ DC migrating from the 
colon than the small intestine, although this did not reach statistical significance (Figure 4. 
12b). This trend also applied to the four DC subsets (Figure 4. 12b), which mirror those 
seen in the LP of the corresponding tissues (Figure 4. 12a), although increased numbers 
would be required to reach a statistically relevant conclusion.
     
Figure 4. 12: A greater percentage of DC are TIM4+ in cMLNx compared with sMLNx lymph 
Lymph was collected from sMLNx and cMLNx mice after thoracic duct cannulation and cells analysed by 
flow cytometry. (a) Representative gating strategy for lymph DC populations gated as single, live, MHCII+, 
CD11c+, B220- cells. (b) Data are shown as the percentage of TIM4+ total DC or DC population in cMLNx 
compared with sMLNx lymph. Error bars represent S.D.; statistical analysis for total DC was carried out 
using a Mann-Whitney test. 
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4.2.7 TIM4 is expressed on migratory and resident DC in mesenteric and 
peripheral lymph nodes 
The findings that TIM4 was upregulated on DC subsets migrating in lymph compared to 
the LP suggested to us that it might be involved in the maturation process undergone by 
DC in preparation for antigen presentation in the lymph node. We therefore determined 
the percentage of DC that were TIM4+ in the MLN that drain the small intestine (sMLN), 
and colon (cMLN), as well as the inguinal lymph nodes (ILN). Migratory DC in the LN 
present higher levels of MHCII on their surface than resident DC (Figure 4. 13a) (Houston 
et al. 2016), which was used to distinguish the two populations. Whilst TIM4 expression 
hardly differed between resident and migratory DC in the MLN, the cMLN contained a 
higher frequency of TIM4+ DC among both resident and migratory populations compared 
with the sMLN (Figure 4. 13b). Interestingly, the proportion of migratory TIM4+ DC was 
highest in the ILN (Figure 4. 13b). 
        
Figure 4.13 continued on next page
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Figure 4. 13: More migratory and resident DC in the cMLN are TIM4+ compared with the sMLN 
Small intestine (sMLN) and colon-draining (cMLN) MLN and inguinal lymph nodes (ILN) were harvested 
from C57BL/6 mice and cells analysed by flow cytometry. (a) Representative plots showing gating strategy for 
DC gated on single, live cells. The level of MHCII expression helps distinguish between migratory and 
resident DC. DC are defined as CD64- (F4/80-), B220- cells. (b) Representative plots are shown of the 
expression of TIM4 on migratory and resident DC in sMLN, cMLN and ILN. The percentage of TIM4+ cells 
among migratory and resident DC is higher in the cMLN compared with the sMLN, and ILN migratory DC 
have the highest TIM4 expression of all. Error bars represent S.D.; statistical analysis performed within 
migratory and resident populations using a Kruskal-Wallis test with a Dunn’s post-test for multiple 
comparisons. * p < 0.01, ** p < 0.001. 
We compared the different migratory DC populations in the sMLN and cMLN for their 
levels of TIM4 expression and found that the increase in proportion of TIM4+ DC in the 
cMLN compared with the sMLN was true for all subsets but the CD11b- CD103- DC 
(Figure 4. 14a, b). Strikingly, CD11b+ CD103+ DC in both the sMLN and cMLN had the 
highest proportion of TIM4+ cells, with 20% and 50% expressing TIM4 in the respective 
tissues (Figure 4. 14b). 
         
Figure 4.14 continued on next page
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Figure 4. 14: CD11b+ CD103+ DC have the highest percentage of TIM4+ cells in both sMLN and cMLN 
Small intestine (sMLN) and colon-draining (cMLN) MLN were harvested from C57BL/6 mice and cells 
analysed by flow cytometry. (a) Representative plots showing migratory DC populations and their expression 
of TIM4 in sMLN and cMLN gated on single, live, CD45+, MHCIIhi, CD11c+, CD64-, B220- cells. Four DC 
populations can be defined based on expression of CD11b and CD103: CD11b+ CD103- (green), CD11b+ 
CD103+ (red), CD11b- CD103+ (blue) and CD11b- CD103- (orange). (b) Percentage of TIM4+ cells among 
migratory DC populations of sMLN and cMLN. Error bars represent S.D.; statistical analyses performed 
using (top row) a Mann-Whitney test, or (bottom row) a Kruskal-Wallis test with a Dunn’s post-test for 
multiple comparisons. * p < 0.05, ** p < 0.0001.
Mapping the changes in TIM4 expression with the path of migration for small intestinal 
and colonic tissues helps identify two main patterns. First, the percentage of TIM4+ cells 
increases for all DC populations with migration to the MLN (Figure 4. 15a). Second, once 
arrived in the cMLN, migratory colonic DC exhibit a population-specific pattern of TIM4 
expression, where the percentage of TIM4+ cells is only further increased for CD11b+ 
CD103- and CD11b+ CD103+ DC in the cMLN (Figure 4. 15b). Conversely, proportions of 
TIM4-expressing CD11b- CD103+ and CD11b- CD103- DC decrease, albeit to levels higher 
than those found in the LP (Figure 4. 15b).
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Figure 4. 15: Mapping TIM4 expression with DC migration 
(a) TIM4 expression on total DC increases with migration and remains high in the MLN for both small 
intestinal (SI) and colonic DC. Data are shown as the percentage of TIM4+ cells among total DC in small 
intestinal and colonic associated tissues. (b) Summary of TIM4 expression changes on DC populations in 
small intestinal and colonic associated tissues. Data are shown as the percentage of TIM4+ cells within the DC 
populations. Error bars represent S.D.; statistical analysis was carried out using a Kruskal-Wallis test, and a 
Dunn’s post-test for multiple comparisons. * p < 0.05, * p < 0.001.
4.2.8 TIM1 is preferentially expressed on colonic CD45- and CD45+ populations in 
intestinal but not lymphoid tissue 
Having observed that the expression of TIM4 on DC is not limited to the intestine, but 
increases in lymph, we hypothesised that TIM4 may be acting in a capacity other than 
purely as an apoptotic cell receptor. Previous work has demonstrated that TIM4 is the 
natural ligand for TIM1 (Meyers et al. 2005), also a member of the TIM family of proteins 
that acts as a PS receptor (Kobayashi et al. 2007). We first analysed TIM1 expression on the 
CD45- cell compartment of the intestines, which is comprised of IEC, stromal cells and 
endothelial cells. Interestingly, a greater percentage of colonic CD45- cells expressed TIM1 
when compared with the small intestine (Figure 4. 16). 
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Figure 4. 16: TIM1 expression on CD45- cells is higher in the colon than the small intestine 
Small intestinal (SI) and colonic tissues were harvested from Cx3cr1+/gfp mice and cells analysed by flow 
cytometry. Representative plots show CD45- TIM1+ cells gated on single, live cells. Data are shown as the 
percentage of CD45- TIM1+ cells of live cells. Error bars represent S.D.; statistical analysis was performed 
using a Mann-Whitney test. * p < 0.001.
Furthermore, we found that 80% of mature CX3CR1hi macrophages expressed TIM1 in 
both the small intestine and the colon (Figure 4. 17). 
 
Figure 4. 17: TIM1 is highly expressed on CX3CR1hi macrophages in the intestine 
Intestinal tissues from Cx3cr1+/gfp mice were collected and LP cells analysed by flow cytometry. 
(a) Representative plots of colonic tissue are shown illustrating the gating strategy for CD11b+ CD64+ 
CX3CR1hi macrophages. (b) Representative plots of TIM1 staining on small intestinal and colonic 
macrophage populations, and summary data shown as the percentage of TIM1+ cells within CX3CR1hi 
macrophages of the small intestine (SI) and colon. Error bars represent S.D.; statistical analysis was 
performed using a Mann-Whitney test.
In lymph, the expression of TIM1 on migrating cells was much lower than that seen on 
macrophages in the LP. Lymph cells that made up the total TIM1+ populations were 
MHCII+ B220+ B cells (40%), CD8+ T cells (15-25%) and B220- CD8- lymphocytes 
(20-30%), most likely to be mainly CD4+ T cells (Figure 4. 18a). Interestingly, within the 
TIM1+ CD8+ T cell compartment, a distinct population of CD103int cells could be identified 
(Figure 4. 18a). Overall, TIM1+ cells only corresponded to ≤ 0.5% of either lymph B cells or 
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CD8+ T cells (Figure 4. 18b). There was no significant difference in TIM1 expression on 
lymphocyte populations between sMLNx and cMLNx lymph (Figure 4. 18). 
 
Figure 4. 18: TIM1 is expressed on a small subset of B cells and CD8+ T cells in lymph 
Lymph was collected after thoracic duct cannulation of sMLNx and cMLNx animals and the expression of 
TIM1 on lymphocyte populations analysed by flow cytometry. (a) Total TIM1+ cells were gated on single, live 
cells. The TIM1+ population was made up of MHCII+ B220+ B cells, and CD8+ and CD8- lymphocytes. The 
CD8+ lymphocytes could be further separated into CD103int and CD103- populations. (b) B cells were gated 
as single, live, MHCII+ B220+ cells. CD8+ T cells were gated as single, live, MHCII-, CD8α+, SSClo, FSClo cells. 
Data are represented as percentage of TIM1+ cells among lymphocyte populations. Error bars represent S.D.; 
statistical analysis was carried out using a Mann-Whitney test. 
In the MLN, the majority of TIM1+ cells were MHCII+ B220+ B cells (Figure 4. 19a). TIM1 
staining on CD8+ T cells could not be detected in the MLN (Figure 4. 19a). Overall, only 
about 2% of B cells expressed TIM1 in both sMLN and cMLN (Figure 4. 19b).
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Figure 4. 19: TIM1 is mainly expressed on B cells in the MLN 
Small intestinal (sMLN) and colonic (cMLN) draining MLN were harvested from C57BL/6 mice and cell 
populations analysed by flow cytometry. (a) TIM1+ CD11c- cells were gated on single, live, CD45+ cells. These 
were comprised of mainly B220+ MHCII+ B cells, and a small population of CD8α- CD103- cells. (b) B cells 
were gated as single, live, CD45+, MHCII+, B220+ cells. Data are represented as percentage of B cells among 
TIM1+ cells (a), and TIM1+ cells among B cells (b). Error bars represent S.D.; statistical analysis was carried 
out using a Mann-Whitney test.
4.2.9 TIM4 expression on colonic DC may correspond with a migratory signature 
Given that a significant proportion of DC upregulate TIM4 when they migrate, we sought 
to establish if this could in fact be used as a marker of colonic CD11b- CD103+ DC that had 
taken up antigen and were just ready to begin migration to the cMLN. One important step 
in this process is the upregulation of CCR7 (Förster et al. 1999). To begin to answer this 
question, we FACS-sorted TIM4+ and TIM4- colonic CD11b- CD103+ DC (Figure 4. 20a, b) 
and measured mRNA levels of Ccr7 by quantitative real-time PCR (qRT-PCR). In 
accordance with our hypothesis, we found that TIM4+ DC expressed higher levels of Ccr7 
than TIM4- DC (Figure 4. 20c). Interestingly, Il1b mRNA levels were also higher in TIM4+ 
CD11b- CD103+ DC compared with their TIM4- counterparts, thereby implicating the 
inflammasome pathway as preferentially upregulated in these cells (Figure 4. 20c).
4. Expression of ACR in the intestine 
 
135 
 
Figure 4. 20: Colonic TIM4+ CD11b- CD103+ DC express more Ccr7 and Il1b mRNA than their TIM4- 
counterparts 
Colons were harvested from C57BL/6 mice and TIM4+ and TIM4- CD11b- CD103+ DC FACS sorted for 
analysis of Ccr7 and Il1b mRNA levels by quantitative real-time PCR (qRT-PCR). (a) Representative plots 
showing pre-sort gating strategy of TIM4+ and TIM4- CD11b- CD103+ DC gated on single, live, CD45+, 
MHCII+, CD11c+, CD64-, B220- cells. (b) Representative plots showing sort purity of TIM4+ and TIM4- 
populations. (c) The levels of Ccr7 and Il1b mRNA are higher in TIM4+ CD11b- CD103+ DC compared with 
their TIM4- counterparts. Data are represented as normalised to expression of housekeeping gene 
TATA-binding protein (ΔCt), and relative to the mean ΔCt value of the TIM4- population. Data pooled from 
two experiments (grey and black symbols). Error bars represent S.D.; statistical analysis was carried out using 
an unpaired t test. * p < 0.05.
We analysed the colonic LP of Ccr7gfp/gfp knockout/knockin mice, in which both copies of 
the Ccr7 gene has been replaced by gfp, by flow cytometry to confirm the protein levels of 
CCR7 on TIM4+ and TIM4- colonic DC. The experimental procedures for this analysis 
were kindly carried out by Dr Vuk Cerovic at the Universitätsklinikum Aachen. Indeed, as 
previously found on an mRNA level, TIM4+ DC had a trend towards higher proportion of 
gfp+ cells than TIM- DC, therefore pointing towards increased expression of CCR7 (Figure 
4. 21a). Furthermore, the same trend was observed for all colonic DC populations, except 
for CD11b+ CD103- DC (Figure 4. 21b). The low percentage of TIM4+ cells in all but 
CD11b- CD103+ DC, however, indicates the need for caution when interpreting these data 
(Figure 4. 21b). Not all CCR7+ cells were TIM4+, which corresponds to the fact that not all 
migrating lymph DC express TIM4. However, the reverse was also true in that not all 
TIM4+ cells expressed CCR7. This suggests that TIM4 is not a straightforward marker for 
migrating cells in the LP, but is likely to have a broader spectrum of functionality.
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Figure 4. 21: Colonic TIM4+ DC may comprise a higher percentage of CCR7-gfp+ cells than TIM4- DC 
Colonic tissues were harvested from Ccr7gfp/gfp knockout/knockin mice and LP cells analysed by flow 
cytometry. (a) Representative plots and summary data showing GFP expression in TIM4- and TIM4+ total 
colonic DC gated on single, live, CD45+, MHCII+, CD11c+, CD64- cells. (b) Representative plots and 
summary data showing GFP expression in TIM4- and TIM4+ cells of DC populations gated on single, live, 
CD45+, MHCII+, CD11c+ CD64- cells. Data are represented as the percentage of GFP+ cells among 
TIM4+/TIM4- populations. Statistical analysis was carried out using a Wilcoxon matched-pairs signed rank 
test.
To better understand the link between TIM4 expression on DC and migration to the MLN, 
we photoconverted the colons of Kaede mice and determined the percentage of Kaede-red+ 
migratory DC in the cMLN 24 h and 48 h post-switching. We observed a trend towards a 
greater percentage of Kaede-red+ cells within the TIM4+ population compared with the 
TIM4- population of migratory DC at both 24 h and 48 h after colon photoconversion 
(Figure 4. 22a, b). However, when we analysed DC in the colonic LP at these time points, 
we also saw that more TIM4+ DC were Kaede-red+ compared with TIM4- DC, even though 
the overall frequency of Kaede-red+ DC decreased, as expected (Figure 4. 22c).
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Figure 4. 22: cMLN TIM4+ DC may comprise a higher percentage of Kaede-red+ migratory DC compared 
with TIM4- DC 
The proximal colons of Kaede mice were photoconverted after surgical laparotomy using violet light and the 
proximal colons and cMLN harvested at 24 h and 48 h timepoints. (a) Total cMLN DC gated on single, live, 
CD45+, MHCIIhi, CD11c+, CD64-, B220- cells. Representative plots showing TIM4 expression on total cMLN 
DC and the percentage of Kaede-red+ cells among TIM4- and TIM4+ DC at 24 h and 48 h post-
photoconversion. (b) The percentage of Kaede-red+ DC among TIM4+ DC and TIM4- DC in the cMLN. 
(c) Summary plots showing the percentage of Kaede-red+ cells among total DC, and TIM4- and TIM4+ DC, in 
the colonic LP 24 h and 48 h post-photoconversion. Error bars represent S.D.; statistical analysis carried out 
using a Wilcoxon matched-pairs signed rank test (b), and a Mann-Whitney test or a Kruskal-Wallis test with 
a Dunn’s post-test for multiple comparisons (c).
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 4.2.10 TIM4+ and TIM4- MLN DC have different RA-producing capacity and 
Aldh1a2 mRNA expression levels 
Having found that TIM4 expression may correlate with a migratory signature in colonic LP 
and cMLN, we next aimed to determine whether TIM4+ and TIM4- DC differed 
functionally after arrival in the MLN. The ability of migratory CD103+ DC to induce 
gut-homing T cells in the MLN through the production of RA has been extensively studied 
(Iwata et al. 2004, Coombes et al. 2007, Jaensson et al. 2008). Recent work from our 
laboratory has shown that DC from the small intestinal LP and sMLN have greater activity 
of RALDH (Aldh1a2), the enzyme required for metabolism of vitamin A to RA, than 
colonic and cMLN DC (Houston et al. 2016). However, it is conceivable that cMLN DC 
still require the ability to produce RA, albeit at reduced levels. Given that MLN CD11b+ 
CD103+ DC have the highest frequency of TIM4+ cells compared with the other DC 
populations (Figure 4. 14b), we assessed the RALDH activity of sMLN and cMLN CD11b+ 
CD103+ DC. Consistent with previously published work, we found a trend towards higher 
RA producing capacity in sMLN migratory DC compared with the cMLN (Figure 4. 23a, 
b). Interestingly, in the sMLN TIM4+ CD11b+ CD103+ DC had a greater proportion of 
RALDH+ cells than TIM4- DC (Figure 4. 23c). The same trend was not, however, observed 
in the cMLN. Furthermore, the number of TIM4+ RALDH+ DC in the sMLN is very small 
(Figure 4. 23c), so it is difficult to draw a valid conclusion from this observation. Finally, 
when we determined the mRNA levels of Aldh1a2 in FACS-sorted TIM4+ and TIM4- total 
CD11b+ migratory sMLN and cMLN DC by qRT-PCR, we did not find a difference in 
Aldh1a2 expression (Figure 4. 23d).
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Figure 4. 23: TIM4+ and TIM4- MLN DC have different Aldh1a2 mRNA expression levels and retinoic 
acid producing capacity 
(a-c) Small intestine (sMLN) and colon (cMLN) draining MLN were harvested from C57BL/6 mice and 
subjected to the Aldefluor assay to detect RALDH activity before staining with antibodies to surface markers 
and analysis by flow cytometry. (a) Representative plots show TIM4 expression levels on CD11b+ CD103+ 
migratory MLN DC (gated on single, live, MHCII+, CD11c+, CD64-, B220- cells) and the levels of RALDH 
activity (corresponding to Aldefluor fluorescence intensity) exhibited by TIM4- and TIM4+ populations. 
DEAB-treated cells served as an internal negative control for each sample, allowing the positive gate to be 
determined and background staining to be disregarded. (b) Percentage of RALDH+ cells among total 
migratory DC compared between the sMLN and cMLN. (c) Data are shown as percentage of RALDH+ cells 
among the TIM4+ and TIM4- subsets of CD11b+ CD103+ migratory MLN DC and their absolute cell number. 
(c) sMLN and cMLN cells were harvested from C57BL/6 mice and single, live, CD45+, MHCII+, CD11c+, 
CD64-, B220-, total CD11b+ migratory DC were FACS-sorted and Aldh1a2 mRNA expression levels 
determined by qRT-PCR. Data are shown as normalised to expression of the housekeeping gene Tbp (ΔCt) 
and relative to the mean ΔCt value of the TIM4- DC population of either sMLN or cMLN. Data are 
representative of two separate experiments. Error bars represent S.D.; statistical analysis was performed using 
a Mann-Whitney test within each tissue group (b), or a Kruskal-Wallis test and a Dunn’s post-test for 
multiple comparisons (c)
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4.2.11 TIM4 expression on DC does not influence their ability to prime antigen-
specific CD4+ T cell responses in vitro 
We next aimed to determine if this potential difference in RALDH expression had any 
functional impact on induction of CCR9 on T cells. We also aimed to test the hypothesis 
that TIM4+ migratory DC in the MLN were more mature and able to drive antigen-specific 
T cell responses than TIM4- DC. We FACS-purified TIM4+ and TIM4- subsets of MLN 
migratory total CD11b+ and CD103+ CD11b- DC (Figure 4. 24), pulsed them with 
ovalbumin (OVA) 323-339 peptide and co-cultured them with CFSE-labelled OT-II MLN 
cells for five days before analysis of T cell proliferation, CCR9 and cytokine expression by 
flow cytometry. 
     
Figure 4. 24: FACS sort gating for MLN DC co-cultured with OT-II MLN cells 
Total MLN were harvested from C57BL/6 mice and migratory DC populations FACS sorted for co-culture 
with OT-II MLN cells. (a) Cells were gated as single, live, CD45+, MHCII+ CD11c+, CD64-, B220-; populations 
sorted were TIM4- and TIM4+ cells within total CD11b+ DC and CD103+ CD11b- DC populations. 
(b) Representative plots showing sort purity of MLN DC populations.
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However, no significant differences were observed in the ability of TIM4- and TIM4+ DC to 
drive antigen-specific CD4+ T cell expansion (Figure 4. 25a), or differentiation into Th1 
(Figure 4. 25b), Th17 (Figure 4. 25c) or Treg cells (Figure 4. 25d). The levels of CCR9 
detected at this time point were too low to allow us to make any valid conclusions (data not 
shown).
 
Figure 4. 25: TIM4- and TIM4+ MLN DC can induce antigen-specific T cell responses with equivalent 
efficiency in vitro 
Total MLN were harvested from C57BL/6 mice and migratory DC populations FACS sorted for co-culture 
with OT-II MLN cells. For this, 4,000 DC were pulsed with 3 µg/ml ovalbumin (OVA) 323-339 peptide for 
30 min, and co-cultured with 200,000 CFSE-labelled OT-II total MLN cells. After five days, these were 
harvested and analysed by flow cytometry. Representative plots for CD11b+ TIM4+/- subsets and summary 
data shown as percentages of CD44+ CFSE- (a), IFNγ+ CFSE- (b), IL-17A+ CFSE- (c) and FoxP3+ CFSE- (d) 
cells among single, live, CD3+, CD4+ T cells are shown. Symbols of the same shade of grey represent technical 
replicates from DC sorted from the same MLN. Error bars represent S.D.
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4.2.12 TIM4- and TIM4+ lymph DC can induce specific T cell responses to in vivo 
acquired antigen with equivalent efficiency 
We could not determine any difference in the ability of TIM4- and TIM4+ MLN DC to 
drive antigen-specific T cell responses in vitro. This may point to the fact that TIM4 on DC 
is important in controlling antigen acquisition and processing rather than priming itself. In 
order to investigate this, we performed thoracic duct cannulation of MLNx mice that had 
been gavaged with 10 mg OVA immediately prior to surgery (Figure 4. 26a). TIM4+ and 
TIM4- cells among total lymph DC were then FACS sorted and co-cultured with OT-II 
MLN cells for six days before analysis of T cell proliferation by flow cytometry (Figure 4. 
26a, b). We could detect low-level antigen-specific proliferation at this time point in both 
groups to the same extent (Figure 4. 26c), suggesting that TIM4 expression does not play a 
role in antigen acquisition or processing in this system. 
 
Figure 4. 26: TIM4- and TIM4+ lymph DC can induce specific T cell responses to in vivo acquired antigen 
with equivalent efficiency 
(a) MLNx mice were fed with 10 mg OVA protein by gavage before undergoing thoracic duct cannulation. 
TIM4+ and TIM4- DC were FACS sorted from collected lymph and 12,500 DC co-cultured with 200,000 
CFSE-labelled OT-II total MLN cells. After six days, these were harvested and analysed by flow cytometry. 
(b) Representative plots showing sort gating for TIM4- and TIM4+ DC (gated on single, live, CD45+, MHCII+, 
CD11c+, CD64-, B220- cells), and sort purity for TIM4- and TIM4+ DC. (c) Representative plots showing 
CD44+ CFSE- divided CD4+ CD3+ OT-II cells after six days of co-culture with lymph DC. Data represented as 
percentage of CD44+ CFSE- cells of live, CD3+, CD4+ OT-II T cells; one well with no added DC served as 
negative control for non-specific proliferation. Closed circles represent technical replicates using lymph 
collected from one mouse. Error bars represent S.D.
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4.3 Discussion 
The recognition and phagocytosis of apoptotic cells by DC is likely to play an important 
part in determining the outcome of downstream tissue-specific T cell responses. Given the 
different transcriptional profiles of DC subsets and their specialised functions in priming 
adaptive immunity (Watchmaker et al. 2014), we hypothesised that the expression of 
certain ACR is subset-specific. In particular, due to the unique ability of both intestinal and 
lung CD11b- CD103+ DC to acquire and cross-present cell-derived antigen in vivo (Desch 
et al. 2011, Cerovic et al. 2014b), we aimed to establish if this subset indeed expressed 
higher levels of ACR than other DC subsets. Our results show that the PSR TIM4 is most 
highly expressed on colonic and lung CD11b- CD103+ DC compared with the other DC 
populations found in those tissues. In fact, while only about 10% of colonic CD11b- 
CD103+ DC expressed TIM4, this was much higher on lung DC, where up to 90% were 
TIM4+. Expression of another ACR, CD205, was also highest on small intestinal and 
colonic CD11b- CD103+ DC. Previous work has shown that CD11b- CD103+ lymph DC 
also uniquely express Clec9A (DNGR-1) (Cerovic et al. 2014b), a mannose receptor that 
enables DC to recognise actin filaments on damaged cells (Zhang et al. 2012). Interestingly, 
SIRPα- (OX41-) CD4- DC in rat lymph and MLN have been shown to contain apoptotic 
cell inclusions and epithelial cell derived cytokeratins (Huang et al. 2000), similarly to the 
CD11b- CD103+ DC in mouse lymph (Cerovic et al. 2014b), further supporting the 
hypothesis that this is indeed the main subset of DC responsible for carrying IEC derived 
apoptotic cell antigen to the MLN. However, recent findings also implicate CD11b+ CD103- 
DC in the sampling of apoptotic IEC derived antigen through recognition of PS via the 
glycoprotein CD300a and thereby suppressing Treg cell maintenance in the colon 
(Nakahashi-Oda et al. 2015). These observations suggest that a range of ACR on different 
DC subsets may be important in fine-tuning downstream T cell responses. One possible 
reason for the enhanced specialisation of CD11b- CD103+ DC in this regard may be their 
tissue localisation. The molecule CD103 (integrin αE) binds E-Cadherin found on IEC 
(Cepek et al. 1994). As well as on DC, CD103 is found on IEL, where it may mediate 
retention of the cells in the epithelial layer (Schon et al. 1999), although some evidence 
indicates it may instead be important in IEL recruitment (Sheridan et al. 2014). DC 
maintain expression of CD103 upon migration in lymph. Its role in retaining DC in 
proximity to the epithelium therefore remains unclear. Nevertheless, investigation of the 
tissue distribution of XCR1, a chemokine receptor expressed by CD11b- CD103+ DC 
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(Cerovic et al. 2014b), showed that XCR1+ cells indeed reside in the small intestinal villous 
LP under the epithelium (Becker et al. 2014). 
In the human intestine, SIRPα- CD103+ DC are transcriptionally and functionally most 
similar to murine CD11b- CD103+ DC (Watchmaker et al. 2014). Unlike in the mouse 
intestine, however, human colonic SIRPα- CD103+ DC did not express TIM4. CD11c+ 
PBMC from healthy donors have been shown to upregulate TIM4 upon stimulation with 
staphylococcal enterotoxin B (Liu et al. 2007). However, little is otherwise known about 
which cells express TIM4 in humans. While we could not detect TIM4 on human colonic 
DC, we found that about 25% colonic CD64+ macrophages express TIM4 in the healthy 
human colon. This was also the case in the murine intestine, where about 10-20% of 
mature CX3CR1hi macrophages were TIM4+. With differentiation, macrophages in the gut 
upregulate cell machinery required for the specialised function they fulfil in the intestine 
(Schridde et al. 2017). These include genes associated with phagocytosis, such as TAM 
receptors and the scavenger receptor CD36 (Schridde et al. 2017). In keeping with this 
pattern, Schridde et al. (2017) also found that TIM4 expression increased on macrophages 
both in the colon and small intestine with differentiation, with the highest expression being 
on CX3CR1hi macrophages. TIM4 expression has also been found on peritoneal 
macrophages, where it is thought to be a marker of the tissue resident macrophage 
population (Rosas et al. 2014) and mediates the efficient clearance of apoptotic cells (Wong 
et al. 2010). These findings indicate that TIM4 expression on mature macrophages helps 
underpin their homeostatic functions in the tissue. We further analysed the expression of 
another PSR in the same family of TIM proteins, TIM1, and were able to show that an even 
higher proportion of CX3CR1hi macrophages in the intestinal LP (80%) express this 
protein. The ACR CD205, however, did not follow this same pattern, as its expression on 
intestinal macrophages was lower than that on DC. This is in line with CD205 first being 
described as a DC- and epithelial cell-specific marker (Kraal et al. 1986).  
Together, these findings confirm that, at barrier sites such as the intestinal LP and the lung, 
TIM4 is upregulated mainly on cell populations that are specialised in taking up and 
processing apoptotic cell derived antigen, such as mature intestinal macrophages and 
CD11b- CD103+ DC. The differential expression pattern of various ACR on antigen-
presenting cell populations in the intestinal LP is likely to not simply be a result of 
redundancy, but also allow cells to fine-tune the downstream response elicited by the 
encountered apoptotic cell material.  
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We hypothesised that TIM4 expression would decrease on DC once antigen had been 
taken up and migration had been initiated. To our surprise however, we found that 20-30% 
of DC upregulated TIM4 upon migration in mesenteric lymph. Furthermore, once in the 
MLN, expression on all migratory DC remained higher than that in observed in the LP. It 
would have been interesting to compare these findings to the mediastinal LN, to elucidate 
whether expression of TIM4 on lung CD11b- CD103+ DC changes or remains high after 
migration in lymph. In the MLN, CD11b+ CD103+ migratory DC had the highest frequency 
of TIM4+ cells (up to 50%). Interestingly, this was also the main subset of DC in the PP to 
express TIM4, even though expression was not as high as in the MLN. Previous work has 
shown CD11b+ CD103+ DC to be developmentally dependent on the transcription factors 
IRF4 (Persson et al. 2013b) and Notch2 (Satpathy et al. 2013), as well as requiring 
signalling through the GM-CSF receptor (Bogunovic et al. 2009). Recently, TGFβ 
signalling has been similarly implicated as important for differentiation of CD11b+ CD103+ 
DC (Bain and Montgomery et al. in press). This population of DC is thought to be unique 
to the intestine, as it is not present in the murine lung or spleen. Mice that lack IRF4 
signalling in CD11c+ cells have a decreased ability to mount Th17 responses in the small 
intestine and MLN, which may not only be due to the reduced number of CD11b+ CD103+ 
present, but also a reduction in their ability to produce IL-6 (Persson et al. 2013b). CD11b+ 
CD103+ DC express SIRPα and are reduced in number in Sirpa-/- mice, which also have 
diminished Th17 responses to infection with C. rodentium (Scott et al. 2014b). SIRPα 
recognises CD47 on live cells, which functions as a “don’t eat me” signal by negatively 
regulating phagocytosis (Okazawa et al. 2005). Furthermore, interactions between CD47 
on T cells and SIRPα on DC may indeed be important in regulating the activation and 
maturation of both cell types (Latour et al. 2001). Interestingly, CD11b+ CD103+ DC are 
not potent inducers of IL-17 production from CD4+ T cells in vitro, but induce IFNγ 
secretion by CD8+ T cells after stimulation (Cerovic et al. 2013). Recently, CD11b+ CD103+ 
DC have further been implicated in the induction of Th2 responses in the small intestinal 
LP against S. mansoni eggs (Mayer et al. 2017).  
Together, these findings indicate that CD11b+ CD103+ DC are efficient inducers of a range 
of different T cell responses, depending on the antigen and stimulus. Given the increased 
expression of TIM4 on these cells in the MLN, the site of T cell priming, suggests that this 
molecule may have a role in supporting these functions. This could take place through the 
sampling of cell-free antigen that is carried to the MLN in lymph in the form of exosomes 
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(Srinivasan et al. 2016). TIM4 has been shown to bind PS exposed on exosomes in vitro 
(Miyanishi et al. 2007), which may allow cells to engulf and process exosome-associated 
antigen for presentation. The fact that TIM4 is also expressed on resident LN DC supports 
this idea. However, a second possible explanation for the expression of TIM4 on CD11b+ 
CD103+ DC in the MLN is that it may enable these cells to take up antigen from dying DC 
that have previously arrived and carry antigen. Apoptosis of DC is required to maintain 
immunological tolerance, as ablation of apoptosis in CD11c+ cells led to enhanced antigen-
specific proliferation of CD4+ and CD8+ T cells in vitro, and enhanced autoimmunity in 
vivo, though without affecting the number of Treg cells in these mice (Chen et al. 2006). 
There is some evidence that injecting apoptotic bone marrow derived DC (BMDC) either 
systemically or locally into mice leads to increased production of TGFβ by the engulfing 
viable DC and enhanced Treg cell induction (Kushwah et al. 2009, Notley et al. 2015). 
Previous stimulation of the BMDC with LPS abolishes this response and instead leads to 
production of IL-6 (Notley et al. 2015). However, these findings should be interpreted with 
caution, given the fact that bone marrow cell differentiation with GM-CSF yields a mixture 
of macrophages and DC (Helft et al. 2015), and that the method of identifying DC in vivo 
used in these investigations was not rigorous enough to be sure of a DC-specific effect. 
However, they indicate that recognition of apoptotic cell material in the LN may be an 
important way of regulating T cell differentiation. TIM4-mediated uptake of 
previously-activated apoptotic DC by CD11b+ CD103+ DC may constitute one mechanism 
that contributes to their reported ability to drive IL-6 induced Th17 differentiation 
(Persson et al. 2013b), given that uptake of infected apoptotic cells by DC indeed stimulates 
production of IL-6 (Torchinsky et al. 2009).  Furthermore, recent work on colonic LP DC 
suggests that functional specialisation of DC subsets allows fine-tuning and balancing of 
T cell responses to bacterial pathogens (Aychek et al. 2015). In this case, IL-23 produced by 
CX3CR1+ macrophages and CD11b+ DC was required to dampen down IL-12 production 
by CD11b- CD103+ DC during infection with C. rodentium, that otherwise led to an 
inappropriately strong IFNγ-mediated response (Aychek et al. 2015). It is plausible that 
such an example of cellular crosstalk may also be in place in the MLN, where T cell 
differentiation is first initiated. There it may be important in limiting IFNγ responses 
induced by IL-12-secreting CD11b- CD103+ DC, and instead skewing T cells towards 
protective Th17 or Treg responses. This could be one reason why TIM4 expression on 
CD11b- CD103+ DC is lower than on CD11b+ CD103+ in the MLN. Treg cell differentiation 
is reported to be supported by the production of RA by CD103+ DC (Coombes et al. 2007). 
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We compared TIM4+ and TIM4- CD11b+ CD103+ DC from the sMLN and cMLN for their 
capacity to metabolise vitamin A to RA and found that in the sMLN, TIM4+ cells indeed 
had greater RALDH activity than TIM4- DC. However, due to the low proportion of TIM4+ 
DC in the sMLN, these results must be interpreted with caution. Moreover, the same trend 
was not observed in cMLN DC, or in the mRNA expression level of Aldh1a2 of total 
CD11b+ DC in the MLN. 
Our second hypothesis was that TIM4 expression is tissue-specific. Indeed, not only did we 
find that TIM4 expression on DC subsets is tissue-dependent, but we also observed that the 
level of expression differed across tissues. For example, 80% of CD11b- CD103+ DC in the 
lung were TIM4+, whereas the same subset in the colon had only 10% TIM4+ cells. This was 
reduced even further in the small intestine, where staining was minimal, as reported 
previously (Hilligan et al. 2016). Comparison of TIM4 expression on migratory DC across 
the sMLN, cMLN and ILN revealed a similar pattern, with sMLN DC exhibiting the lowest 
proportion of TIM4+ cells (10%), followed by the cMLN (25%), and finally the ILN (45%). 
When comparing DC between the small intestine and colon, one caveat to these results is 
the use of two enzymatic digestion protocols, which could differentially affect the retention 
of TIM4 on the cell surface. However, this can not explain the marked difference in 
expression observed between colonic and lung CD11b- CD103+ DC, nor between lymph 
nodes, suggesting that this variation is indeed tissue-specific. The tissue environment plays 
a crucial part in determining the eventual differentiated phenotype incoming precursor 
cells will adopt after arrival. Elegant work in macrophages has illustrated the profound 
epigenetic imprinting effect elicited by tissue factors (Lavin et al. 2014). In DC 
development, two separate stages of transcriptomic imprinting are thought to occur before 
they display the subset and tissue-specific differences observed in fully differentiated tissue 
DC. The first takes place in the bone marrow during transition of the common DC 
precursor (CDP) to a pre-DC (Schlitzer et al. 2015). After tissue seeding of pre-DC, tissue 
derived factors then constitute the second signal that shapes DC subset phenotype. For 
example, expression and activation of the chemotactic receptor EBI2 is required for 
development and function of the splenic CD4+ DC (Gatto et al. 2013). We demonstrated 
that bone marrow pre-DC only exhibit very low levels of TIM4 on their surface. This 
confirms that, rather than being part of the first subset-specific imprinting event in the 
bone marrow, TIM4 expression is regulated during differentiation and DC encounter with 
specific stimuli in the tissue. The three main tissues that exhibited high expression of TIM4 
on DC in our investigation were the lung, the cMLN and the ILN. One factor that could be 
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a common stimulus regulating TIM4 on DC at these sites could be TGFβ. Schridde et al. 
(2017) have demonstrated the importance of TGFβ signalling on colonic macrophages for 
their differentiation. Furthermore, tissue resident lung macrophages are able to induce 
Treg cells at steady state via a TGFβ-dependent mechanism (Soroosh et al. 2013), 
suggesting a role for this mediator in governing lung homeostasis. TGFβ is also required 
for Langerhans cell retention in the epidermis (Borkowski et al. 1996, Kel et al. 2010) and 
in vitro studies have further shown a role for TGFβ1 in inducing expression of the TAM 
receptor Axl on Langerhans cells and GM-CSF generated BMDC (Bauer et al. 2012). 
However, to date there is no evidence for a similar enhancing effect of TGFβ on TIM4 
transcription. 
The marked increase in TIM4+ DC in the colonic compared with the small intestinal 
associated tissues is worth exploring further. This pattern could be observed in the LP, 
lymph and the distinct MLN draining these tissues. We also found the colon to contain a 
greater proportion of CD205+ DC than the small intestine. Furthermore, we established 
that TIM1 is expressed more highly on colonic CD45- cells than on those of the small 
intestine. This population is comprised of IEC, endothelial cells and stromal cell subsets, 
and further work is required to accurately differentiate between these with regard to TIM1 
expression. However, TIM1 has previously been described on the epithelium in the kidney 
(Ichimura et al. 1998), which may therefore also be the case in the intestine. Overall, our 
observations indicate that transcription of both TIM1 and TIM4 may be governed by 
similar tissue-specific factors. Nevertheless, the fact that macrophage expression of TIM4 
did not follow the same trend, but if anything was decreased in the colon compared with 
the small intestine, illustrates that cell-specific programmes can override the impact of 
tissue factors. While we were able to detect TIM4 staining on human colonic macrophages, 
we did not investigate expression in small intestinal tissue, and it would be interesting to 
determine if the pattern there is similar to that in the mouse. 
One of the most important environmental factors in the colon is the microbiota. Work in 
GF mice has revealed a role for microbiota derived PAMPs in regulating IEC turnover, as 
both proliferation and apoptosis are synergistically induced via a TLR2-dependent 
mechanism in the small intestine (Hormann et al. 2014). Several authors have reported the 
ability of PAMPs such as flagellin (Li et al. 2014) or staphylococcal enterotoxin B (Liu et al. 
2007, Yang et al. 2007) to upregulate TIM4 expression on immune cells, implicating the 
microbiota as a likely factor driving TIM4 expression in the colon. GF mice have been 
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shown to lack expression of the TAM receptor adapter protein Gas6 on oral mucosal 
epithelial cells (Nassar et al. 2017). However, little is known about the expression of other 
ACR, including TIM4, in the intestine of GF mice. Given the role for PAMPs in TIM4 
transcriptional regulation, it is possible that the increased expression on DC in the colon 
and cMLN constitutes a protective mechanism in allowing DC to be ready to deal more 
efficiently with apoptosis during bacterial infection. This being the case, one would expect 
to see enhanced TIM4 expression during in vivo infection with enteric pathogens, and in 
the mucosa of IBD patients. Some evidence suggests that adjuvant-induced colitis increases 
TIM4 expression on colonic CD11c+ cells (Li et al. 2016). However, more work is needed to 
determine if the same holds true in bacterial infections and in human disease. 
Our final aim was to better understand the functional role TIM4 was playing on DC in 
different tissues. We showed that Il1b mRNA expression was greater in TIM4+ CD11b- 
CD103+ DC than in their TIM4- counterparts. However, this would need to be repeated, as 
the difference seen was only present in one of the two pooled experiments. If correct, this 
would indicate that TIM4-mediated phagocytosis might lead to activation of the 
inflammasome pathway in DC. On the other hand, recently published work has shown that 
DC from the small intestinal LP do not respond with enhanced transcription of Il1b after 
phagocytosis of apoptotic cells (Cummings et al. 2016). Instead, in BMDC this leads to 
production of TGFβ (Torchinsky et al. 2009). Uptake of apoptotic cells during bacterial 
infection has been shown to also induce the production of IL-6 (Torchinsky et al. 2009), 
and comparison between TIM4+ and TIM4- DC in the colonic LP under those 
circumstances might therefore be more informative.  
We also found that colonic TIM4+ CD11b- CD103+ DC have a greater expression of Ccr7 
mRNA. The observed trend towards a greater percentage of CCR7+ cells when using 
Ccr7gfp/gfp mice further supports this and may indicate that TIM4 expression correlates with 
a migratory signature in colonic DC. Moreover, when we photoconverted the proximal 
colon in Kaede mice, we found that TIM4+ DC in the cMLN contained a greater percentage 
of Kaede-red+ cells than did TIM4- DC, indicating that TIM4+ DC may be more efficient at 
migrating than TIM4- DC. The number of biological repeats per time point in this 
experiment would need to be increased, however, as the difference recorded was only small 
and did not reach statistical significance. Of note, we saw a similar trend in the colonic LP 
with TIM4+ DC having a higher proportion of photoconverted cells than TIM4-. Hence, the 
observations made in the cMLN may also be due to a difference originating in the LP 
4. Expression of ACR in the intestine 
 
150 
before migration, possibly based on the tissue localisation of TIM4+ cells, and must 
therefore be interpreted with caution. 
The upregulation of TIM4 on DC in lymph does, however, suggest that it is part of a 
molecular signature initiated upon migration. A possible explanation may be that it serves 
as a marker of mature DC that are ready to present antigen. It would have been worthwhile 
to assess the levels of co-stimulatory markers such as CD80, CD40 and CD86 on TIM4+ 
and TIM4- DC to help test this hypothesis. We were, however, not able to show an 
increased propensity of MLN TIM4+ DC to induce antigen-specific T cell responses in vitro 
at steady state. TLR stimulation of DC is important in this process and activation of lymph 
DC with bacterial lipoprotein has been shown to increase production of IFNγ by CD4+ and 
CD8+ T cells in vitro (Cerovic et al. 2013). We did not include this in our investigation, 
however, which, together with the absence of conditioning cytokines such as TGFβ, IL-6 or 
IL-12 may explain the low yield of IFNγ+ and IL-17A+ CD4+ T cells generated in our co-
cultures. In the future, it would also be of interest to compare the ability of TIM4+ and 
TIM4- CD11b- CD103+ DC to cross-present antigen to CD8+ T cells and to ascertain if 
TIM4 expression is required to help capture self-antigen in the gut. In IFABP-tOVA 232-4 
mice, OVA is constitutively expressed under control of the fatty acid binding protein 
promoter in small intestinal epithelial cells (Vezys et al. 2000). These mice were 
successfully used to first show the subset specificity of cross-presentation in mesenteric 
lymph DC (Cerovic et al. 2014b). Yet lack of TIM4 expression in the small intestine limits 
the usefulness of this model in determining its role on CD11b- CD103+ mediated priming 
of CD8+ T cells. 
TIM4 on DC in lymph and MLN might also be engaging in homotypic interactions with 
TIM1 on lymphocytes, thereby acting as a co-stimulatory molecule. TIM1 expression has 
been described previously on activated CD4+ T cells (Umetsu et al. 2005). Using 
immunisation with peptide antigen in complete Freund’s adjuvant Meyers et al. (2005) 
were able to show that blocking TIM1 in vivo reduced T cell activation, while 
administration of TIM4-Ig had the opposite effect by inducing T cell hyperproliferation. 
Moreover, proliferation induced by TIM1 ligation on T cells is polyclonal and occurs in the 
absence of TCR engagement (Mariat et al. 2009). It is, however, dependent on 
co-stimulation by mature DC (Mariat et al. 2009).These data suggest that TIM4-TIM1 
interactions between DC and T cells may be important in sustaining CD4+ T cell responses. 
When we sought to identify populations of lymphocytes in the MLN and lymph that 
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express TIM1, we found it mainly on a small population of B cells (0.5-2%). TIM1 
identifies regulatory B cells (Ding et al. 2011) and is required for their induction and 
maintenance (Yeung et al. 2015). Therefore, rather than facilitating interactions with DC, it 
is more likely that TIM1 is functioning in its main capacity as a PSR on B cells, with the 
uptake of apoptotic cells stimulating differentiation into a regulatory phenotype (Yeung et 
al. 2015). Our antibody panel was not comprehensive enough to allow accurate 
identification of CD4+ T cells, although a small population of B220- CD8- lymphocytes was 
found to express TIM1. As well as B cells and B220- CD8- cells, we could also detect two 
populations of TIM1+ CD8+ T cells in lymph, differentiated based on expression levels of 
CD103. However, unlike DC, due to the ability of T cells to egress LN via the efferent 
lymph, it is impossible to ascertain the origin of these cells. Given the very small percentage 
of non-B cell lymphocytes that expresses TIM1 compared with the much higher percentage 
of DC that express TIM4 in lymph and the MLN, it is unlikely that homotypic interactions 
between the two play a significant role at steady state. However, this proportion a may 
increase during inflammation, and future investigations should take this into account. 
Finally, TIM4 on DC may be acting to facilitate migration directly. The TIM4 molecule is 
made up of a large mucin domain containing O-linked glycosylation sites, and a V-type Ig 
domain. In Drosophila melanogaster mutation in the glycosylating enzyme PGANT3 led to 
decreased cell adhesion and resulting wing malformation (Zhang et al. 2008), suggesting a 
role for these structures in interactions between cells and the extracellular matrix. This is 
supported by the fact that TIM4 binding to glycosylation-deficient cells in vitro is reduced 
(Wilker et al. 2007). Furthermore, the Ig domain of TIM4 binds CD4+ and CD8+ 
splenocytes in vitro in a calcium-dependent manner, thus establishing similarity with C-
type lectins (Wilker et al. 2007). Intriguingly, TIM4 exhibits similarity in domain structure 
with the cell adhesion molecule MAdCAM1, and contains an RGD peptide motif in its Ig 
domain, which is required for facilitating integrin binding (Newham et al. 1997). 
Moreover, TIM4 has been shown to co-localise with integrins during phagocytic uptake of 
PS-bearing targets (Flannagan et al. 2014), although further investigation is needed to 
establish if direct binding takes place. TIM1 has been shown to act as a ligand for P-
selectin, and mediate T cell recruitment to sites of inflammation in vivo (Angiari and 
Constantin 2014). Taken together, it is plausible that TIM4 may be interacting with the 
lymphatic endothelium via integrins and other glycosylated proteins on their surface, thus 
directly facilitating DC migration.  
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We have succeeded in extensively characterising the expression of TIM4 on DC subsets in 
a range of different tissues and compared it with that of other ACR. As a result, we show 
that TIM4 expression is both population- and tissue-dependent. Our findings also indicate 
that it may correlate with a migratory signature on DC. However, while we carried out 
initial investigations into how TIM4 might bestow subset- and tissue-specific functions on 
DC, we were unable to describe any functional differences between TIM4+ and TIM4- DC. 
Exploring the factors that regulate TIM4 expression, and determining the role of TIM4 in 
intestinal inflammation may therefore help to deepen our understanding of its function on 
DC.
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Chapter 5: Factors that regulate TIM4 expression 
5.1 Aims and hypotheses 
Expression of TIM4 on DC is both population- and tissue-dependent. Our investigations 
showed that it is expressed mainly by CD11b- CD103+ DC in the colon and the lung, but is 
upregulated upon migration in lymph by all DC subsets in the intestine. Once in the MLN, 
CD11b+ CD103+ migratory DC are the dominant TIM4 expressing population. We also 
showed that DC had greater TIM4 expression in tissues associated with the colon 
compared with the small intestine. These findings led us to propose two hypotheses 
relating to the expression of TIM4. 
The first is that TIM4 expression on DC is controlled by specific cytokines present in the 
tissue environment. Previous work has suggested a role for STAT6 in regulating TIM4 
expression on DC (Yang et al. 2016), implicating IL-4 as a potential regulatory factor. 
Consistent with this, polymorphisms in the TIMD4 gene and promoter locus have been 
linked to asthma (Cai et al. 2009, Zhao et al. 2011) and there is some evidence for a role of 
TIM4 on DC in inducing Th2 cell differentiation (Liu et al. 2007, Yang et al. 2007). A 
second possible factor regulating TIM4 expression is TGFβ, an important mediator of 
colonic macrophage differentiation (Schridde et al. 2017). Interestingly, TGFβ1 has 
previously been shown to induce expression of another ACR, Axl, on BMDC (Bauer et al. 
2012). This cytokine also has important regulatory functions in the lung (Soroosh et al. 
2013) and the skin (Borkowski et al. 1996, Kel et al. 2010). Given that the expression of 
TIM4 on DC was highest in the lung, cMLN and ILN, we investigated whether TGFβR 
signalling on DC is important for inducing the expression of TIM4 on these cells.  
The observation that TIM4 expression was higher on colonic compared with small 
intestinal DC led us to formulate our second hypothesis, that TIM4 expression was 
regulated by the microbiota. In vitro studies have indeed confirmed a role for PAMPs in 
upregulating TIM4 on various immune cells (Liu et al. 2007, Li et al. 2014). However, no 
studies to date have investigated the role of the microbiota in shaping its expression in vivo. 
We therefore used two approaches to begin to answer this question; in the first instance we 
depleted the microbiota using oral antibiotics to determine if this would reduce TIM4 
expression on colonic DC. Our second approach was to establish if infection with the 
enteric bacterial pathogen C. rodentium would augment TIM4 expression on DC. 
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Answering these questions will be vital to understanding the role of TIM4 on DC and how 
it impacts their function during inflammation.  
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5.2 Results 
5.2.1 TIM4 expression on DC is not altered in IL-4-deficient mice 
In order to determine if IL-4 functions as a factor regulating TIM4 expression in vivo, we 
used KN2 mice, in which both copies of the Il4 gene have been replaced by the gene 
encoding human CD2 (Mohrs et al. 2005). KN2het mice served as a control, which retain a 
functioning copy of the Il4 gene and are therefore IL-4 sufficient. We first determined if 
IL-4-deficient animals had an altered distribution of DC subsets in the colonic LP or cMLN 
and found no significant changes in either tissue compartment (Figure 5. 1).
       
Figure 5.1 continued on next page
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Figure 5. 1: IL-4 deficiency does not change the distribution of colonic or cMLN DC populations 
Colons and cMLN from KN2het and KN2 mice were harvested and cells analysed by flow cytometry. 
(a) Representative plots showing colonic DC subsets in KN2het and KN2 mice gated on single, live, CD45+, 
MHCII+, CD11c+, B220-, CD64- cells. Summary data are shown as percentage of DC subsets among live cells. 
(b) Representative plots showing migratory cMLN DC subsets in KN2het and KN2 mice gated on single, live, 
CD45+, MHCIIhi, CD11c+, B220-, CD64- cells. Summary data are shown as percentage of migratory DC 
subsets among live cells. Error bars represent S.D.; statistical analysis carried out using a Mann-Whitney test.
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Next, we compared TIM4 expression on total DC and macrophages in the colonic LP 
between KN2 and KN2het mice. We could not detect any significant differences in TIM4 
expression on total DC (Figure 5. 2a) or macrophages (Figure 5. 2b) in the colonic LP, 
although there was a trend towards increased expression on both cell populations in IL-4-
deficient animals. 
 
Figure 5. 2: IL-4 deficiency does not reduce expression of TIM4 on colonic DC or macrophages 
Colons from KN2het and KN2 mice were harvested and LP cells analysed by flow cytometry. 
(a) Representative plots showing TIM4 expression on total colonic LP DC of KN2het and KN2 mice, and 
summary data shown as percentage of TIM4+ cells among total colonic DC. DC gated on single, live, CD45+, 
MHCII+, CD11c+, CD64-, B220- cells. (b) Representative plots showing TIM4 expression on colonic 
macrophages of KN2het and KN2 mice, and summary data shown as percentage of TIM4+ cells among total 
colonic macrophages, gated on single, live, CD45+, CD11b+, Ly6G-, SSClo, CD64+, MHCII+ cells. Error bars 
represent S.D.; statistical analysis using a Mann-Whitney test.
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Moreover, there were no significant DC population-specific changes in TIM4 expression in 
KN2 compared with KN2het mice (Figure 5. 3). 
 
Figure 5. 3: IL-4 deficiency does not change TIM4 expression on colonic DC populations 
Colons from KN2het and KN2 mice were harvested and LP cells analysed by flow cytometry. 
(a) Representative plots showing TIM4 staining on DC populations gated on single, live, CD45+, MHCII+, 
CD11c+, CD64-, B220- cells. (b) Summary data shown as percentage of TIM4+ cells among DC subsets. Error 
bars represent S.D.; statistical analysis carried out using a Mann-Whitney test.
5. Factors that regulate TIM4 expression 
 
159 
In the cMLN, TIM4 expression on both total migratory and resident populations of DC 
was independent of IL-4 (Figure 5. 4), as was its expression on the four migratory DC 
populations (Figure 5. 5). 
 
Figure 5. 4: IL-4 deficiency does not change the expression of TIM4 on cMLN migratory and resident DC 
populations 
The cMLN from KN2het and KN2 mice were harvested and cells analysed by flow cytometry. (a) 
Representative plots showing migratory (mig) and resident (res) populations, and TIM4 staining on these, 
gated on single, live, CD45+, MHCIIhi/int, CD11c+, CD64-, B220- cells. (b) Summary data shown as percentage 
of TIM4+ cells among migratory and resident DC populations. Error bars represent S.D.; statistical analysis 
carried out using a Mann-Whitney test.
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Figure 5. 5: IL-4 deficiency has no effect on the expression of TIM4 on migratory DC populations in the 
cMLN 
The cMLN from KN2het and KN2 mice were harvested and cells analysed by flow cytometry. 
(a) Representative plots showing TIM4 expression on migratory DC populations in KN2het and KN2 mice 
gated on single, live, CD45+, MHCII+, CD11c+, CD64-, B220- cells. (b) Summary data shown as percentage of 
TIM4+ cells among migratory DC subsets. Error bars represent S.D.; statistical analysis carried out using a 
Mann-Whitney test. 
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As observed in the colon, lung DC subset frequencies were unchanged in KN2 mice 
(Figure 5. 6a), and expression of TIM4 on both CD11b+ and CD103+ DC did not differ 
significantly between IL-4-deficient and sufficient mice (Figure 5. 6b, c).
 
Figure 5. 6: IL-4 deficiency does not affect the distribution of lung DC subsets, or their TIM4 expression 
Lung from KN2het and KN2 mice were harvested and cells analysed by flow cytometry. (a) Representative 
plots showing lung DC subsets gated on single, live, CD45+, MHCII+, CD11c+, CD64-, B220- cells. Summary 
data are shown as percentage of DC subsets among live cells. (b) Representative plots showing TIM4 
expression on lung DC subsets. Summary data are shown as the percentage of TIM4+ cells among DC subsets. 
Error bars represent S.D.; statistical analysis carried out using a Mann-Whitney test.
5.2.2 Lack of TGFβ signalling induces tissue-specific changes in TIM4 expression 
on DC  
After not having found any evidence that TIM4 expression on colonic or lung DC is 
dependent on IL-4, we next sought to establish if TGFβR signalling was required to allow 
DC to express TIM4 in vivo. To do this, we used CD11c-Cre Tgfbr1fl/fl mice (Kel et al. 2010) 
that had been backcrossed onto a Rag1-/- background to stop the development of multi-
organ inflammation that otherwise developed due to the activation of Cre recombinase in a 
small subset of CD11c+ T cells (Bain and Montgomery et al., personal communication). The 
CD11c-Cre not only targets DC, which express high levels of CD11c, but also 
macrophages, and these mice have been used previously to describe the role of TGFβ in the 
development of colonic macrophages (Schridde et al. 2017). This system therefore allowed 
us to examine the need for TGFβR signalling on both DC and macrophages in the LP. 
TGFβ is one of the factors involved in driving the development of CD11b+ CD103+ DC in 
the small intestine, and CD11c-Cre Tgfbr1fl/fl Rag1-/- mice also have a decreased percentage 
of colonic and lung CD11b- CD103+ DC compared with Cre- littermate controls (Bain and 
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Montgomery et al., in press). We were able to replicate these findings for the colon (Figure 
5. 7a), but not the lung (Figure 5. 7b) when comparing the frequency of DC subsets 
between Cre+ and Cre- littermate controls. 
     
Figure 5. 7: Lack of TGFβR significantly changes the distribution of DC populations in the colon, but not 
the lung 
Colons and lungs from CD11c-Cre Tgfbr1fl/fl Rag1-/- mice were harvested and cells analysed by flow 
cytometry. (a) Representative plots of colonic DC subsets in Cre+ and Cre- mice gated on single, live, CD45+, 
MHCII+, CD11c+, CD64-, B220- cells. Summary data are shown as the percentage of DC populations among 
total LP DC. (b) Representative plots of lung DC subsets in Cre+ and Cre- mice gated on single, live, CD45+, 
MHCII+, CD11c+, CD64-, B220- cells. Summary data are shown as the percentage of DC subset among total 
lung DC. Error bars represent S.D.; statistical analysis was carried out for each subset using a Mann-Whitney 
test between Cre+ and Cre- groups. * p = 0.0381
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However, TIM4 expression was not altered in mice that had lost the ability to mediate 
TGFβ signalling in total colonic LP DC (Figure 5. 8a) or Ly6C- MHCII+ macrophages 
(Figure 5. 8b). 
 
Figure 5. 8: Lack of TGFβR does not significantly change TIM4 expression on colonic macrophages or 
total DC 
Colons from CD11c-Cre Tgfbr1fl/fl Rag1-/- mice were harvested and LP cells analysed by flow cytometry. 
(a) Representative plots and summary data showing percentage of TIM4+ cells among total LP DC, gated on 
single, live, CD45+, MHCII+, CD11c+, CD64- cells. (b) Representative plots and summary data showing 
percentage of TIM4+ cells among colonic macrophages, gated on single, live, CD45+, CD11b+, (SiglecF-), 
SSClo, CD64+, Ly6C-, MHCII+ cells. Error bars represent S.D.; statistical analysis was carried out using a 
Mann-Whitney test.
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Interestingly however, the percentage of TIM4+ cells among colonic CD11b+ CD103+ DC 
was lower in TGFβR1-deficient mice compared with littermate controls (Figure 5. 9).
 
Figure 5. 9: Lack of TGFβR reduces TIM4 expression on colonic CD11b+ CD103+ DC 
Colons from CD11c-Cre Tgfbr1fl/fl Rag1-/- mice were harvested and LP cells analysed by flow cytometry. 
(a) Representative plots showing TIM4 expression on colonic LP DC populations gated on single, live, 
CD45+, MHCII+, CD11c+, CD64- cells. (b) Summary data shown as percentage of TIM4+ cells among colonic 
LP DC populations. Error bars represent S.D.; statistical analysis carried out using a Mann-Whitney test. 
* p = 0.0095. 
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Whilst TIM4 expression on CD11b+ DC did not change significantly in the lung (Figure 5. 
10a), Cre+ mice had a higher percentage of CD103+ DC expressing TIM4 (Figure 5. 10b), 
contrary to the pattern observed in the colonic LP.
      
Figure 5. 10: Lack of TGFβR increases expression of TIM4 on lung CD103+ DC 
Lungs from CD11c-Cre Tgfbr1fl/fl Rag1-/- mice were harvested and cells analysed by flow cytometry. 
Representative plots and summary data showing percentage of TIM4+ cells among (a) CD11b+ and 
(b) CD103+ lung DC subsets in Cre+ and Cre- animals. DC gated on single, live, CD45+, MHCII+, CD11c+, 
CD64- cells. Error bars represent S.D.; statistical analysis carried out using a Mann-Whitney test. * p = 0.019.
5.2.3 Antibiotic treatment does not change TIM4 expression on DC 
After investigating the role of IL-4 and TGFβ in regulating TIM4 expression on DC, our 
second aim was to determine if its expression was dependent on the microbiota. We orally 
treated C57BL/6 mice with a cocktail of five antibiotics (ampicillin, gentamicin, neomycin, 
metronidazole and vancomycin) by supplementing these in the drinking water, and 
analysed DC from the colonic LP and cMLN after seven days of treatment. The frequency 
of the four DC populations in the colon (Figure 5. 11a) or the cMLN (Figure 5. 11b) did 
not change significantly between antibiotic-treated and control mice. 
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Figure 5. 11: The distribution of colonic and cMLN DC populations does not change after antibiotic 
treatment 
C57BL/6 mice were given drinking water supplemented with five antibiotics and saccharin (Abx), or 
saccharin alone (Ctrl), for seven days. After this, colons and cMLN were harvested and cells analysed by flow 
cytometry. Representative plots and summary data showing the distribution of DC populations does not 
change in the (a) colon or (b) cMLN after seven days of antibiotic treatment compared with controls. Data 
are shown as the percentage of DC populations among live cells. Error bars represent S.D.; statistical analysis 
was carried out using a Mann-Whitney test. 
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We next compared expression of TIM4 on total colonic DC and CD64+ MHCII+ 
macrophages between antibiotic-treated and control mice, and found that depletion of the 
microbiota did not affect the expression of TIM4 on either cell population (Figure 5. 12a). 
There was also no DC population-specific change in TIM4 expression in the LP (Figure 5. 
12b).  
      
Figure 5. 12: TIM4 expression does not change on colonic DC or macrophages after antibiotic treatment 
C57BL/6 mice were given drinking water supplemented with five antibiotics and saccharin (Abx), or 
saccharin alone (Ctrl), for seven days. After this, colons were harvested and LP cells analysed by flow 
cytometry. (a) Representative plots and summary data showing percentage of TIM4+ cells among total LP DC 
and CD64+ MHCII+ macrophages after seven days of antibiotic treatment compared with controls. 
(b) Summary data showing percentage of TIM4+ cells among colonic LP DC subsets after seven days of 
antibiotic treatment compared with controls. Error bars represent S.D.; statistical analysis was carried out 
using a Mann-Whitney test. 
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As expected, we found a similar result in the cMLN, where TIM4 expression on both 
resident and migratory DC was unaffected by antibiotic treatment (Figure 5. 13a). We also 
analysed DC from the ILN to account for any gut-specific effects, and surprisingly found a 
trend towards a higher percentage of TIM4+ cells among resident DC in control mice 
compared with antibiotic-treated mice, although this did not reach significance (Figure 5. 
13b). 
 
Figure 5. 13: Expression of TIM4 on LN resident and migratory populations of DC does not change after 
antibiotic treatment 
C57BL/6 mice were given drinking water supplemented with five antibiotics and saccharin (Abx), or 
saccharin alone (Ctrl), for seven days. After this, cMLN and ILN were harvested and cells analysed by flow 
cytometry. Representative plots showing TIM4 staining on migratory and resident DC populations in the 
(a) cMLN and (b) ILN after seven days of antibiotic treatment compared with controls. Summary data are 
shown as the percentage of TIM4+ cells among total migratory and resident DC populations in the (c) cMLN 
and (d) ILN. Error bars represent S.D.; statistical analysis was carried out using a Mann-Whitney test. 
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Finally, TIM4 expression on the four cMLN migratory DC populations was not dependent 
on an intact microbiota (Figure 5. 14).
      
Figure 5. 14: Expression of TIM4 on migratory cMLN DC populations does not significantly change after 
antibiotic treatment 
C57BL/6 mice were given drinking water supplemented with five antibiotics and saccharin (Abx), or 
saccharin alone (Ctrl), for seven days. After this, cMLN were harvested and cells analysed by flow cytometry. 
(a) Representative plots showing TIM4 expression on migratory cMLN DC subsets, gated on single, live, 
CD45+, MHCIIhi (migratory), CD11c+, B220-, CD64- cells. (b) Summary data are shown as the percentage of 
TIM4+ cells among migratory DC populations after seven days of treatment with antibiotics compared with 
controls. Error bars represent S.D.; statistical analysis was carried out using a Mann-Whitney test.
5.2.4 Population-specific expression of TIM4 increases on colonic DC during 
infection with C. rodentium 
Because depletion of the microbiota by antibiotics did not decrease the expression of TIM4 
on DC in the colon or cMLN, we investigated if bacterial infection would lead to an 
increased frequency of TIM4+ DC in these tissues. To achieve this, we infected mice with 
C. rodentium, an A/E bacterial pathogen which colonises the colon and rectum of infected 
mice. We found that induction of a Th17 response was detectable at seven days p. i. in the 
colon (Figure 5. 15a). Due to the involvement of the distal colon and rectum in 
C. rodentium infection, we included the caudal LN in our analysis and pooled these with 
the caecal and colon draining MLN (collectively referred to as cMLN). A similar trend 
towards increased CD44+ IL-17A+ CD4+ T cells was also detected in the cMLN of infected 
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mice at seven days p. i. compared with PBS-treated controls (Figure 5. 15b). In all the 
following experiments, we therefore harvested tissues at this time point for analysis. 
       
Figure 5. 15: Infection with C. rodentium induces a Th17 response seven days post-infection 
Mice were given PBS or infected with 2 × 109 CFU C. rodentium by oral gavage. Seven days p. i., colons and 
cMLN (caecal, colonic and caudal) were harvested, cells stimulated with phorbol 12-myristate 13-acetate 
(PMA) and ionomycin and analysed by flow cytometry. (a) Representative plots showing CD44+ IL-17A+ 
cells in the colonic LP gated on single, live, CD45+, CD3+, CD4+ T cells. Summary data are shown as the 
percentage of CD44+ IL-17A+ cells among CD4+ T cells. (b) Representative plots showing CD44+ IL-17A+ 
cells in the cMLN gated on single, live, CD45+, CD3+, CD4+ T cells. Summary data are shown as the 
percentage of CD44+ IL-17A+ cells among CD4+ T cells. Error bars represent S.D.; statistical analysis carried 
out using Mann-Whitney test. * p < 0.05. 
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When we compared expression of TIM4 on total DC (Figure 5. 16a) and macrophages 
(Figure 5. 16b) in the colonic LP, we did not observe any significant changes, although 
there was a trend towards increased expression on DC. 
 
Figure 5. 16: Infection with C. rodentium does not significantly change expression on total colonic DC or 
macrophages 
Mice were given PBS or infected with 2 × 109 CFU C. rodentium by oral gavage. Seven days p. i., colons were 
harvested and LP cells analysed by flow cytometry. Representative plots and summary data showing 
percentage of TIM4+ cells among (a) total DC and (b) macrophages of infected (C. rod) and control (PBS) 
animals. DC were gated on single, live, CD45+, MHCII+, CD11c+, CD64-, B220- cells. Macrophages were gated 
on single, live, CD45+, CD11b+, Ly6G-, SSClo, CD64int-hi, Ly6C-, MHCII+ cells. Error bars represent S.D.; 
statistical analysis was carried out using a Mann-Whitney test.
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In order to dissect this further, we first determined if colonic LP population frequencies 
were altered in infected mice. However, neither percentages nor the absolute number of 
DC populations changed in the colon seven days p. i. (Figure 5. 17). 
 
Figure 5. 17: Infection with C. rodentium does not significantly alter the distribution of colonic DC 
populations 
Mice were given PBS or infected with 2 × 109 CFU C. rodentium by oral gavage. Seven days p. i., colons were 
harvested and LP cells analysed by flow cytometry. (a) Representative plots show DC populations gated on 
single, live, CD45+, MHCII+, CD11c+, CD64-, B220- cells. (b) Summary data are shown as the percentage of 
DC populations among live cells. Error bars represent S.D.; statistical analysis carried out using a Mann-
Whitney test. 
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We did, on the other hand, detect a significant increase in the frequency of TIM4+ CD11b+ 
CD103- DC and CD11b- CD103- DC in infected mice (Figure 5. 18). 
 
Figure 5. 18: TIM4 expression increases on colonic CD11b+ CD103- and CD11b- CD103- DC during 
infection with C. rodentium 
Mice were given PBS or infected with 2 × 109 CFU C. rodentium by oral gavage. Seven days p. i., colons were 
harvested and LP cells analysed by flow cytometry. (a) Representative plots showing TIM4 expression on 
colonic DC subsets from PBS-treated and infected (C. rod) mice. (b) Summary data shown as percentage of 
TIM4+ cells among DC populations. Error bars represent S.D.; statistical analysis carried out using a Mann-
Whitney test. * p < 0.05, ** p < 0.01 
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We had previously seen that colonic TIM4+ CD11b- CD103+ DC from naïve mice had 
greater expression of Ccr7 and Il1b mRNA than their TIM4- counterparts (Figure 4. 20). 
Unfortunately, due to technical issues we were unable to accurately determine the 
transcript levels of Ccr7 and Il1b in CD11b- CD103+ DC from infected mice. However, in 
order to determine if the increase in TIM4 expression on CD11b+ CD103- DC correlated 
with higher transcript levels for Ccr7 and Il1b, we FACS-purified colonic CD11b+ CD103- 
DC from PBS-treated and infected mice for qRT-PCR analysis (Figure 5. 19a). Surprisingly, 
we did not observe an upregulation of Ccr7 expression after infection with C. rodentium 
(Figure 5. 19b). Furthermore, while there was a trend towards decreased expression of Il1b 
expression in CD11b+ CD103- DC from infected animals, this was not statistically 
significant (Figure 5. 19b). 
     
Figure 5. 19: Expression of Ccr7 and Il1b mRNA in colonic CD11b+ CD103- DC does not significantly 
change during infection with C. rodentium  
Mice were given PBS or infected with 2 × 109 CFU C. rodentium by oral gavage. Seven days post-infection, 
colons were harvested and CD11b+ CD103- DC FACS-sorted for qRT-PCR analysis. (a) Representative plots 
showing FACS sort gating and purity for CD11b+ CD103- DC in PBS-treated and C. rodentium (C. rod) 
infected mice, gated on single, live, CD45+, MHCII+, CD11c+, CD64-, B220- cells. (b) Level of Ccr7 and Il1b 
mRNA in colonic CD11b+ CD103- DC from PBS-treated and C. rod infected mice as measured by qRT-PCR. 
Summary data are shown as Ccr7 and Il1b mRNA expression relative to the housekeeping gene Tbp. Error 
bars represent S.D.; statistical analysis was carried out using a Mann-Whitney test.
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TIM4 expression on lymph DC from cMLNx mice was unaffected by infection with 
C. rodentium (Figure 5. 20). 
 
Figure 5. 20: TIM4 expression does not change on cMLNx lymph DC during infection with C. rodentium 
Mice that had previously undergone colonic mesenteric lymphadenectomy (cMLNx) were infected with C. 
rodentium (C. rod). Six days p. i. thoracic duct cannulation was carried out with non-infected naïve cMLNx 
animals serving as controls. Lymph was collected over 16-24 h and cells analysed by flow cytometry. 
(a) Representative plots showing expression of TIM4 on cMLNx lymph DC populations gated on single, live, 
MHCII+, CD11c+, B220- cells. (b) Summary data are shown as the percentage of TIM4+ cells among DC 
populations. 
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We next compared the frequency of the individual migratory DC populations in the cMLN 
between infected and uninfected mice. As in the colon, we found no significant changes in 
the frequency of migratory DC populations (Figure 5. 21). 
 
Figure 5. 21: The distribution of migratory DC populations in the cMLN does not change significantly 
during infection with C. rodentium 
Mice were given PBS or infected with 2 × 109 CFU C. rodentium by oral gavage. Seven days p. i. cMLN were 
harvested and cells analysed by flow cytometry. (a) Representative plots showing DC populations gated on 
single, live, CD45+, MHCIIhi, CD11c+, CD64-, B220- cells. (b) Summary data are shown as the percentage of 
DC populations among live cells. Error bars represent S.D.; statistical analysis carried out using a Mann-
Whitney test. 
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However, contrary to the LP, TIM4 expression levels remained constant, with only a slight 
decrease on CD11b+ CD103+ DC that was not statistically significant (Figure 5. 22).
 
Figure 5. 22: TIM4 expression does not change on cMLN DC populations during infection with 
C. rodentium 
Mice were given PBS or infected with 2 × 109 CFU C. rodentium by oral gavage. Seven days p. i., cMLN 
(caecal, colonic and caudal LN) were harvested and cells analysed by flow cytometry. (a) Representative plots 
showing TIM4 expression on cMLN DC populations from PBS-treated and infected (C. rod) mice. 
(b) Summary data shown as percentage of TIM4+ cells among DC populations. Error bars represent S.D.; 
statistical analysis carried out using a Mann-Whitney test.
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5.3 Discussion 
Our previous work showed that TIM4 expression on DC was both population- and tissue-
specific. We therefore set out to determine what factors might be involved in driving its 
expression. Firstly, we hypothesised that TIM4 was regulated by cytokines released in the 
local environment that acted on DC. IL-4 seemed a promising candidate, due to the 
importance of STAT6 signalling in driving TIM4 upregulation in a model of food allergy in 
vivo (Yang et al. 2016) and the reported role of TIM4 in inducing Th2 responses after 
treatment of human MNP with staphylococcal enterotoxin B (Liu et al. 2007). We therefore 
characterised the expression of TIM4 on DC from KN2 mice, which have had both copies 
of the Il4 gene replaced by human CD2 (Mohrs et al. 2005), and compared them with 
KN2het mice, which are IL-4 sufficient. KN2 mice had normal DC population frequencies 
in the colonic LP and the cMLN, and TIM4 expression in these was not reduced compared 
with KN2het mice. In fact, there was a trend towards increased expression on total DC and 
macrophages in the LP of KN2 animals, although this did not reach statistical significance. 
More biological replicates would be required to determine if this difference is indeed 
consistently observed. IL-4 deficiency did not alter TIM4 expression on lung CD103+ DC.  
One explanation for these findings could be that the requirement for STAT6 in 
upregulating TIM4 expression observed previously (Yang et al. 2016) is dependent on 
IL-13 rather than IL-4 (Kaplan et al. 1996). A second reason for this independence of IL-4 
could be the low basal levels of IL-4 in the gut and the lung. During parasite infections and 
allergic responses, large amounts of IL-4 are produced by a range of cells including CD4+ 
T cells (Connor et al. 2014), mast cells (Wang et al. 1999), basophils (Motomura et al. 2014) 
and ILC2 (Pelly et al. 2016). However, less is known about the release of IL-4 at steady 
state. Recently, group 2 invariant natural killer T cells (NKT2) have been identified as 
producers of IL-4 in the MLN of naïve mice, leading to STAT6 phosphorylation on CD4+ 
T cells (Lee, Wang, et al. 2015). This effect was especially pronounced in BALB/c mice, and 
significantly lower in C57BL/6 mice (Lee, Wang, et al. 2015), in concordance with the 
differential propensity of these strains to elicit Th2 responses (Locksley et al. 1987). There 
is evidence to suggest that the intestinal microbiota act to dampen baseline Th2 responses 
(Sudo et al. 1997, Wu et al. 2016). Together, these findings suggest that IL-4 availability in 
the intestine is tightly regulated in naïve mice. The fact that we saw no reduction of TIM4 
on DC from IL-4-deficient animals suggests that TIM4 expression in the gut and the lung 
is IL-4 independent at steady state. Our results do not, however, negate the possibility that 
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TIM4 expression may be increased by IL-4 secretion during a Th2 challenge. Some work 
has been carried out in food allergy models in the small intestine using challenge with 
cholera toxin (Hilligan et al. 2016, Yang et al. 2016). However, as others (Hilligan et al. 
2016) and we have found, basal levels of TIM4 on DC are low in the small intestine and it is 
difficult to assess the physiological relevance of these models in understanding tissue-
specific regulation of TIM4 expression. Little is known about its regulation in more 
physiological models of Th2 induction in the colon and lung such as helminth infections or 
house dust mite challenge. These could be useful systems in which to test the hypothesis 
that TIM4 is indeed upregulated by IL-4 signalling and is important in the induction of 
Th2 responses in the tissues that actually contain TIM4 expressing DC. 
Having found no role for homeostatic IL-4 in the induction of TIM4 expression, we next 
investigated if TGFβ signalling might be an important factor driving the cell and tissue-
specific expression pattern we had observed. In the bone marrow, TGFβ supports the 
differentiation of conventional DC from CDP (Felker et al. 2010) and TGFβ signalling on 
DC is required for differentiation of CD11b+ CD103+ DC in the small intestine and to a 
lesser extent CD11b- CD103+ DC in the colon and lung (Bain and Montgomery et al., in 
press). Furthermore, DC-specific deficiency in Smad7, a potent negative regulator of TGB-
β signalling, increased the frequency of splenic CD8α+ CD103+ DC in vivo (Lukas et al. 
2017). CD11b- CD103+ DC at mucosal sites and CD8α+ DC in the spleen are members of 
the same lineage of conventional DC (cDC1) (Guilliams et al. 2014), based on their shared 
transcriptional profile (Guilliams et al. 2016), and ability to cross-present antigen (Haan et 
al. 2000, Desch et al. 2011, Cerovic et al. 2014b). Expression of the cDC1-associated 
transcription factor IRF8 is upregulated by TGFβ (Ju et al. 2007), a further indication of its 
importance in regulating the development of cDC1. TGFβ is produced in a latent form that 
requires activation by the integrin αvβ8 (Travis et al. 2007), which is most highly expressed 
on intestinal CD103+ DC (Worthington et al. 2011). Furthermore, IRF8 is required for the 
expression of αvβ8 on DC (Yoshida et al. 2014). Together, these observations suggest that 
TGFβ is an important factor influencing the function of cDC1, possibly via an autocrine 
mechanism (Belladonna et al. 2008, Kashiwagi et al. 2015). This is especially intriguing in 
the context of apoptotic cell uptake, as this induces TGFβ production by antigen-
presenting cells (Torchinsky et al. 2009), which in turn could convey autocrine signals to 
the DC and lead to the sustained upregulation of ACR. TGFβ positively regulates 
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expression of Axl on Langerhans cells (Bauer et al. 2012) and a similar mechanism might 
be applicable to TIM4. 
Based on these findings and the preferential expression of TIM4 on cDC1 in the colon and 
the lung, we hypothesised that TGFβ signalling may be important in its regulation. To test 
this, we used mice that lacked TGFβR1 on CD11c+ cells (CD11c-Cre Tgfbr1fl/fl Rag1-/-), 
therefore abrogating the effects of TGFβ signalling on DC and macrophages. These mice 
had a decrease in colonic CD11b- CD103+ DC, thus confirming previous reports (Bain and 
Montgomery et al., in press), however, we did not detect a change in lung CD103+ DC 
frequencies. When we analysed TIM4 expression on DC subsets in the colonic LP, we 
found that the frequency of TIM4+ cells did not, as anticipated, decrease on CD11b- 
CD103+ with lack of TGFβ signalling. On the other hand, CD11b+ CD103+ DC from Cre+ 
mice did exhibit a significant decrease in TIM4+ cells compared with Cre- littermate 
controls. This was unexpected, and given the low baseline expression of TIM4 on this 
subset of DC in the LP, difficult to interpret. It would have been interesting to investigate if 
CD11b+ CD103+ DC in the MLN also had decreased expression of TIM4 in Cre+ animals. 
Unfortunately, due to the need to keep mice on a Rag1-/- background, the resultant lack of 
properly formed LN made this impossible. 
We did not find a significant change in the frequency of TIM4+ cells among colonic 
macrophages. Schridde et al. (2017) have shown that TGFβ signalling is required for 
colonic macrophage differentiation and the accompanying upregulation of genes involved 
in tissue repair. Both they and we have found that TIM4 is expressed on fully differentiated 
macrophages (Schridde et al. 2017). However, Timd4 gene expression was not significantly 
downregulated in colonic macrophages from CD11c-Cre Tgfbr1fl/fl Rag1-/- mice (Schridde et 
al. 2017), although a trend towards decreased expression was observed (A. Schridde, 
personal communication). This may explain why we also did not find a clear difference.  
TIM4 expression on colonic CD11b- CD103+ DC did not significantly change. In the lung, 
on the other hand, while we saw no change in subset frequency, we did find a significant 
increase in TIM4+ cells among CD103+ DC (from 80% TIM4+ cells in Cre- to 90% in Cre+ 
animals). These findings could be explained in two ways; firstly, instead of inducing TIM4 
expression on cDC1, TGFβ signalling serves as a negative regulator. However, the changes 
observed are small and as CD103+ DC in the lung already express high levels of TIM4, this 
explanation seems unlikely. An alternative explanation could be that the observed changes 
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are secondary to the loss of TGFβR1 on DC, rather than due to a cell intrinsic mechanism. 
For example, loss of TGFβ signalling in DC could affect their regulatory function within 
the tissue, which in turn could shift the microenvironment to a more pro-inflammatory 
state and increase the rate of epithelial cell apoptosis. There is some evidence that such a 
feedback mechanism might be in place in the colon, as CD11c-Cre Tgfbr2fl/fl mice develop 
spontaneous colitis characterised by dysbiosis and goblet cell depletion (Ihara et al. 2016). 
In contrast to the inflammation observed in our mice if not maintained on a Rag1-/- 
background, this is not likely to be due to a reduction of Treg cell frequencies induced by 
the deletion of TGFβR2 on T cells, as expression of the receptor and TGFβ induced Smad2 
signalling in these was not altered (Ihara et al. 2016). Lack of TGFβ signalling was shown to 
elevate Notch ligand expression in colonic DC and Cre+ epithelial cells exhibited a 
concomitant rise in Hes1 transcript levels in vivo (Ihara et al. 2016). IEC-specific 
constitutive activation of Notch signalling leads to lack of goblet cell differentiation and 
IEC apoptosis (Fre et al. 2005). These findings point to a possible crosstalk mechanism 
between intestinal DC and epithelial cells that is dependent on DC intrinsic TGFβ 
signalling. The enhanced apoptosis that may ensue as a result of abrogating this interaction 
could lead to an increase in ACR such as TIM4 that is secondary to deletion of the TGFβR. 
However, to test this hypothesis, further experiments would need to be designed. These, in 
turn, may reveal an alternative or additional mechanisms connecting TIM4 and TGFβ. 
An additional secondary factor in these mice might be the targeted deletion of TGFβR1 on 
alveolar macrophages, which also express CD11c. Indeed, when TGFβR2 was specifically 
deleted on macrophages using a LysM-Cre system, mice exhibited increased granulocyte 
infiltration in the lung, as well as reduction in epidermal growth factor expression, an 
important regulator of epithelial cell homeostasis (Heitmann et al. 2012). These findings 
support the conclusion that increased TIM4 expression on CD103+ DC in the lung may in 
fact be secondary to pro-inflammatory changes and increased apoptosis in the tissue 
induced by DC-epithelial cell interactions or off-target TGFβR1 deletion. To test this 
hypothesis, the extent of apoptosis in the epithelium should have been assessed in the 
epithelium Cre+ mice and changes in TIM4 expression analysed in mice treated with a 
caspase-3 inhibitor. An unfortunate confounding factor that must be considered when 
interpreting our results is that the mice used in this experiment had concurrent pinworm 
infection. This colonic infection was accompanied by an increase in SiglecF+ eosinophils in 
the colonic LP (data not shown) and may have had a significant effect on LP DC subset 
5. Factors that regulate TIM4 expression 
 
182 
function. Furthermore, given previous indications of a role of TIM4 in Th2 responses (Liu 
et al. 2007, Yang et al. 2016), it is possible that this strong Th2 stimulus could have 
increased TIM4 expression on DC, thus masking a potential decrease in Cre+ mice. 
Using our systems we were unable to show that TIM4 expression is dependent on either 
IL-4 or TGFβ signalling in the colon and lung. Given the higher frequency of TIM4+ cells 
in the colon when compared with the small intestine, our second main hypothesis was that 
TIM4 expression on DC is controlled by the microbiota. In vitro evidence of TIM4 
upregulation by flagellin on bone marrow derived mast cells (Li et al. 2014) and by LPS 
activation of bone marrow derived macrophages (Ji et al. 2014) indicates that PAMPs may 
indeed be important regulators of TIM4 expression. We therefore treated WT C57BL/6 
mice with a cocktail of antibiotics for seven days to deplete a broad spectrum of the 
microbiota and analysed DC subsets and their expression of TIM4 in different tissues. We 
found that the distribution of DC subsets in the colonic LP and cMLN were not altered in 
mice that had received antibiotics compared with controls. Previously, antibiotic treatment 
has been shown to increase the frequency of CD103+ and CD103- DC subsets in the MLN 
(Diehl et al. 2013), although this apparent discrepancy with our findings may be due to the 
shorter treatment duration used in our study (one week as opposed to four weeks). Of 
note, antibiotic induced changes in DC frequencies were not observed in a more recent 
study, where antibiotic treatment had no effect on the number of CD103+ DC in the MLN 
(Hägerbrand et al. 2015), or in our own unpublished work. GF mice have been reported to 
have fewer total CD11c+ (Walton et al. 2006, Chung et al. 2012) and CD11c+ CD103+ cells 
in the MLN (Niess et al. 2008), as well as fewer CD11c+ CX3CR1+ CD103- cells in the 
colonic LP (Niess et al. 2008). Given that macrophages also express CD11c and CX3CR1, 
these cell populations are likely to be composed of a mixture of CD11b+ CD103+ DC and 
macrophages, therefore making it difficult to draw a valid conclusion from these findings. 
Much more definitive data was provided by analysis of DC subset proportions in 
mesenteric lymph from GF and SPF mice, which were unchanged (Hägerbrand et al. 2015). 
This is consistent with our findings that DC subset composition is stable even after 
depletion of the microbiota. 
We did not detect any significant changes in the expression of TIM4 on either total DC or 
individual DC subsets, or macrophages in the colonic DC after antibiotic treatment. 
Furthermore, TIM4 expression was not significantly altered on resident and migratory 
populations of DC in the cMLN or the ILN, included as a peripheral LN control. There 
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was, however, a trend towards a greater percentage of TIM4+ cells in resident ILN DC of 
control mice. Contrary to the antibiotic-treated mice, tail bite wounds were evident in 
these mice, suggesting that they had been fighting. The trend that we observed may 
therefore be due to skin involvement, rather than microbiota-specific changes, especially 
given that no difference was seen in the cMLN. This admits the intriguing possibility that 
inflammation increases the expression of TIM4 on LN DC, but further work would be 
required to confirm this observation. 
Microbiota-derived metabolites such as SCFA have strong immunomodulatory functions. 
The production of SCFA is dependent of the metabolism of dietary fibre by anaerobic 
bacteria. Interestingly, mice fed a high fibre diet have an increased proportion and RALDH 
activity of MLN CD103+ DC compared with mice maintained on a fibre-deficient diet (Tan 
et al. 2016). This effect was specific to the SCFA butyrate and acetate (Tan et al. 2016). It is 
unclear, however, by what mechanism these metabolites influence the distribution of DC 
subsets in the MLN. The same report also showed that the proportional increase in CD103+ 
DC after high fibre feeding was in part dependent on MyD88 signalling, thereby 
implicating PAMPs as a second important microbiota-derived signal that influences DC 
subsets (Tan et al. 2016). However, it is as yet unknown how the microbiota influences 
expression of ACR on antigen-presenting cells. Gas6 was reduced in the oral mucosa of GF 
mice (Nassar et al. 2017), implicating microbiota derived signals in its induction. Yet the 
expression pattern of other ACR in GF mice compared with SPF control animals remains 
unclear. Moreover, the role of TLR signalling induced by PAMPs, or SCFA signalling in 
regulating the expression of TIM4 or other ACR has not yet been clarified.  
There is evidence to suggest that maturation of small intestinal DC induced by cholera 
toxin increases the expression of TIM4 on CD11b+ CD103+ DC in the LP and MLN 
(Hilligan et al. 2016). Furthermore, TIM4hi DC in the MLN had greater expression levels of 
co-stimulatory molecules compared with TIM4- DC (Hilligan et al. 2016). Together with 
our observation that TIM4 is upregulated in lymph, these findings suggest the possibility 
that DC maturation can lead to TIM4 expression. MyD88 signalling in DC is required for 
DC maturation (Sporri and Reis e Sousa 2005, Yarovinsky et al. 2006). In the intestine, 
steady state migration of CD11b+ CD103+ and CD11b- CD103+ DC to the MLN is 
dependent on MyD88 signalling (Hägerbrand et al. 2015). Given, however, that DC 
migration is not changed in GF mice, it is likely that MyD88 activation in intestinal DC is 
not limited to PAMPs, but could also be constituted by DAMPs from dying cells 
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(Hägerbrand et al. 2015). Furthermore, apoptotic cell inclusions can also be found in MLN 
DC of GF rats (Huang et al. 2000), suggesting that expression of ACR is not exclusively 
dependent on the microbiota. Taken together, these findings could explain why we did not 
observe a decrease in TIM4 expression in antibiotic-treated mice. 
We next investigated if bacteria-induced inflammation in the intestine had any effect on 
TIM4 regulation by infecting mice with C. rodentium, an A/E pathogen that induces a 
robust colonic Th17 response (Mangan et al. 2006). Previous reports have shown the peak 
of infection to take place around ten days p.i. (Symonds et al. 2009). However, we were able 
to detect the induction of Th17 cells already at seven days p.i. in both the colonic LP and 
the cMLN, which in these experiments included the caudal LN due to involvement of rectal 
pathology (Wiles et al. 2006). This suggests that the infection has established and the tissue 
environment become pro-inflammatory at this time point. Nonetheless, it is early enough 
to detect and explore how changes in DC might influence T cell priming before the peak of 
infection is reached. We therefore chose this time point in our subsequent investigations.  
Depletion of DC leads to decreased survival of C. rodentium infected mice, which fail to 
induce T cell priming and differentiation into the Th17 lineage (Schreiber et al. 2013). 
Furthermore, MyD88 signalling in CD11c+ cells is required for animal survival and 
clearance of C. rodentium (Longman et al. 2014), suggesting that recognition of PAMPs by 
DC is likely to contribute to the mounting of a protective immune response against the 
pathogen. In particular, pathogen clearance relies on Notch2-dependent CD11b+ DC 
(Satpathy et al. 2013), which have further been implicated functionally as sources of IL-23 
in the tissue, thus helping maintain the Th17 pool and inducing IL-22 production by ILC3 
(Satpathy et al. 2013, Aychek et al. 2015). BATF3 deficiency, on the other hand, depletes 
CD11b- CD103+ DC (cDC1) in the intestine (Edelson et al. 2010), and Batf3-/- mice do not 
succumb to infection with C. rodentium, in contrast to CD11c-Cre Notch2fl/fl mice 
(Satpathy et al. 2013), suggesting that these DC are not essential for clearance of the 
pathogen. Interestingly, IL-23 deficiency during infection with C. rodentium leads to 
enhanced production of IL-12 by CD11b- CD103+ DC, and subsequent IFNγ-induced 
immunopathology (Aychek et al. 2015), suggesting that tight regulation of this 
populations’s function is essential to prevent an inappropriately strong Th1 response. We 
found no evidence of a change in DC population frequency in the LP or cMLN of infected 
animals. However, further experiments would be required to determine if C. rodentium 
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infection impacts DC function in a population-specific manner, and if this is dependent on 
TIM4 expression.  
C. rodentium induces IEC apoptosis, dependent on effector protein EspF (Torchinsky et al. 
2009), and an increase in TIM4 expression on DC and macrophages in response to this 
higher apoptotic burden is therefore plausible. Next to DC, macrophages are important 
players that help orchestrate the protective immune response against C. rodentium. For 
example, production of IL-23 by CX3CR1+ cells, likely to be mainly mature macrophages, 
is an important driver of IL-22 production (Longman et al. 2014, Aychek et al. 2015). We 
therefore aimed to ascertain if expression of TIM4 on either DC or macrophages changes 
during infection, thereby helping further define a function for this molecule in shaping 
downstream immunity. We found that while the percentage of TIM4+ Ly6C- MHCII+ 
mature macrophages did not change seven days p.i. with C. rodentium, there was a trend 
towards increased TIM4 expression on total DC in the colonic LP. Furthermore, when we 
assessed if TIM4 expression changed in a subset-specific manner on DC, we found that it 
was indeed increased only on CD11b+ CD103- and CD11b- CD103- DC.  
Uptake of apoptotic cells by phagocytes has been shown to induce a regulatory phenotype 
(Torchinsky et al. 2009, Cummings et al. 2016) and reduce the production of IL-23 (Stark 
et al. 2005). However, the intracellular presence of TLR ligands due to phagocytosis of 
infected apoptotic cells can instead induce the production of IL-6 (Torchinsky et al. 2009). 
It is conceivable that this can also activate the inflammasome via NLR to induce IL-1β 
production (Rathinam et al. 2012), which in turn can stimulate the differentiation of Th17 
cells (Ghoreschi et al. 2010). Furthermore, NOD2 expression in human MNP is required 
for the production of IL-23 after stimulation with TLR ligands (van Beelen et al. 2007), 
highlighting the importance of intracellular PAMP sensing in production of this mediator. 
We reasoned that increased expression of TIM4 on CD11b+ CD103- DC during 
C. rodentium infection would have a downstream effect on their expression profile of pro-
inflammatory mediators. We therefore measured the transcript levels of Il1b in FACS-
sorted colonic CD11b+ CD103- DC from infected and PBS-treated animals, but were 
unable to detect a significant difference between the two groups. Given the importance of 
IL-23 production by CD11b+ DC during C. rodentium infection, a more comprehensive 
investigation should have also included transcript level assessment of Il23p19. 
Furthermore, analysis of Il6 expression and that of its receptor Il6ra could also have been 
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informative, due to the importance of IL-6 trans-presentation by DC in Th17 induction 
(Heink et al. 2017). 
The increased expression of TIM4 on colonic LP CD11b+ CD103- DC did not translate to 
the colon draining lymph or cMLN of infected mice. We had previously shown that TIM4 
expression on DC increases in lymph, and suggested that this could be indicative of a more 
mature migratory phenotype. The fact that C. rodentium infection did not further increase 
this proportion seems to provide evidence against this hypothesis, as previous work 
investigating the maturation of DC in response to infection with S. Typhimurium has 
shown that expression of co-stimulatory molecules on migratory MLN DC increases under 
these circumstances (Sundquist and Wick 2005). Interestingly, the essential role of DC in 
orchestrating protective immunity to C. rodentium seems to be restricted to DC in the LP, 
as Ccr7-/- mice don’t exhibit decreased survival compared with WT animals (Satpathy et al. 
2013). As well as being indicative of a tissue-specific response to enhanced apoptosis, 
upregulation of TIM4 on colonic rather than cMLN DC may therefore also be important 
for shaping DC production of pro-inflammatory mediators in the LP. 
While having shown that TIM4 expression is increased in a population-specific manner in 
the colonic LP during C. rodentium infection, our experimental approach was not 
comprehensive enough to identify the upstream signals that induced this upregulation. In 
the first place, it would have been important to confirm that in our hands and at the time 
point chosen, infection with C. rodentium indeed does induce enhanced apoptosis in the 
colon, thereby providing a potential trigger for the upregulation of TIM4. In vivo 
inhibition of caspases during C. rodentium infection decreases IEC apoptosis (Torchinsky 
et al. 2009) and a similar approach could have helped provide evidence for a functional link 
between the two. Alternatively, TIM4 expression on DC could have been assessed during 
DSS colitis, which induces widespread apoptosis in the colonic epithelium (Edelblum et al. 
2008, Araki et al. 2010), and could have been used as a comparison to infective colitis. 
Consequently, it would also have been useful to confirm if TIM4 upregulation was a 
MyD88-dependent mechanism initiated by the phagocytosis of dying infected cells. Use of 
bacterial mutants defective in specific TLR ligands such as flagellin could help to answer 
this question, although the lack of pathogenicity that often characterises these strains might 
limit their usefulness in elucidating this in vivo.  
We were also unable to establish if TIM4 upregulation has any functional effect on CD11b+ 
CD103- DC during infection. For example, it would have been of interest to FACS-sort 
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TIM4+ and TIM4- CD11b+ CD103- DC during infection and compare their ability to take 
up apoptotic bodies in vitro. The small number of TIM4+ cells recovered and the difficulty 
in maintaining LP DC ex vivo does place some constraints on this approach. More 
comprehensive transcriptional profiling of TIM4+ and TIM4- populations would be a 
further informative and important way of testing the hypothesis that TIM4+ cells 
upregulate the expression of pro-inflammatory mediators after phagocytosing infected 
apoptotic cells. Based on the work carried out by Torchinsky et al. (2009), it is tempting to 
speculate that increased TIM4 expression on DC during C. rodentium infection is 
protective by enhancing their ability to help establish Th17 responses. However, more 
functional experiments are required to confirm if this truly is the case. 
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Chapter 6: TIM4 function in the intestine and MLN 
6.1 Aims and hypotheses 
TIM4 expression may correlate with a migratory signature on DC and is upregulated in a 
population-specific manner in the colonic LP during C. rodentium infection. These 
findings indicate three possible roles for this molecule in regulating DC function. First, it 
may directly be involved in DC migration to the LN, by interacting with integrins or other 
glycoproteins on the lymphatic endothelium. The presence of an RGD peptide motif in its 
Ig domain, and the great number of O-linked glycosylation sites found in the mucin 
domain of TIM4 support this as a likely hypothesis. We therefore used Kaede mice to 
determine if DC migration to the LN was indeed dependent on functional TIM4. 
Second, expression of TIM4 is upregulated in lymph and remains high on DC in the MLN, 
indicating that it may also have a role in antigen presentation. TIM4 is the ligand for TIM1 
(Meyers et al. 2005), which is induced on T cells upon activation (de Souza et al. 2005). 
Ligation of TIM1 in the presence of co-stimulatory signals induces polyclonal T cell 
proliferation independently of TCR engagement (Mariat et al. 2009). Based on these 
observations, it is possible that TIM4 expressed on DC in the MLN can help sustain and 
amplify T cell activation. An alternative role during antigen presentation could be given by 
its native function as a PSR. During TCR ligation, the membrane surrounding the 
immunological synapse undergoes rearrangement (Gagnon et al. 2012), leading to the 
limited exposure of PS (Fischer et al. 2006, Albacker et al. 2013) on the cell surface. 
Recognition of PS by TIM4+ DC during antigen presentation could therefore allow further 
tethering and stabilisation of the immunological synapse. To address this question, we 
assessed the ability of MLN DC populations to drive an antigen-specific T cell response in 
vitro whilst concomitantly blocking TIM4. 
Finally, as well as a possible role in supporting these functions in naïve mice, TIM4 may 
also shape DC function during bacterial-induced intestinal inflammation, as we found 
colonic DC upregulate TIM4 expression during C. rodentium infection. This could be due 
to the increased level of IEC apoptosis, or the increased abundance of PAMPs in the 
colonic LP of infected mice. However, it is unknown if TIM4-mediated uptake of apoptotic 
cells in this setting is required for instructing T cell differentiation during antigen 
presentation. Infection with both C. rodentium (Torchinsky et al. 2009) and 
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S. Typhimurium (Liu et al. 2010, Srikanth et al. 2010) causes the upregulation of apoptotic 
pathways in the colonic epithelium but contrary to C. rodentium, S. Typhimurium elicits a 
mixed Th1 and Th17 response (Lee et al. 2012). Given the importance of apoptotic cell 
uptake in the induction of Th17 responses to C. rodentium (Torchinsky et al. 2009), we 
asked if TIM4 upregulation on DC during infection was a driving factor for this. We 
therefore compared the importance of TIM4 in skewing T cell responses in these two 
different bacterial infections to help further elucidate its function.   
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6.2 Results 
6.2.1 TIM4 function in DC migration to the cMLN 
To test the hypothesis that TIM4 played a role in directly enhancing the efficiency of DC 
migration to the cMLN, we injected Kaede mice with αTIM4 antibody or Rat IgG2a 
isotype control 24 h before photoconverting the proximal colon using violet light (Figure 6. 
1). After 48 h we harvested the cMLN and analysed the proportion of Kaede-red+ DC that 
had migrated from the colon (Figure 6. 1). 
 
Figure 6. 1: Experimental setup to investigate the function of TIM4 in steady state DC migration to the 
cMLN 
Schematic showing experimental setup, where Kaede mice were given 200 µg αTIM4 antibody or Rat IgG2a 
(ISO) by intraperitoneal (i.p.) injection 24 h before laparotomy and photoconversion (photo) of the proximal 
colon using violet light. Tissues were harvested 48 h post-photoconversion and cells analysed by flow 
cytometry.
6. TIM4 function in the intestine and MLN 
 
191 
The rate of colonic photoconversion in mice receiving αTIM4 or isotype control was 
comparable (Figure 6. 2a). Furthermore, TIM4 staining on colonic and cMLN DC was 
drastically reduced in mice that had received the blocking antibody compared with the 
isotype control (Figure 6. 2b, c). 
       
Figure 6. 2: The photoconversion rate between groups is comparable and TIM4 staining is reduced on 
colonic and cMLN DC 
Kaede mice were given 200 µg αTIM4 antibody or Rat IgG2a (ISO) by intraperitoneal (i.p.) injection 24 h 
before laparotomy and photoconversion of the proximal colon using violet light. Colons and cMLN were 
harvested 48 h post-photoconversion and cells analysed by flow cytometry. (a) Representative plots showing 
total Kaede-red+ DC in the colonic LP from αTIM4- and ISO-treated mice gated on single, live, CD45+, 
MHCII+, CD11c+, CD64-, B220- cells. Summary data are shown as percentage of Kaede-red+ cells among total 
DC. (b) Representative plots showing total TIM4+ colonic DC gated on single, live, CD45+, MHCII+, CD11c+, 
CD64-, B220- cells. Summary data are shown as percentage of TIM4+ cells among total DC. (c) Representative 
plots showing total TIM4+ migratory DC in the cMLN gated on single, live, CD45+, MHCIIhi, CD11c+, CD64-, 
B220- cells. Summary data are shown as the percentage of TIM4+ cells among total DC. Error bars represent 
the S.D.; statistical analysis carried out using a Mann-Whitney test.
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To confirm that this decrease was not caused by the selective depletion of TIM4+ DC in the 
colonic LP or cMLN, we compared the percentage and number of DC for each population 
in these tissues and found no significant change with αTIM4 treatment (Figure 6. 3 and 
Figure 6. 4). We concluded, therefore, that the reduction in TIM4 staining we had observed 
was either due to its internalisation or masking by the circulating injected antibody. We 
reasoned that its function would likely to be compromised in either case. Indeed, 
previously published work indicates that this approach successfully abolishes TIM4 
function in vivo (Yeung et al. 2013, Ji et al. 2014).
    
Figure 6. 3: Colonic DC population distribution does not change significantly after TIM4 blocking  
Kaede mice were given 200 µg αTIM4 antibody or Rat IgG2a (ISO) by intraperitoneal (i.p.) injection 24 h 
before laparotomy and photoconversion of the proximal colon using violet light. Colons were harvested 48 h 
post-photoconversion and cells analysed by flow cytometry. (a) Representative plots showing DC 
populations in the colonic LP from αTIM4- and ISO-treated mice gated on single, live, CD45+, MHCII+, 
CD11c+, CD64-, B220- cells. Summary data are shown as (b) percentage of DC populations among live cells 
and (c) absolute cell number. Error bars represent S.D.; statistical analysis was carried out using a Mann-
Whitney test.
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Figure 6. 4: Migratory DC population distribution in the cMLN does not change significantly after TIM4 
blocking 
Kaede mice were given 200 µg αTIM4 antibody or Rat IgG2a (ISO) by intraperitoneal (i.p.) injection 24 h 
before laparotomy and photoconversion of the proximal colon using violet light. Colon draining MLN 
(cMLN) were harvested 48 h post-photoconversion and cells analysed by flow cytometry. (a) Representative 
plots showing migratory DC populations in the cMLN from αTIM4- and ISO-treated mice gated on single, 
live, CD45+, MHCIIhi, CD11c+, CD64-, B220- cells. Summary data are shown as (b) percentage of DC 
populations among live cells and (c) absolute cell number. Error bars represent S.D.; statistical analysis was 
carried out using a Mann-Whitney test. 
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When we compared the migratory DC compartment in the cMLN of mice given αTIM4 
with those that had received the isotype control, we found no difference in the percentage 
or number of Kaede-red+ DC between the two groups (Figure 6. 5). Moreover, this was true 
for all migratory DC subsets (Figure 6. 6). 
 
Figure 6. 5: Blocking TIM4 in vivo does not significantly decrease Kaede-red+ migratory DC proportions 
or numbers in the cMLN 
Kaede mice were given 200 µg αTIM4 antibody or Rat IgG2a (ISO) by intraperitoneal (i.p.) injection 24 h 
before laparotomy and photoconversion of the proximal colon using violet light. Colon draining MLN 
(cMLN) were harvested 48 h post-photoconversion and cells analysed by flow cytometry. Representative 
plots show Kaede-red+ migratory DC in the cMLN from αTIM4- and ISO-treated mice gated on single, live, 
CD45+, MHCIIhi, CD11c+, CD64-, B220- cells. Summary data are shown as the absolute cell number and 
percentage of Kaede-red+ cells among migratory DC. Error bars represent S.D; statistical analysis carried out 
using a Mann-Whitney test.
      
Figure 6.6 continued on next page
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Figure 6. 6: Blocking TIM4 does not alter the percentage or number of Kaede-red+ cells among cMLN 
migratory DC populations 
Kaede mice were given 200 µg αTIM4 antibody or Rat IgG2a (ISO) by intraperitoneal (i.p.) injection 24 h 
before laparotomy and photoconversion of the proximal colon using violet light. Colon draining MLN 
(cMLN) were harvested 48 h post-photoconversion and cells analysed by flow cytometry. (a) Representative 
plots show Kaede-red+ cells among each migratory DC subset in the cMLN from αTIM4- and ISO-treated 
mice gated on single, live, CD45+, MHCIIhi, CD11c+, CD64-, B220- cells. Summary data show as (b) the 
percentage of Kaede-red+ cells among each DC subset and (c) their absolute cell number. Error bars represent 
S.D.; statistical analysis carried out using a Mann-Whitney test. 
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6.2.2 TIM4 function in antigen presentation on MLN DC 
Having seen little evidence for a role of TIM4 in directly facilitating DC migration to the 
MLN in vivo, we used an in vitro system to determine if TIM4 was required for efficient 
antigen-specific T cell proliferation. Total MLN migratory DC subsets were FACS-sorted 
(Figure 6. 7) and pulsed with OVA protein before co-culturing for three days with CFSE-
labelled OT-II MLN cells in the presence of αTIM4 antibody or Rat IgG2a isotype control. 
 
Figure 6. 7: FACS sort gating and purity for MLN DC migratory populations 
Whole MLN from naïve C57BL/6 mice were harvested and migratory DC populations FACS sorted for co-
culture with OT-II and OT-I MLN cells. (a) Representative plots showing gating strategy for MLN migratory 
DC populations, gated on single, live, MHCIIhi, CD11c+, CD64-, B220- cells. (b) Representative plots showing 
sort purity of DC populations.
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All DC subsets were able to induce antigen-specific proliferation of CD4+ T cells, with 
CD11b+ CD103- DC eliciting the strongest response (Figure 6. 8). However, blocking TIM4 
in vitro had no effect on the ability of DC subsets to induce CD4+ T cell proliferation 
(Figure 6. 8). 
    
Figure 6. 8: Blocking TIM4 does not alter antigen-specific proliferation of CD4+ T cells in vitro 
Whole MLN from naïve C57BL/6 mice were harvested and migratory DC subsets FACS sorted for co-culture 
with OT-II MLN cells. For each subset, 7,500 DC were incubated with 2 mg/ml OVA for two hours and 
subsequently co-cultured with 200,000 CFSE-labelled OT-II MLN cells in the presence of 5 µg/ml αTIM4 or 
Rat IgG2a isotype control (ISO) for three days. OT-II MLN cells were then analysed by flow cytometry. 
(a) Representative plots showing proliferated CD44+ CFSEneg cells gated on single, live, CD3+ CD4+ T cells. A 
control without added DC was included to discount any non-specific proliferation (“No DC”). (b) Summary 
data shown as the percentage of CD44+ CFSEneg cells among CD4+ T cells. Error bars represent S.D.; statistical 
analysis was carried out using a Mann-Whitney test.
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On the other hand, a small but significant decrease in the proportion of proliferated T cells 
expression CCR9 was observed after blocking TIM4 in cultures with CD11b+ CD103+ DC 
(Figure 6. 9). 
     
Figure 6. 9: Blocking TIM4 reduces CCR9 induction on CD4+ T cells by CD11b+ CD103+ DC in vitro 
Whole MLN from naïve C57BL/6 mice were harvested and migratory DC subsets FACS sorted for co-culture 
with OT-II MLN cells. For each subset, 7,500 DC were incubated with 2 mg/ml OVA for two hours and 
subsequently co-cultured with 200,000 CFSE-labelled OT-II MLN cells in the presence of 5 µg/ml αTIM4 or 
Rat IgG2a isotype control (ISO) for three days. OT-II MLN cells were then analysed by flow cytometry. 
(a) Representative plots showing CCR9+ CFSEneg cells gated on single, live, CD3+, CD4+ T cells. A control 
without added DC was included to discount any non-specific proliferation (“No DC”). (b) Summary data 
shown as the percentage of CCR9+ CFSEneg cells among CD4+ T cells. Error bars represent S.D.; statistical 
analysis was carried out using a Mann-Whitney test. * p < 0.05.
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Conversely, expression of the integrin β7 was not reduced when OT-II cells were 
co-cultured with DC in the presence of αTIM4 (Figure 6. 10).
     
Figure 6. 10: Blocking TIM4 in vitro does not significantly change integrin β7 expression on CD4+ T cells 
after antigen-specific proliferation 
Whole MLN from naïve C57BL/6 mice were harvested and migratory DC subsets FACS sorted for co-culture 
with OT-II MLN cells. For each subset, 7,500 DC were incubated with 2 mg/ml OVA for two hours and 
subsequently co-cultured with 200,000 CFSE-labelled OT-II MLN cells in the presence of 5 µg/ml αTIM4 or 
Rat IgG2a isotype control (ISO) for three days. OT-II MLN cells were then analysed by flow cytometry. 
(a) Representative plots showing β7+ CFSEneg cells gated on single, live, CD3+, CD4+ T cells. A control without 
added DC was included to discount any non-specific proliferation (“No DC”). (b) Summary data shown as 
the percentage of β7+ CFSEneg cells among CD4+ T cells. Error bars represent S.D.; statistical analysis was 
carried out using a Mann-Whitney test. 
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Given the ability of CD11b- CD103+ DC to cross-present self-derived antigen, we tested if 
TIM4 had any functional role in this process in vitro. We co-cultured OVA-pulsed MLN 
migratory CD11b- CD103+ DC with OT-I MLN cells in the presence of αTIM4 antibody or 
Rat IgG2a isotype control for three days. As seen before with OT-II cells, proliferation of 
OT-I CD8+ T cells was not impacted by blocking TIM4 in vitro (Figure 6. 11).
         
Figure 6. 11: Blocking TIM4 does not alter antigen-specific proliferation of CD8+ T cells in vitro 
Whole MLN from naïve C57BL/6 mice were harvested and migratory CD11b- CD103+ DC FACS sorted for 
co-culture with OT-I MLN cells. To achieve this, 7,500 CD11b- CD103+ DC were incubated with 2 mg/ml 
OVA for two hours and subsequently co-cultured with 200,000 CFSE-labelled OT-I MLN cells in the 
presence of 5 µg/ml αTIM4 or Rat IgG2a isotype control (ISO) for three days. OT-I MLN cells were then 
analysed by flow cytometry. Representative plots show CD44+ CFSEneg cells gated on single, live, CD3+, CD8+ 
T cells. A control without added DC was included to discount any non-specific proliferation (“No DC”). 
Summary data are shown as the percentage of CD44+ CFSEneg cells among CD8+ T cells. Error bars represent 
S.D.; statistical analysis carried out using a Mann-Whitney test.
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Furthermore, expression of CCR9 and integrin β7 (Figure 6. 12) were also unchanged on 
proliferated CD8+ T cells
 
Figure 6. 12: Blocking TIM4 does not alter induction of intestinal homing markers on CD8+ T cells in 
vitro 
Whole MLN from naïve C57BL/6 mice were harvested and migratory CD11b- CD103+ DC FACS sorted for 
co-culture with OT-I MLN cells. To achieve this, 7,500 CD11b- CD103+ DC were incubated with 2 mg/ml 
OVA for two hours and subsequently co-cultured with 200,000 CFSE-labelled OT-I MLN cells in the 
presence of 5 µg/ml αTIM4 or Rat IgG2a isotype control (ISO) for three days. OT-I MLN cells were then 
analysed by flow cytometry. A control without added DC was included to discount any non-specific 
proliferation (“No DC”). (a) Representative plots show CCR9+ CFSEneg cells gated on single, live, CD3+, CD8+ 
T cells. Summary data are shown as the percentage of CCR9+ CFSEneg cells among CD8+ T cells. 
(b) Representative plots show β7+ CFSEneg cells gated on single, live, CD3+, CD8+ T cells. Summary data are 
shown as the percentage of β7+ CFSEneg cells among CD8+ T cells. Error bars represent S.D.; statistical 
analysis carried out using a Mann-Whitney test. 
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We next assessed whether antigen-specific activation of CD4+ and CD8+ T cells by MLN 
DC in vitro could induce TIM1 expression, as had previously been reported in other 
systems (de Souza et al. 2005). Interestingly, we did not detect any TIM1 induction on 
proliferated OT-II CD4+ T cells, while a small proportion of OT-I CD8+ T cells did 
upregulate TIM1 after proliferation, independently of blocking TIM4 (Figure 6. 13).
  
Figure 6. 13: TIM1 is induced on CD8+ but not CD4+ T cells in vitro independently of TIM4 blocking 
Whole MLN from naïve C57BL/6 mice were harvested and migratory CD11b- CD103+ DC FACS sorted for 
co-culture with OT-II or OT-I MLN cells. To achieve this, 7,500 CD11b- CD103+ DC were incubated with 
2 mg/ml OVA for two hours and subsequently co-cultured with 200,000 CFSE-labelled OT-II or OT-I MLN 
cells in the presence of 5 µg/ml αTIM4 or Rat IgG2a isotype control (ISO) for three days. OT-II and OT-I 
MLN cells were then analysed by flow cytometry. A control without added DC was included to discount any 
non-specific proliferation (“No DC”). (a) Representative plots showing TIM1+ CFSEneg cells gated on single, 
live, CD3+, CD4+ OT-II T cells. (b) Representative plots showing TIM1+ CFSEneg cells gated on single, live, 
CD3+, CD8+ OT-I T cells. Summary data are shown as the percentage of TIM1+ CFSEneg cells among CD8+ 
T cells. Error bars represent S.D.; statistical analysis was carried out using a Mann-Whitney test. 
6.2.3 TIM4 function in C. rodentium infection 
During C. rodentium infection we the percentage of TIM4+ cells increased for CD11b+ 
CD103- and CD11b- CD103- DC in the colonic LP (Figure 5. 18). Given the importance of 
apoptotic cell uptake in initiation of Th17 responses (Torchinsky et al. 2009), we tested if 
TIM4 had a functional role in facilitating this in vivo. We infected mice with 
bioluminescent C. rodentium for seven days, during which time we treated them twice with 
αTIM4 antibody or Rat IgG2a isotype control by intraperitoneal (i.p.) injection (Figure 6. 
14). 
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Figure 6. 14: Experimental setup for investigating the role of TIM4 during infection with C. rodentium 
Schematic showing experimental setup, where mice were given PBS of infected with 2 × 109 CFU 
bioluminescent C. rodentium (C. rod) by oral gavage. Four and six days p. i. (dpi), infected mice were treated 
with intraperitoneal (i.p.) injections of 200 µg αTIM4 antibody or Rat IgG2a isotype control (ISO). Seven 
days p. i., tissues were harvested and cells analysed by flow cytometry. 
We did not observe any differences in bacterial burden at the rectum after seven days in the 
two infected groups (Figure 6. 15). 
 
Figure 6. 15: Blocking TIM4 during C. rodentium infection does not have an impact on bacterial burden 
Mice were given PBS of infected with 2 × 109 CFU bioluminescent C. rodentium (C. rod) by oral gavage. Four 
and six days p. i. (dpi), infected mice were treated with intraperitoneal (i.p.) injections of 200 µg αTIM4 
antibody or Rat IgG2a isotype control (ISO). Seven days p. i. colons and caeca were harvested. (a) Bacterial 
luminescence in the organs was measured and images acquired using an IVIS Spectrum Imaging System. For 
each specimen the rectum was identified as a region of interest (ROI) for quantification of luminescence. 
(b) Total flux (photons/s) was measured for individual ROI and subsequently normalised by subtracting the 
mean total flux of uninfected PBS controls to eliminate background luminescence.
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As described previously, there was a trend towards increased TIM4 expression on total 
colonic LP DC after infection with C. rodentium in the group given the isotype control, but 
treatment with αTIM4 significantly reduced TIM4 staining (Figure 6. 16a). This reduction 
was also seen on colonic Ly6C- MHCII+ macrophages (Figure 6. 16b), and on migratory 
DC in the cMLN (Figure 6. 16c).
 
Figure 6. 16: Percentage of TIM4+ DC and macrophages during infection with C. rodentium and 
concurrent blocking of TIM4 
Mice were given PBS or infected with 2 × 109 CFU bioluminescent C. rodentium (C. rod) by oral gavage. Four 
and six days p. i., infected mice were treated with intraperitoneal (i.p.) injections of 200 µg αTIM4 antibody 
or Rat IgG2a isotype control (ISO). Seven days p. i., colons and cMLN were harvested and cells analysed by 
flow cytometry. (a) Representative plots showing TIM4+ colonic LP DC gated on single, live, CD45+, 
MHCII+, CD11c+, CD64-, B220- cells. Summary data are shown as TIM4+ cells among total LP DC. 
(b) Representative plots showing TIM4+ colonic macrophages gated on single, live, CD45+, CD11b+, (Ly6G-), 
SSClo, CD64int-hi, Ly6C-, MHCII+ cells. Summary data are shown as TIM4+ cells among Ly6C- MHCII+ 
macrophages. (c) Representative plots showing TIM4+ cMLN migratory total DC gated on single, live, 
CD45+, MHCIIhi, CD11c+, CD64-, B220- cells. Summary data are shown as percentage of TIM4+ cells among 
total migratory DC. Error bars represent S.D.; statistical analysis carried out using a Kruskal-Wallis test with 
a Dunn’s post-test for multiple comparisons. * p < 0.05, ** p < 0.01.
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Analysis of colonic LP DC subsets revealed, as previously observed, that C. rodentium 
infection reduced the percentage of CD11b- CD103+ DC (Figure 6. 17a, b), but not their 
absolute cell number (Figure 6. 17c). Furthermore, this was not impacted by blocking 
TIM4 (Figure 6. 17). 
        
Figure 6. 17: The distribution of colonic DC populations is not impacted by TIM4 blocking during 
C. rodentium infection 
Mice were given PBS or infected with 2 × 109 CFU bioluminescent C. rodentium (C. rod) by oral gavage. Four 
and six days p. i., infected mice were treated with intraperitoneal (i.p.) injections of 200 µg αTIM4 antibody 
or Rat IgG2a isotype control (ISO). Seven days p. i., colons were harvested and LP cells analysed by flow 
cytometry. (a) Representative plots showing colonic DC subsets from uninfected (PBS) and infected mice 
treated with αTIM4 antibody or ISO, gated on single, live, CD45+, MHCII+, CD11c+, CD64-, B220- cells. 
Summary data shown as (b) the percentage of DC populations among live cells and (c) their absolute cell 
number. Error bars represent S.D.; statistical analysis carried out using a Kruskal-Wallis test with a Dunn’s 
post-test for multiple comparisons. * p < 0.05. 
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Nonetheless, the effect of TIM4 blockade may have been to reduce capacity to phagocytose 
apoptotic material on CD11b- CD103+ DC, impacting downstream functions, such as 
maturation and cytokine production. We therefore FACS-sorted CD11b- CD103+ DC for 
gene transcription analysis from the colons of PBS-treated mice and from C. rodentium 
infected mice, that had or hadn’t received αTIM4 antibody (Figure 6. 18a). In order to 
assess if TIM4 blocking reduces the maturation of DC, we assessed the expression of Ccr7 
mRNA in CD11b- CD103+ DC isolated from the three groups.  However, we saw no 
significant changes in transcript levels of Ccr7 (Figure 6. 18b). Given the importance of 
both IL-1β and TGFβ in the induction of Th17 responses (Mangan et al. 2006, Veldhoen et 
al. 2006, Ghoreschi et al. 2010), we used the same approach to assess the expression of Il1b 
and the TGFβ activating integrin beta8 (Itgb8) in CD11b- CD103+ DC. However, we found 
no difference in expression levels in CD11b- CD103+ DC from the three experimental 
groups (Figure 6. 18b). 
 
Figure 6. 18: Gene expression in colonic CD11b- CD103+ DC during C. rodentium infection does not 
change with TIM4 blocking 
Mice were given PBS or infected with 2 × 109 CFU bioluminescent C. rodentium (C. rod) by oral gavage. Four 
and six days p. i., a group of infected mice was treated with intraperitoneal (i.p.) injections of 200 µg αTIM4 
antibody. Seven days p. i., colons were harvested and CD11b- CD103+ FACS sorted for gene expression 
analysis by qRT-PCR. (a) Representative plots showing sort gating and purity of CD11b- CD103+ DC. These 
were gated as single, live, CD45+, MHCII+, CD11c+, CD64-, B220- cells. (b) Expression levels of Ccr7, Il1b, and 
Itgb8 mRNA normalised to housekeeping gene Tbp. Error bars represent S.D.; statistical analysis was carried 
out using a Kruskal-Wallis test with a Dunn’s post-test for multiple comparisons.
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In order to determine if blocking TIM4 during C. rodentium infection had any impact on 
the severity of the elicited inflammatory response, we analysed the frequency and number 
of CD11b+ Ly6G+ neutrophils in the colonic LP. However, this was unaffected in mice that 
had received αTIM4 compared with those administered the isotype control (Figure 6. 19). 
 
Figure 6. 19: Blocking TIM4 does not significantly alter neutrophil frequencies during C. rodentium 
infection 
Mice were given PBS or infected with 2 × 109 CFU bioluminescent C. rodentium (C. rod) by oral gavage. Four 
and six days p. i., infected mice were treated with intraperitoneal (i.p.) injections of 200 µg αTIM4 antibody 
or Rat IgG2a isotype control (ISO). Seven days p. i., colons were harvested and LP cells analysed by flow 
cytometry. (a) Representative plots show colonic CD11b+ Ly6G+ neutrophils from PBS-treated and infected 
mice given αTIM4 or ISO, gated on single, live, CD45+ cells. (b) Summary data are shown as percentage of 
CD11b+ Ly6G+ neutrophils among total live cells, and their absolute cell number. Error bars represent S.D.; 
statistical analysis was carried out using a Kruskal-Wallis test with a Dunn’s post-test for multiple 
comparisons.
The influx of Ly6C+ MHCII- and Ly6C+ MHCII+ monocytes into the colon is another 
indication of on-going tissue inflammation. Indeed, infected animals treated with the 
isotype control had significantly more monocytes infiltrating the colonic LP compared 
with PBS-treated controls (Figure 6. 20). This was not true, however, after blocking TIM4 
(Figure 6. 20). Mature colonic macrophages also express TIM4, and exhibited loss of TIM4 
staining upon administration of αTIM4 (Figure 6. 20b). While infection with C. rodentium 
significantly increased the number of Ly6C- MHCII+ macrophages, this was not the case for 
αTIM4-treated infected mice, as seen in the monocyte compartment (Figure 6. 20).
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Figure 6. 20: Blocking TIM4 does not significantly alter colonic monocyte and macrophage frequencies 
during C. rodentium infection 
Mice were given PBS or infected with 2 × 109 CFU bioluminescent C. rodentium (C. rod) by oral gavage. Four 
and six days p. i., infected mice were treated with intraperitoneal (i.p.) injections of 200 µg αTIM4 antibody 
or Rat IgG2a isotype control (ISO). Seven days p. i., colons were harvested and LP cells analysed by flow 
cytometry. (a) Representative plots showing Ly6C+ MHCII- (P1) and Ly6C+ MHCII+ (P2) monocyte 
populations, and Ly6C- MHCII+ (P3) macrophages from PBS-treated and infected mice given αTIM4 or ISO, 
gated on single, live, CD45+, CD11b+, (Ly6G-), SSClo, CD64int-hi cells. Summary data are shown as (b) the 
percentage of P1, P2 and P3 populations among total live cells, and (c) their absolute cell number. Error bars 
represent S.D.; statistical analysis was carried out using a Kruskal-Wallis test with a Dunn’s post-test for 
multiple comparisons. * p < 0.05.
We next ascertained if the percentage and number of migratory DC present in the cMLN 
was impacted by blocking TIM4 during C. rodentium infection. While infected mice that 
had received blocking antibody exhibited significantly reduced frequencies of all migratory 
DC populations except CD11b+ CD103- DC in the cMLN compared with PBS-treated mice, 
there was no statistical difference between αTIM4- and isotype control-treated animals 
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(Figure 6. 21a, b). Furthermore, the reduction in proportion did not translate to changes in 
absolute cell number (Figure 6. 21c).
       
Figure 6. 21: Blocking TIM4 does not significantly alter cMLN migratory DC population frequencies  
Mice were given PBS or infected with 2 × 109 CFU bioluminescent C. rodentium (C. rod) by oral gavage. Four 
and six days p. i., infected mice were treated with intraperitoneal (i.p.) injections of 200 µg αTIM4 antibody 
or Rat IgG2a isotype control (ISO). Seven days p. i., cMLN were harvested and cells analysed by flow 
cytometry. (a) Representative plots showing cMLN DC populations from PBS-treated and infected mice 
given αTIM4 or ISO, gated on single, live, CD45+, MHCIIhi, CD11c+, CD64- B220- cells. Summary data are 
shown as (b) the percentage of DC populations among total live cells and (c) their absolute cell number. 
Error bars represent S.D.; statistical analysis was carried out using a Kruskal-Wallis test with a Dunn’s post-
test for multiple comparisons. * p < 0.05. 
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Finally, we investigated the importance of TIM4 in the induction of T cell responses during 
infection with C. rodentium. Blocking TIM4 did not change the percentage or number of 
activated IL-17A+ or IFNγ+ CD4+ T cells in the cMLN (Figure 6. 22a, b). Interestingly, the 
proportion of FoxP3+ CD4+ Treg cells in the cMLN dropped significantly during infection, 
but not if TIM4 was blocked (Figure 6. 22c). This was only true for the percentage, but not 
for the absolute number of Treg cells (Figure 6. 22c). 
 
Figure 6. 22: CD4+ T cell responses in the cMLN do not change significantly with TIM4 blocking during 
C. rodentium infection 
Mice were given PBS or infected with 2 × 109 CFU bioluminescent C. rodentium (C. rod) by oral gavage. Four 
and six days p. i., infected mice were treated with intraperitoneal (i.p.) injections of 200 µg αTIM4 antibody 
or Rat IgG2a isotype control (ISO). Seven days p. i., cMLN were harvested, cells stimulated with PMA and 
Ionomycin, and analysed by flow cytometry. Evaluation of (a) IL-17A+ CD44+ CD4+ T cells, (b) IFNγ+ CD44+ 
CD4+ T cells and (c) FoxP3+ CD4+ Treg cells in the cMLN of PBS-treated and infected mice given αTIM4 or 
ISO. Representative plots show cytokine or transcription factor stained cells gated on single, live, CD45+, 
CD3+, CD4+ T cells. Summary data are shown as the percentage of Th17, Th1 and Treg cells among total live 
cells, as well as their absolute cell number. Error bars represent S.D.; statistical analysis was carried out using 
a Kruskal-Wallis test with a Dunn’s post-test for multiple comparisons. * p < 0.05.
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As seen with CD4+ T cells, the induction of IFNγ+ CD8+ T cells in the cMLN was also 
independent of TIM4 (Figure 6. 23). 
 
Figure 6. 23: Blocking TIM4 during C. rodentium infection does not significantly alter CD8+ T cell 
responses in the cMLN 
Mice were given PBS or infected with 2 × 109 CFU bioluminescent C. rodentium (C. rod) by oral gavage. Four 
and six days p. i., infected mice were treated with intraperitoneal (i.p.) injections of 200 µg αTIM4 antibody 
or Rat IgG2a isotype control (ISO). Seven days p. i., cMLN were harvested, cells stimulated with PMA and 
Ionomycin, and analysed by flow cytometry. Representative plots show IFNγ+ CD44+ CD8+ T cells from the 
cMLN of PBS-treated and infected mice given αTIM4 or ISO, gated on single, live, CD45+, CD3+, CD8+ 
T cells. Summary data are shown as the percentage of IFNγ+ CD44+ CD8+ T cells among total live cells, and as 
their absolute cell number. Error bars represent S.D.; statistical analysis was carried out using a Kruskal-
Wallis test with a Dunn’s post-test for multiple comparisons.
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Production of both IL-17A and IFNγ by stimulated colonic CD4+ T cells was low and TIM4 
blocking had no effect on the levels produced during infection (Figure 6. 24a, b). The 
percentage of CD8+ IFNγ+ T cells in the colonic LP was negligible across groups (data not 
shown). Moreover, in contrast to the cMLN, where C. rodentium infection was found to 
increase the proportion of FoxP3+ CD4+ Treg cells, this was not true in the colon and 
blocking TIM4 had no impact on the percentage or number of Treg cells in the LP (Figure 
6. 24c).
 
Figure 6. 24: Colonic CD4+ T cell responses are not significantly changed during infection with 
C. rodentium and concurrent blocking of TIM4 
Mice were given PBS or infected with 2 × 109 CFU bioluminescent C. rodentium (C. rod) by oral gavage. Four 
and six days p. i, infected mice were treated with intraperitoneal (i.p.) injections of 200 µg αTIM4 antibody or 
Rat IgG2a isotype control (ISO). Seven days p. i., colons were harvested, LP cells stimulated with PMA and 
Ionomycin, and analysed by flow cytometry. Evaluation of (a) IL-17A+ CD44+ CD4+ T cells, (b) IFNγ+ CD44+ 
CD4+ T cells and (c) FoxP3+ CD4+ Treg cells in the colonic LP of PBS-treated and infected mice given αTIM4 
or ISO. Representative plots show cytokine or transcription factor stained cells gated on single, live, CD45+, 
CD3+, CD4+ T cells. Summary data are shown as the percentage of Th17, Th1 and Treg cells among total live 
cells, as well as their absolute cell number. Error bars represent S.D.; statistical analysis was carried out using 
a Kruskal-Wallis test with a Dunn’s post-test for multiple comparisons. * p < 0.05.
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6.2.4 TIM4 function in S. Typhimurium infection 
We were unable to find any evidence that blocking TIM4 had any significant impact on 
innate or adaptive responses to C. rodentium. We next aimed to determine if this was also 
the case with S. Typhimurium infection, which induces a mixed Th1/Th17 response (Lee et 
al. 2012). To this end we used a well-established model (Barthel et al. 2003), involving pre-
treatment with oral streptomycin 24 h before infection with S. Typhimurium. 
Concurrently, animals were given i.p. injections of either αTIM4 blocking antibody or Rat 
IgG2a isotype control (Figure 6. 25). The next day, animals were either given PBS or orally 
infected with S. Typhimurium (Figure 6. 25). 
 
Figure 6. 25: Experimental setup for investigating the function of TIM4 in S. Typhimurium infection 
Schematic describing experimental setup, where C57BL/6 mice were treated with 20 mg streptomycin by oral 
gavage and given 200 µg αTIM4 antibody or Rat IgG2a (ISO) by intraperitoneal (i.p.) injection 24 h before 
infection with 6 × 107 CFU S. Typhimurium (STM) per mouse, or treatment with PBS, by oral gavage. Two 
days p. i. (dpi) tissues were harvested and cells analysed by flow cytometry.
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 Weight loss over the course of infection was comparable between αTIM4 and isotype 
control-treated mice (Figure 6. 26a). Two days p. i. we measured colon lengths and found 
no differences between mice that had received αTIM4 compared with control mice in PBS-
treated or infected groups (Figure 6. 26b). 
           
Figure 6. 26: Blocking TIM4 does not significantly impact weight loss or colon shortening during 
S. Typhimurium infection 
C57BL/6 mice were treated with 20 mg streptomycin by oral gavage and given 200 µg αTIM4 antibody or Rat 
IgG2a (ISO) by intraperitoneal (i.p.) injection 24 h before infection with 6 × 107 CFU S. Typhimurium (STM) 
per mouse, or treatment with PBS, by oral gavage. (a) Weights were monitored throughout. Data are shown 
as the percentage weight relative to that before streptomycin treatment. (b) At two days p. i., colon lengths 
were determined. Error bars represent S.D.; statistical analysis was carried out using a Kruskal-Wallis test 
with a Dunn’s post-test for multiple comparisons. * p < 0.05 between PBS + αTIM4 and STM + αTIM4. 
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As in previous experiments, blocking TIM4 systemically reduced the percentage of TIM4+ 
DC in the colon and cMLN, as well as TIM4+ colonic macrophages (Figure 6. 27).
 
Figure 6. 27: Percentage of TIM4+ DC and macrophages during S. Typhimurium infection and TIM4 
blockade 
C57BL/6 mice were treated with 20 mg streptomycin by oral gavage and given 200 µg αTIM4 antibody or Rat 
IgG2a (ISO) by intraperitoneal (i.p.) injection 24 h before infection with 6 × 107 CFU S. Typhimurium (STM) 
per mouse, or treatment with PBS, by oral gavage. Two days p. i. colons and cMLN were harvested and cells 
analysed by flow cytometry. (a) Representative plots show the expression of TIM4 on total colonic DC gated 
on single, live, CD45+, MHCII+, CD11c+, CD64-, B220 cells. Summary data are shown as the percentage of 
TIM4+ cells among total LP DC. (b) Representative plots show the expression of TIM4 on Ly6C- MHCII+ 
colonic macrophages gated on single, live, CD45+, CD11b+, SSClo, CD64int-hi, Ly6C-, MHCII+ cells. Summary 
data are shown as the percentage of TIM4+ cells among total colonic macrophages. (c) Representative plots 
show the expression of TIM4 on total cMLN DC, gated on single, live, CD45+, MHCII+, CD11c+, CD64-, 
B220- cells. Summary data are shown as the percentage of TIM4+ cells among total cMLN DC. Error bars 
represent S.D.; statistical analysis was carried out using a Kruskal-Wallis test with a Dunn’s post-test for 
multiple comparisons. * p < 0.05, ** p < 0.01. 
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Comparing the expression of TIM4 on DC from isotype-treated mice that had either 
received PBS or were infected with S. Typhimurium, we found a trend towards increased 
expression of TIM4 on CD11b+ CD103+ and CD11b- CD103- DC in the colonic LP of 
infected animals, though this was not statistically significant (Figure 6. 28). 
           
Figure 6. 28: The percentage of TIM4+ cells among colonic DC populations does not change significantly 
with S. Typhimurium infection 
C57BL/6 mice were treated with 20 mg streptomycin by oral gavage and given 200 µg αTIM4 antibody or Rat 
IgG2a (ISO) by intraperitoneal (i.p.) injection 24 h before infection with 6 × 107 CFU S. Typhimurium (STM) 
per mouse, or treatment with PBS, by oral gavage. Two days p. i. colons were harvested and LP cells analysed 
by flow cytometry. (a) Representative plots showing TIM4+ cells among DC populations from PBS-treated 
and S. Typhimurium infected mice, both of which had received ISO antibody. DC are gated on single, live, 
CD45+, MHCII+, CD11c+, CD64-, B220- cells. (b) Summary data are shown as the percentage of TIM4+ cells 
among DC populations. Error bars represent S.D.; statistical analysis was carried out using a Mann-Whitney 
test.
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Interestingly, we found the opposite to be true in the cMLN, with a trend towards 
downregulation in TIM4 on CD11b+ CD103- and CD11b+ CD103+ DC (Figure 6. 29).
          
Figure 6. 29: The percentage of TIM4+ cells among cMLN migratory DC populations does not change 
significantly with S. Typhimurium infection 
C57BL/6 mice were treated with 20 mg streptomycin by oral gavage and given 200 µg αTIM4 antibody or Rat 
IgG2a (ISO) by intraperitoneal (i.p.) injection 24 h before infection with 6 × 107 CFU S. Typhimurium (STM) 
per mouse, or treatment with PBS, by oral gavage. Two days p. i. cMLN were harvested and cells analysed by 
flow cytometry. (a) Representative plots showing TIM4+ cells among DC subsets from PBS-treated and 
S. Typhimurium infected mice, both of which had received ISO antibody. DC are gated on single, live, 
CD45+, MHCII+, CD11c+, CD64-, B220- cells. (b) Summary data are shown as the percentage of TIM4+ cells 
among DC subsets. Error bars represent S.D.; statistical analysis was carried out using a Mann-Whitney test.
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When we analysed the distribution of colonic DC subsets, we found that neither 
S. Typhimurium infection, nor blocking TIM4 had any significant effect on the percentage 
or number of DC within each subset (Figure 6. 30). 
         
Figure 6. 30: Blocking TIM4 does not significantly impact colonic DC population distribution during 
S. Typhimurium infection 
C57BL/6 mice were treated with 20 mg streptomycin by oral gavage and given 200 µg αTIM4 antibody or Rat 
IgG2a (ISO) by intraperitoneal (i.p.) injection 24 h before infection with 6 × 107 CFU S. Typhimurium (STM) 
per mouse, or treatment with PBS, by oral gavage. Two days p. i. colons were harvested and LP cells analysed 
by flow cytometry. (a) Representative plots show colonic LP DC populations, gated on single, live, CD45+, 
MHCII+, CD11c+, CD64-, B220- cells. Summary data are shown as (b) the percentage of DC subsets among 
total live cells and (c) their absolute cell number. Error bars represent S.D.; statistical analysis was carried out 
using a Kruskal-Wallis test with a Dunn’s post-test for multiple comparisons. 
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S. Typhimurium-infected and αTIM4-treated mice did, however, have a significantly 
higher proportion of infiltrating Ly6C+ MHCII- and Ly6C+ MHCII- monocytes in the 
colonic LP compared with PBS controls (Figure 6. 31). This was accompanied by a similar 
trend in Ly6C+ MHCII+ monocyte numbers (Figure 6. 31c). Isotype control-treated 
infected animals also had a trend towards increased monocytes, although this was not 
statistically significant (Figure 6. 31).
        
Figure 6. 31: Colonic monocyte and macrophage populations are not significantly altered with TIM4 
blocking during S. Typhimurium infection 
C57BL/6 mice were treated with 20 mg streptomycin by oral gavage and given 200 µg αTIM4 antibody or Rat 
IgG2a (ISO) by intraperitoneal (i.p.) injection 24 h before infection with 6 × 107 CFU S. Typhimurium (STM) 
per mouse, or treatment with PBS, by oral gavage. Two days p. i. colons were harvested and LP cells analysed 
by flow cytometry. (a) Representative plots show Ly6C+ MHCII- (P1) monocyte, Ly6C+ MHCII+ (P2) 
monocyte and Ly6C- MHCII+ (P3) macrophage populations, gated on single, live, CD45+, CD11b+, SSClo, 
CD64int-hi cells. Summary data are shown as (b) the percentage of P1 and P2 monocyte populations and P3 
macrophages among total live cells, and (c) as their absolute cell number. Error bars represent S.D.; statistical 
analysis was carried out using a Kruskal-Wallis test with a Dunn’s post-test for multiple comparisons. 
* p < 0.05.
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To further determine if TIM4 blocking interfered with antigen presentation in the cMLN, 
we first assessed if the distribution of DC populations was altered upon infection and TIM4 
blockade. Unfortunately, we were unable to differentiate migratory and resident 
populations of DC in these samples based on the level of MHCII staining (data not shown), 
but instead gated on total MHCII+ CD11c+ cells, which will therefore represent a mixture 
of migratory and resident DC. Infection with S. Typhimurium did not alter DC population 
distribution in the cMLN, and neither did blocking TIM4 systemically (Figure 6. 32). 
 
Figure 6. 32: Blocking TIM4 does not significantly alter cMLN DC population frequencies during 
S. Typhimurium infection 
C57BL/6 mice were treated with 20 mg streptomycin by oral gavage and given 200 µg αTIM4 antibody or Rat 
IgG2a (ISO) by intraperitoneal (i.p.) injection 24 h before infection with 6 × 107 CFU S. Typhimurium (STM) 
per mouse, or treatment with PBS, by oral gavage. Two days p. i. cMLN were harvested and cells analysed by 
flow cytometry. (a) Representative plots showing cMLN DC populations gated on single, live, CD45+, 
MHCII+, CD11c+, CD64-, B220- cells. Summary data are shown as (b) the percentage of DC populations 
among total live cells and (c) their absolute cell number. Error bars represent S.D.; statistical analysis was 
carried out using a Kruskal-Wallis test with a Dunn’s post-test for multiple comparisons. 
6. TIM4 function in the intestine and MLN 
 
221 
While we observed a trend towards an increased proportion of IFNγ+ CD44+ CD4+ T cells 
in the cMLN and colons of infected mice, this was not statistically significant and was not 
affected by blocking TIM4 (Figure 6. 33). 
     
Figure 6. 33: Blocking TIM4 has no effect on the cMLN or colonic Th1 response during S. Typhimurium 
infection 
C57BL/6 mice were treated with 20 mg streptomycin by oral gavage and given 200 µg αTIM4 antibody or Rat 
IgG2a (ISO) by intraperitoneal (i.p.) injection 24 h before infection with 6 × 107 CFU S. Typhimurium (STM) 
per mouse, or treatment with PBS, by oral gavage. Two days p. i. cMLN and colons were harvested, cells 
stimulated with PMA and Ionomycin, and analysed by flow cytometry. Representative plots showing IFNγ+ 
CD44+ CD4+ T cells in (a) the cMLN and (b) the colonic LP. Cells were gated on single, live, CD45+, CD3+, 
CD4+ T cells. (c) Summary data are shown as the percentage of IFNγ+ CD44+ CD4+ T cells among total live 
cells in the colon and cMLN, and as their absolute cell number. Error bars represent S.D.; statistical analysis 
was carried out using a Kruskal-Wallis test with a Dunn’s post-test for multiple comparisons. 
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Infection with S. Typhimurium did not induce a strong colonic Th17 response either in the 
cMLN or the LP (Figure 6. 34), and there was no difference between mice that had received 
αTIM4 compared with those administered isotype control (Figure 6. 34). 
       
Figure 6. 34: Th17 responses in the cMLN and colon are not affected by blocking TIM4 during 
S. Typhimurium infection 
C57BL/6 mice were treated with 20 mg streptomycin by oral gavage and given 200 µg αTIM4 antibody or Rat 
IgG2a (ISO) by intraperitoneal (i.p.) injection 24 h before infection with 6 × 107 CFU S. Typhimurium (STM) 
per mouse, or treatment with PBS, by oral gavage. Two days p. i. cMLN and colons were harvested, cells 
stimulated with PMA and Ionomycin, and analysed by flow cytometry. Representative plots showing IL-17A+ 
CD44+ CD4+ T cells in (a) the cMLN and (b) the colonic LP. Cells were gated on single, live, CD45+, CD3+, 
CD4+ T cells. (c) Summary data are shown as the percentage of IL-17A+ CD44+ CD4+ T cells among total live 
cells in the colon and cMLN, and as their absolute cell number. Error bars represent S.D.; statistical analysis 
was carried out using a Kruskal-Wallis test with a Dunn’s post-test for multiple comparisons.
6. TIM4 function in the intestine and MLN 
 
223 
We had found that mice infected with C. rodentium had a reduced proportion of Treg cells 
in the cMLN (Figure 6. 22c). However, this was not the case in S. Typhimurium infected 
mice (Figure 6. 35a, c). In the colon of mice that had received αTIM4, on the other hand, 
infection with S. Typhimurium did significantly decrease the proportion, but not number, 
of Treg cells when compared with PBS-treated mice. However, overall TIM4 blocking had 
no impact on Treg cell frequencies or number in the cMLN or colon during 
S. Typhimurium infection (Figure 6. 35). 
        
Figure 6. 35: Blocking TIM4 has no effect on Treg cell frequencies in the cMLN or colon during 
S. Typhimurium infection 
C57BL/6 mice were treated with 20 mg streptomycin by oral gavage and given 200 µg αTIM4 antibody or Rat 
IgG2a (ISO) by intraperitoneal (i.p.) injection 24 h before infection with 6 × 107 CFU S. Typhimurium (STM) 
per mouse, or treatment with PBS, by oral gavage. Two days p. i. cMLN and colons were harvested, cells 
stimulated with PMA and Ionomycin, and analysed by flow cytometry. Representative plots showing FoxP3+ 
CD4+ T cells in (a) the cMLN and (b) the colonic LP. Cells were gated on single, live, CD45+, CD3+, CD4+ 
T cells. (c) Summary data are shown as the percentage of FoxP3+ CD4+ T cells among total live cells in the 
colon and cMLN, and as their absolute cell number. Error bars represent S.D.; statistical analysis was carried 
out using a Kruskal-Wallis test with a Dunn’s post-test for multiple comparisons. * p < 0.05.
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Finally, IFNγ+ CD8+ T cells were generally increased in frequency and number, though not 
always significantly, during S. Typhimurium infection in both the cMLN and colon (Figure 
6. 36). As seen with CD4+ T cells, this was not affected by blocking TIM4 (Figure 6. 36).
       
Figure 6. 36: CD8+ T cell responses in the cMLN and colon remain unchanged by TIM4 blocking during 
S. Typhimurium infection 
C57BL/6 mice were treated with 20 mg streptomycin by oral gavage and given 200 µg αTIM4 antibody or Rat 
IgG2a (ISO) by intraperitoneal (i.p.) injection 24 h before infection with 6 × 107 CFU S. Typhimurium (STM) 
per mouse, or treatment with PBS, by oral gavage. Two days p. i. cMLN and colons were harvested, cells 
stimulated with PMA and Ionomycin, and analysed by flow cytometry. (a) Representative plots showing 
IFNγ+ CD44+ CD8+ T cells in the cMLN, gated on single, live, CD45+, CD3+, CD8+ T cells. (b) Representative 
plots showing IFNγ+ CD8+ T cells in the colonic LP gated on single, live, CD45+, CD3+, CD8+ T cells. 
(c) Summary data are shown as the percentage of IFNγ+ (CD44+) CD8+ T cells among total live cells in the 
colon and cMLN, and as their absolute cell number. Error bars represent S.D.; statistical analysis was carried 
out using a Kruskal-Wallis test with a Dunn’s post-test for multiple comparisons. * p < 0.05.
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6.3 Discussion 
Instead of being ubiquitously expressed on DC, we found that TIM4 expression was tightly 
controlled. It was upregulated upon migration and remained high in the cMLN on CD11b+ 
DC. Furthermore, bacterial-induced inflammation increased its expression on DC in the 
colonic LP. However, it remains unclear whether or not the function of TIM4 in these 
different settings is limited to that of a PSR, or if its expression on DC is important in 
shaping adaptive immunity. We therefore tested three hypotheses to begin to address these 
questions; firstly, we postulated that if TIM4 expression on DC were required for efficient 
migration to the MLN, blocking TIM4 in vivo would reduce the number of migratory DC 
in the MLN. Secondly, having found that a sizeable proportion of DC expressed TIM4 in 
the MLN, we hypothesised that it played a role in antigen presentation. Lastly, as TIM4 is 
upregulated on DC during bacterial induced colonic inflammation, we determined if it was 
required for the induction of protective T cell responses in the cMLN and colon during 
infection. 
Previously, we had found that after photoconverting the proximal colon of Kaede mice, 
TIM4+ migratory DC in the cMLN showed a trend towards a higher percentage of 
Kaede-red+ cells compared with TIM4- DC. Using a similar approach, we quantified 
Kaede-red+ DC in the cMLN 48 h post photoconversion after having blocked TIM4 in vivo 
using an αTIM4 antibody. However, we found that this did not significantly change the 
migration efficiency of DC. It is possible, but unlikely, that this was caused by incomplete 
blocking of the molecule, as we showed antibody staining of TIM4 on cMLN DC was 
substantially decreased on DC. Moreover, previous investigations have successfully used 
this approach to abrogate TIM4 function in vivo (Yeung et al. 2013, Ji et al. 2014). The 
antibodies used for our investigations in vivo and for detection by flow cytometry were 
different clones, but both were originally raised against the entire extracellular domain of 
TIM4 (Nakayama et al. 2009, Yeung et al. 2013). There is a possibility, therefore, that they 
bind to the same epitope. While we attempted to determine if lack of TIM4 staining was 
due to epitope shielding by surface-bound antibody, we were unable to succeed technically, 
and further experiments would be required to confirm if this is indeed the case, or if TIM4 
is internalised upon antibody binding. We saw no overall changes in colonic LP DC 
population distribution, suggesting that in vivo administration does not selectively induce 
antibody-dependent depletion of TIM4+ cells. This was also confirmed by analysing 
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CD103+ DC in the lungs of αTIM4-treated animals, which have a much higher expression 
level than their colonic counterparts (data not shown). 
From our results, we cannot conclude that TIM4 has any role in directly mediating DC 
migration to the MLN. This is perhaps not surprising, given previous work that has 
demonstrated that mice lacking all major integrin homodimers do not exhibit any 
migratory defects (Lämmermann et al. 2008). Instead, DC migration to LN is chemokine 
driven and dependent on the expression of CCR7 (Förster et al. 1999). This ability to move 
independently of the cellular and tissue environment is underpinned by actin 
rearrangements that cause cellular protrusions independently of cell adhesion 
(Lämmermann et al. 2008). Furthermore, TIM4 expression on lymph DC is not 
ubiquitous, with between 20-40% expression depending on the tissue it is draining, which 
also speaks against a fundamental role in orchestrating migration.  
We next investigated if blocking TIM4 on MLN DC had any effect on antigen-specific 
T cell proliferation. However, OVA-specific CD4+ T cell proliferation was not impacted by 
blocking TIM4 in vitro. Further experiments confirming no dose-dependent effect would 
have been necessary to fully optimise this approach. The concentration of antibody was 
chosen based on previous work using different antibody clones that reported efficient 
inhibition of phagocytosis by blocking TIM4 in vitro (Kobayashi et al. 2007). However, 
subsequent publications detail use at six-fold (Nakayama et al. 2009) and even 20-fold 
(Yeung et al. 2013) concentrations for co-culture assays of CD11c+ cells with T cells. It is 
possible, therefore, that a higher concentration of antibody in our hands would have 
yielded different results. 
We were able to show, however, that blocking TIM4 in vitro slightly, but significantly, 
reduced the induction of CCR9 on proliferated CD4+ T cells by CD11b+ CD103+ MLN DC. 
Previously, we had been unable to ascertain if TIM4+ total CD11b+ MLN DC had any 
enhanced ability to induce CCR9 expression on CD4+ T cells in vitro, possibly due to the 
extended culture time of five days rather than three. This would be an important approach 
required to confirm our results. It would also be of interest to determine if this 
phenomenon is dose-dependent. CCR9 directs cell homing to the small intestine via 
interactions with its cognate chemokine ligand CCL25 (Svensson et al. 2002), which within 
the gastrointestinal tract is only expressed in the small intestinal epithelium (Kunkel et al. 
2000). The contribution of sMLN DC within the total MLN cells used in our experiment 
will be greater than that of cMLN DC, and it is therefore likely that our results mirror a 
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small intestinal rather than a colonic phenotype. This is consistent with the importance of 
CCR9 in small intestinal homing. However, to confirm this, it would be necessary to 
specifically sort sMLN and cMLN DC separately. Unfortunately, while not impossible, the 
small number of cMLN DC makes this a technically difficult task.  
Induction of CCR9 expression on T cells is dependent on RA production by CD103+ DC 
(Iwata et al. 2004, Jaensson et al. 2008). Previously we had found that TIM4+ CD11b+ 
CD103+ DC in the sMLN had a trend towards a higher percentage of Aldefluor+ cells, 
indicating greater RALDH activity in this population compared with TIM4- cells. This had 
not, however, been the case for cMLN DC. Moreover, Aldh1a2 transcript levels were 
similar in TIM4+ and TIM4- total CD11b+ DC from the sMLN, indicating that while their 
baseline capacity to make RA is unchanged, the actual production levels differ. 
Interestingly, CD103+ DC that have taken up apoptotic cell antigen in vivo have elevated 
levels of Aldh1a2 mRNA (Cummings et al. 2016), which indicates a possible link between 
the uptake of apoptotic cells and the production of RA by DC. The level of apoptosis taking 
place in our in vitro culture system is likely to be quite high, and blocking TIM4 on 
CD11b+ CD103+ DC could have decreased the rate of uptake by these cells. Further 
experiments would be required to confirm this, however. One important point to make 
when assessing the role of TIM4 on MLN DC is that, due to the higher proportion of 
sMLN DC in our culture system, the overall percentage of TIM4+ cells will be fairly low, 
given its lower expression on sMLN DC (20%) compared with their counterparts in the 
cMLN (40%). This could be one reason why the effect on CCR9 induction induced by 
blocking TIM4 was not very pronounced. 
RA signalling also imprints the expression of α4β7 on T cells (Iwata et al. 2004), the 
integrin that recognises MAdCAM-1 on vascular endothelial cells in the small intestine 
(Hamann et al. 1994). We did not, however, find that blocking TIM4 in vitro significantly 
reduced the expression of the β7 subunit on proliferating T cells. One caveat to 
interpreting these results is the absence of the α4 staining in our analysis. The β7 subunit 
can also dimerise with integrin αE, which together constitute the CD103 molecule. As a 
well-functioning antibody to the entire heterodimer is not yet commercially available to 
the best of our knowledge, it would have been important to include staining for CD103 to 
be confident in our identification of α4β7. Nonetheless, our findings suggest that TIM4 
function on DC does not play a role in its induction on T cells.  
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We could not find a role for TIM4 on any other MLN DC subset in the experimental 
readouts we investigated in this system, but the small number of repeats, especially for 
CD11b+ CD103- and CD11b- CD103- DC make sound conclusions impossible. To assess 
whether TIM4 is required functionally for cross-presentation and induction of homing 
markers on CD8+ T cells, we co-cultured OVA-pulsed CD11b- CD103+ DC with OT-I 
MLN cells in the presence of αTIM4 blocking antibody. However, blocking TIM4 had no 
effect on the proliferation or induction of CCR9 or β7 on antigen-specific CD8+ T cells. 
Together with our observations from evaluating homing markers on CD4+ T cells, these 
data indicate that TIM4 on MLN CD11b- CD103+ DC is not involved in this process. This 
also correlates with the lower expression level of TIM4 on CD11b- CD103+ DC compared 
with CD11b+ CD103+ DC in the MLN. 
We had hypothesised that TIM4 on DC might interact with T cells during antigen 
presentation via ligand binding to TIM1. However, we could only detect TIM1 staining on 
CD8+ T cells and not CD4+ T cells. One reason for this could be the lack of 
pro-inflammatory stimuli in our system. Previous identification of TIM1 on activated 
CD4+ T cells has either been limited to a very small percentage (de Souza et al. 2005), or 
induced after incubation with concanavalin A (Meyers et al. 2005), a strong polyclonal 
activation stimulus. Furthermore, Mizui et al. (2008) showed that activation of CD4+ 
T cells in vitro using αCD3/28 treatment led to an increase in TIM1 transcript but not 
protein levels, which is more in line with our findings of non-detectable TIM1 staining on 
antigen-specific CD4+ T cells. Moreover, in our hands expression on CD8+ T cells was 
limited to a small population of cells that had completed all rounds of replication detected 
through loss of CFSE staining, as well as a population of unproliferated cells. Together with 
the fact that blocking TIM4 in OT-I co-cultures did not reduce proliferation, these results 
do not provide any evidence that interactions between TIM1 and TIM4 occur or are vital 
for T cell proliferation under steady state conditions in vitro. This may, however, change in 
a pro-inflammatory setting afforded, for example, by bacterial infection. Future 
investigations should take this into account. 
Our final hypothesis was that TIM4 played a role in determining DC functions during 
bacterial-induced inflammation in the colon. We therefore compared the inflammation 
caused during infection with two different enteric pathogens, C. rodentium and 
S. Typhimurium, and its dependency on TIM4 in vivo by administering systemic αTIM4 
blocking antibody. We did not see a significant difference in bacterial colonisation during 
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C. rodentium infection, suggesting that the host’s ability to take up apoptotic cell material 
through TIM4 is not a limiting factor in bacterial colonisation and replication. 
Furthermore, animal weight loss was comparable between groups during S. Typhimurium 
infection, as was colon shortening. These findings indicate that blocking TIM4 has no 
effect on the course or overall severity of infection. It would, however, have been useful to 
assess the pathology exhibited in the different groups by histological examination of 
colonic tissue, thus affording a more detailed comparison of outcome.  
S. Typhimurium-infected mice displayed a trend towards more TIM4+ cells among CD11b+ 
CD103+ and CD11b- CD103- colonic DC. We had previously seen a similar effect on 
CD11b+ CD103- DC during C. rodentium infection. Interestingly, however, 
S. Typhimurium-infected mice also exhibited a trend towards decreased TIM4 expression 
on cMLN CD11b+ CD103+ DC, which had not previously been found during infection with 
C. rodentium. These differences may stem from the heightened severity of inflammation 
caused by S. Typhimurium. There is evidence to suggest that metabolites enriched in the 
MLN during S. Typhimurium infection can lead to lymphocyte apoptosis (Hulme et al. 
2017). Furthermore, mice lacking the ACR CD300a exhibited greater bacterial 
dissemination after infection with S. Typhimurium (Nakahashi-Oda et al. 2015), indicating 
that the uptake of apoptotic cells is important for limiting systemic spread of bacteria. 
Based on these observations, it appears counterintuitive that expression of an ACR would 
decrease in the cMLN during infection. However, this reduction could also be caused by 
selective killing of TIM4+ DC by S. Typhimurium after uptake of infected apoptotic cells, 
given the ability of this pathogen to induce caspase-1-dependent cell death in CD11c+ cells 
(van der Velden et al. 2003) and macrophages (Hersh et al. 1999). Determining the number 
of viable S. Typhimurium in TIM4+ and TIM4- MLN DC during infection could begin to 
give some indication of whether or not this is a valid hypothesis. On the other hand, we did 
not detect a significant decrease in the number of cMLN CD11b+ CD103+ DC during 
infection, which would be expected if this hypothesis were indeed true. Furthermore, 
blocking TIM4 in S. Typhimurium-infected animals did not have any effect on percentages 
or cell number of any DC population in the colonic LP or cMLN. Similarly, infection with 
C. rodentium also did not alter the distribution of DC populations in these tissues.  
Transcript levels of Ccr7, Il1b and Itgb8 in CD11b- CD103+ colonic DC did not change after 
blocking TIM4 in C. rodentium infected animals, indicating that TIM4-mediated uptake of 
apoptotic cells during infection has little impact on CD11b- CD103+ DC activation. Further 
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investigation would be required with a broader approach in gene expression profiling and 
with an appropriate control constituted by C. rodentium-infected mice treated with isotype 
control antibody to investigate this fully, however. On the other hand, it could be indicative 
of a less prominent role of these DC in mediating TIM4-mediated uptake of apoptotic cells 
during infection. This is especially plausible given that TIM4 expression does not increase 
on this subset during infection, when it does on colonic CD11b+ CD103- DC. It would have 
therefore been interesting to investigate if blocking TIM4 alters gene expression in these 
cells, and although attempted during our investigation, this was not successful technically. 
Both C. rodentium and S. Typhimurium induced an elevated influx of Ly6C+ monocytes 
into the colonic LP. However, in C. rodentium infected mice that had received αTIM4 
antibody, this increase was not statistically significant, indicating a slightly less pronounced 
response. Interestingly, this trend was reversed during S. Typhimurium infection, with 
αTIM4-treated mice showing a significant increase in Ly6C+ MHCII+ monocytes 
compared with uninfected controls, while the increase in isotype-treated infected animals 
did not reach statistical significance. These results require confirmation by further repeats, 
but may indicate that blocking TIM4 impacts inflammation severity differently during 
C. rodentium and S. Typhimurium infection. 
Even though we were unable to provide any evidence for the regulation of steady state 
T cell proliferation by TIM4-TIM1 interactions in vitro, TIM4-mediated interactions with 
T cells may still be important in vivo during inflammation. Given that TIM4 has been 
implicated in the negative regulation of T cell activation (Mizui et al. 2008, Cao et al. 2011), 
the decreased percentage of TIM4+ CD11b+ CD103+ DC in the cMLN of S. Typhimurium 
infected mice could be required for allowing adequate activation for mounting a protective 
immune response. We did not find, however, that blocking TIM4 in vivo during infection 
with either S. Typhimurium or C. rodentium had any effect on T cell differentiation. While 
we could show that S. Typhimurium induced a more robust IFNγ response in both CD4+ 
and CD8+ T cells than C. rodentium, this was independent of TIM4 function. However, to 
fully discount an inhibitory role for TIM4 in this context, further investigations would be 
necessary involving constitutive expression of TIM4 on DC. Previous work has shown that 
the induction of apoptosis during C. rodentium infection is required for the development 
of a Th17 response in vivo (Torchinsky et al. 2009), pointing to a possible role for TIM4 in 
facilitating this. Conversely, plate-bound TIM4-Fc can reduce IL-17 production from naïve 
T cells cultured under Th17-differentiating conditions in vitro (Cao et al. 2011). We could 
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not, in fact, find any evidence that Th17 induction during C. rodentium infection was 
either dependent on or negatively regulated by TIM4. The lack of any difference between 
αTIM4- and isotype-treated animals in the level of neutrophil influx into the colon during 
C. rodentium infection further suggests that TIM4 does not play a vital role in IL-17-
mediated pathology. Previously, blocking TIM4 in vivo has been shown to increase Treg 
cell expansion in a skin allograft model (Yeung et al. 2013). We showed that Treg cell 
frequencies decreased significantly in the cMLN during C. rodentium infection in mice that 
had received isotype control, but not αTIM4 antibody. A similar proportional decrease was 
seen during S. Typhimurium infection compared with PBS controls, but in the colonic LP 
rather than the cMLN.  In both cases this was not mirrored by absolute cell numbers, 
suggesting instead increased expansion of another cell type, such as possibly B cells, during 
infection. Nevertheless, as seen for both Th1 and Th17 responses, blocking TIM4 did not 
significantly change the Treg response during infection.  
A problem faced in these investigations was the high variability encountered between 
individual mice. This could be due to differences in colonisation or development of 
infection, and could be overcome with more experimental repeats. Furthermore, the cell 
death pathways initiated during bacterial infection are likely to not only be represented by 
apoptosis, but also be comprised of responses such as necrosis and pyroptosis. Little is as 
yet known about the role of TIM4 in mediating uptake of cells that have undergone cell 
death via apoptosis distinct mechanisms. This could be a further factor increasing the 
variability observed in this in vivo approach. However, the at times low level detection of 
intracellular cytokines produced by T cells and the resulting variability between samples 
could also stem from technical issues. The use of PMA and Ionomyin to activate T cells 
and stimulate cytokine production, while routinely used, is also not a highly physiologically 
relevant indication of the differentiation state of T cells upon restimulation. In order to 
address this, a better approach would be to mimic restimulation by incubating T cells with 
αCD3 and αCD28 antibodies. Alternatively, transcription factor staining can be used to 
discriminate between T cell subsets. Finally, the use of bacteria expressing a model antigen 
would have allowed identification of antigen-specific T cells and a more accurate 
indication of whether or not blocking TIM4 has an effect on T cell priming during 
infection. 
In conclusion, we were unable to clearly identify a functional role for TIM4 in mediating 
DC migration, antigen presentation, or control of innate and adaptive responses during 
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bacterial infection in the intestine. Our results do, on the other hand, point to the 
possibility that TIM4+ DC might be important in the induction of CCR9 on T cells. Further 
work will be needed to determine if this is the case in vivo and, supposing this is limited to 
the sMLN, what the function of the more abundant TIM4+ DC is in the cMLN, where RA 
production plays a less prominent part in orchestrating mucosal immunity.
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Chapter 7: Final discussion and conclusions 
7.1 Final discussion  
We have investigated some of the cellular and molecular mechanisms that underpin 
bacterial infection and the induction of inflammation in the intestinal mucosa. Specifically, 
we characterised the intestinal immune response to infection with CD-associated AIEC 
strain NRG857c. We have also used infection with C. rodentium and S. Typhimurium to 
better understand the role of apoptotic cell antigen uptake in regulating T cell responses 
during inflammation. Whilst C. rodentium and S. Typhimurium are specialised enteric 
pathogens that employ a range of virulence factors facilitating robust colonisation and 
invasion, NRG857c is a commensal thought to have the capacity to act as a pathobiont 
under certain circumstances. 
Previous work had demonstrated a significant level of chronic inflammation induced by 
NRG857c infection of WT mice after perturbation of the microbiota using a single 
treatment with oral streptomycin (Small et al. 2013). In order to further elucidate the 
cellular mechanisms of inflammation in this model, we performed a comprehensive 
characterisation of the intestinal immune response to infection with NRG857c in vivo. We 
showed that NRG857c was indeed able to colonise the lumen of mice and be shed in the 
faeces for up to nine weeks after infection. However, this was not accompanied by any 
signs of weight loss or tissue pathology in mice. Moreover, infection did not alter the 
frequency or number of infiltrating innate or adaptive immune cell populations in the LP. 
We also found no evidence for increased number or activation of T cells in the MLN. These 
observations indicate that NRG857c infection in our hands is not sufficient to drive 
chronic tissue inflammation. When we additionally caused perturbations in intestinal 
homeostasis by feeding mice a diet deficient in fibre, we did not observe any induction of 
intestinal inflammation by NRG857c. Furthermore, treatment with low-level DSS also did 
not enhance this strain’s ability to invade and cause immune activation. Therefore, despite 
our extensive attempts to detect signs of inflammation both at steady state and after 
disruption of intestinal homeostasis by insult or lack of SCFA, we conclude that NRG857c 
does not cause chronic intestinal inflammation. This critical observation thereby denies the 
fulfilment of the Henle-Koch postulates (Carter 1985) by this strain of E. coli. While our 
work supports the hypothesis that AIEC, whilst correlative, is not causative in CD, the 
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limitations of comparing murine models with the human disease setting cannot be 
overlooked. Our model fails to account for differences in microbiota composition between 
mice and humans, as well as the role of prior insults and the contribution of host 
susceptibility factors. Moreover, great heterogeneity exists within both clinical presentation 
and disease-associated genetic risk in CD. Murine models only allow limited investigation 
of the pathogenic mechanisms involved, and there is therefore a need for more detailed 
study of the interaction between these factors and the microbiota in well-defined patient 
cohorts.  
Given the elevated rate of apoptosis that occurs in the inflamed mucosa of IBD patients, we 
next carried out an in-depth characterisation of the expression of ACR, specifically TIM4, 
on DC and macrophage populations. We found that TIM4 is expressed on a subset of 
mature macrophages in the small intestine and colon (Figure 7. 1). Moreover, about 10% of 
cDC1 in the colon (Figure 7. 1) and 90% of cDC1 in the lung expressed TIM4, highlighting 
a potentially important role of this molecule in mediating the uptake of apoptotic cell 
antigen for cross-presentation by cDC1 at mucosal sites. All DC populations were shown 
to upregulate TIM4 upon migration in mesenteric lymph (Figure 7. 1), and cDC2 further 
increased expression once in the cMLN. CD11b+ CD103+ DC had the highest frequency of 
TIM4+ cells in both sMLN and cMLN compared with the other migratory DC populations 
(Figure 7. 1). Across the LP, lymph and MLN, more colonic DC expressed TIM4 than small 
intestinal DC, indicating that TIM4 is not only controlled in a population specific manner, 
but is also tissue-dependent. We were not, however, able to show any role for IL-4 or 
TGFβR signalling on DC, or the microbiota in controlling TIM4 expression in vivo. 
Instead, C. rodentium infection did increase the percentage of TIM4+ cells among colonic 
LP CD11b+ CD103- and CD11b- CD103- DC. 
7. Final discussion and conclusions 
 
235 
 
Figure 7. 1: Expression pattern of TIM4 on MNP in the intestine and potential tissue-dependent 
functions 
Schematic representation of the small intestinal and colonic LP, lymphatics and MLN, showing cell 
populations that express TIM4 in the various tissues. In the LP of both small intestine and colon, TIM4 is 
expressed by macrophages, but only colonic CD11b- CD103+ express TIM4. All migratory DC populations 
upregulate TIM4 in lymph, and the frequency of TIM4+ cDC2, especially CD11b+ CD103+ further increases 
in the MLN. Inset boxes give an overview of potential functions mediated by TIM4 on DC in the various 
tissues.  
Taken together, these data indicate that TIM4 may have context-dependent roles on DC 
(Figure 7. 1). In the LP, TIM4 is likely to function as a bona fide PSR and facilitate the 
uptake of apoptotic cells both in the epithelium and the LP by macrophages and cDC1 
(Figure 7. 1). We found that TIM4+ cDC1 had higher expression levels of Ccr7 and Il1b 
mRNA, indicating that they may be more mature and ready to migrate to the MLN. 
However, more work will be required to fully understand the downstream effects of 
apoptotic cell uptake via TIM4 in these cells. For example, it remains unclear if these could 
be mediated by TIM4 itself, of which as yet no intrinsic signalling capability has been 
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reported, or if TIM4-mediated phagocytosis and subsequent activation of autophagy-
associated pathways may play a role in DC maturation. Our observation that the frequency 
of TIM4+ DC increases during infection with C. rodentium in a population-specific manner 
indicates that it may have further important functions during bacterial-induced intestinal 
inflammation. In this context, the elevated expression of TIM4 may be due to the increased 
levels of TLR ligands and activation of downstream MyD88 signalling. It could also be 
controlled by a cell-intrinsic mechanism, where phagocytic uptake of apoptotic cells during 
infection leads to upregulation of the PSR on the cell membrane. However, more in depth 
in vitro and in vivo approaches will be required to elucidate what mechanisms control 
TIM4 expression in this setting. Blocking TIM4 in vivo had no effect on the generation of 
protective Th17 responses in C. rodentium infected mice, indicating that despite the 
increase in expression, TIM4 is likely to play a redundant role together with other ACR in 
sampling apoptotic cell antigen in the LP and supporting Th17 cell differentiation. 
Furthermore, the innate protective responses in these mice characterised by the influx of 
monocytes or neutrophils to the LP were also not significantly changed after blocking 
TIM4. 
Together with the observations that TIM4+ LP cDC1 have higher Ccr7 mRNA levels than 
their TIM4- counterparts, and that an increased frequency of DC express TIM4 in 
mesenteric lymph compared with the LP, we hypothesised that TIM4 is important during 
DC migration to the MLN. This could be supported by integrin binding on lymphatic 
endothelial cells via the RGD motif in its IgV domain, or by interactions between the 
highly glycosylated mucin domain and other glycoproteins on the endothelium (Figure 7. 
1). However, blocking TIM4 in vivo did not significantly decrease the migration efficiency 
of DC, indicating that while these interactions may indeed play a part in supporting DC 
entry into, migration through, or exit out of the lymphatics, TIM4 is not essential for these 
functions. Again, the lack of an effect after TIM4 blockade may reflect the large amount of 
redundancy for cell adhesion molecules in DC migration, which to date has been shown 
only to be dependent on CCR7 (Lämmermann et al. 2008). A second possible role for 
TIM4 on migrating DC in lymph is its ability to bind PS on exosomes (Miyanishi et al. 
2007, Nakai et al. 2016). These can traffic via the lymphatics (Srinivasan et al. 2016) and 
have indeed been found to be present in substantial quantities in mesenteric lymph 
(Milling, personal communication). While the ability of DC to take up antigen after the 
initiation of migration to the MLN has not yet been demonstrated, TIM4-mediated 
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exosome uptake represents an intriguing possibility that warrants further investigation 
(Figure 7. 1).  
We found that both migratory and resident DC populations express TIM4 in the MLN. In 
this context it may serve several purposes. First, TIM4 could allow for antigen transfer 
from apoptotic DC to either resident or newly arrived migratory DC (Figure 7. 1). 
However, we were unable to test this hypothesis in vitro or in vivo and further work will be 
required to ascertain if this indeed takes place and if so, what downstream effects on T cell 
differentiation this might have. On the other hand, we did find that TIM4+ CD11b+ 
CD103+ sMLN DC had higher RALDH activity than their TIM4- counterparts and that 
blocking TIM4 on CD11b+ CD103+ MLN DC in vitro led to a small, but significant, 
reduction in the induction of CCR9 expression on antigen-specific CD4+ T cells. Given that 
this is a small intestinal homing marker (Stenstad et al. 2006, Jaensson et al. 2008), but the 
frequency of TIM4+ DC is higher in the cMLN compared with the sMLN, the relevance of 
these findings, especially with respect to cMLN DC, is unclear. More in-depth investigation 
in relation to these observations will be required to fully ascertain if TIM4-mediated uptake 
of apoptotic cell antigen in the MLN indeed stimulates the production of RA by DC, and 
what other downstream effects this might have in the cMLN, where this metabolite plays a 
less important role.  
A substantial, but somewhat contradictory, body of literature exists in support of 
interactions between TIM4 and TIM1 on T cells being important positive or negative 
regulators of T cell activation and differentiation. We were unable to show that TIM1 was 
upregulated upon antigen-specific activation of CD4+ T cells, although we could detect it 
on a small population of proliferated CD8+ T cells in vitro. TIM4+ DC did not show any 
altered ability to prime and skew antigen-specific CD4+ T cell responses in vitro compared 
with TIM4- DC. Moreover, blocking TIM4 on MLN DC also had no effect on the 
proliferation of CD4+ or CD8+ T cells in vitro. We therefore do not have any evidence to 
support the hypothesis that TIM4 binding of TIM1 acts as a co-stimulatory or inhibitory 
signal at steady state. Nevertheless, this could become evident in settings of inflammation. 
Indeed, mice infected with S. Typhimurium had a reduced frequency of CD11b+ CD103+ 
DC that expressed TIM4 in the cMLN compared with uninfected controls. We were unable 
to show, however, that blocking TIM4 had a significant effect on altering T cell 
differentiation in mice infected with S. Typhimurium or C. rodentium.  
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A number of open questions therefore remain regarding the function of TIM4 on MLN DC 
during steady state and inflammation. Even though our functional investigations did not 
yield any significant findings, the observation that TIM4 is enriched on CD11b+ CD103+ 
DC in the migratory population indicates that it may have a role in regulating the function 
of these DC. Further work comparing its expression of other ACR on this population, as 
well as transcriptomic profiling of CD11b+ CD103+ MLN DC from Timd4-/- and WT mice 
would help to further shed light on this issue. 
7.2 Final conclusion 
Herein we have provided evidence that the expression pattern of the ACR TIM4 on murine 
DC is both tissue- and subset-specific. While enriched on cDC1 in the mucosa of lung and 
colon, it is upregulated on all DC populations in mesenteric lymph and remains high on 
cDC2 in the cMLN. We were unable to investigate its role on DC in a chronic intestinal 
inflammatory setting due to the failure to demonstrate that CD-associated AIEC strain 
NRG857c induced intestinal disease in mice. We instead showed that TIM4 expression 
increases on LP DC during C. rodentium infection, but showed that it does not play an 
essential role in DC migration or the induction of protective T cell immunity to enteric 
bacterial pathogens. Having therefore begun to characterise this molecule’s expression and 
function in the murine intestine, further work will be required to understand its role on 
human MNP in the healthy gut and during IBD, where recognition of apoptosis and the 
clearance of bacteria are likely to be vital for disease remission.
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